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Mechanical cues have been shown to influence cell gene expression, cell protein 
expression, and cell behaviors critical for homeostasis and disease progression. Cells 
experience the mechanical cue of confinement in vivo, such as within the extracellular 
matrix, and in vitro, such as within tissue engineered scaffolds. Despite its prevalence, 
the impact of mechanical confinement on cell fate is poorly understood. Cues from the 
mechanical microenvironment are primarily sensed and responded to by the 
cytoskeleton, which transmits forces to the nucleus and can thereby alter gene 
expression. The nucleus itself is also a mechanosensor, sensing external forces and again 
altering gene expression. Mesenchymal stem cells (MSCs) and lung fibroblasts are 
known to be sensitive to mechanical forces, yet the effect of mechanical confinement 
on these cells is unclear.  
In this dissertation, we investigated how mechanical confinement induced by 





show that confinement alters the relative contributions of cytoskeletal and contractile 
machinery in MSC migration in unconfined and confined spaces. We next investigated 
how mechanical confinement induced by microchannels influences MSC and fibroblast 
nucleus volume. When certain cytoskeletal machinery was inhibited, nucleus volume 
was altered only in MSCs in wide channels, suggesting diverging roles of the 
cytoskeleton in regulating nuclear deformation and migration in different degrees of 
confinement and in different cell types. While performing this work, we observed a lack 
of assays that provide precise control over the degree of confinement induced on cells, 
yield a large sample size, enable long-term culture, and enable easy visualization of cells 
over time. Therefore, we designed, created, and validated a confining micropillar assay 
that achieves these requirements. Using these confining micropillars, we investigated 
the effect of confinement on lung fibroblast to myofibroblast transition (FMT), a 
hallmark of idiopathic pulmonary fibrosis. Cell density was more predictive of FMT 
than the degree of confinement induced by micropillar arrays. These results improve 
our understanding of how MSCs and lung fibroblasts respond to confinement, which 
















THE IMPACT OF ENGINEERED MECHANICAL CONFINEMENT ON 














Dissertation submitted to the Faculty of the Graduate School of the 
University of Maryland, College Park, in partial fulfillment 
of the requirements for the degree of 













Assistant Professor Kimberly M. Stroka, Chair 
Assistant Professor Gregg Duncan 
Professor John P. Fisher 
Professor Wolfgang Losert 






























© Copyright by 


















 So many people have helped me throughout the making of this dissertation. 
While I cannot exhaustively thank everyone who has assisted me along the way, I will 
try. 
 I would like to thank Dr. Kim Stroka for her endless support, optimism, and 
mentorship. She has taught me valuable lessons about science, life, and everything in 
between. I will be happy if I can be a fraction of the wonderful woman she is.  
 Thank you to Dr. Helim Aranda Espinoza for convincing me that maybe I’m an 
alright scientist, and for teasing me on a constant basis. Your sense of humor, 
conversation, and support helped get me through the last year of my PhD. 
 I would like to thank my lab mates, past and present. Dr. Kelsey Gray for her 
support and the joy she brought to lab. Dr. Marina Pranda for her sense of humor and 
diversions throughout the day. Ariana Decastro for being an ideal travel partner and 
staying grounded when some of us are not so much. Dr. Li Yan for her kind spirit. 
Rebecca Moriarty for being a true friend, an excellent conversationalist, and an amazing 
scientist.  
 I would like to thank all my friends within the department, especially Michelle 
Bookstaver, Emily Gosselin, and Sarah Van Belleghem for their support and for 
continuing to be my friends even after living with me for a whole year. Also thank you 
to my incredible friends Sarah Williams, Molly O’Lena, Sara Goss, Lucy Lee, and 
Sophie Stypeck for their love and for being the most fun people I know. 
 I would like to thank my boyfriend’s family, of which there are too many to list, 
who have accepted me into their family with such open arms. Specifically, I would like 
iii 
 
to thank Kim, Keith, Glee, Gail, and Austin for their love and support, which includes 
letting me hang around their house in my pajamas all day while eating all their food. 
 I would like to thank my parents, Eileen and Len, for being the best role models 
anyone could ask for. Thank you to my mom for listening to me gripe when I was down 
and celebrating with me when I was up. Thank you for making me laugh, keeping me 
sane, always knowing what to say, and being an inspiration. I hope to be as cool of a 
woman as you are. Thank you to my dad for instilling in me a love of learning, 
knowledge, and science and for showing me the power of calm and logical thinking. I 
would never have obtained a PhD if not for his work ethic, support, and guidance, and 
because I value his opinion so deeply.  
 I would also like to thank my sister, Tricia, and my brother, Kyle, for always 
supporting me and being the second best role models anyone could ask for (sorry, Mom 
and Dad come first, you understand). Thank you to Kyle for being the funniest human 
I know, always showing me new music and games, and accepting me as I am without 
question. Thank you to Tricia for showing me how to advocate for myself without 
shame and showing me that it is possible to be smart, sophisticated, and a complete 
goofball. Also thank you to their partners, Jess and Anthony, for being so kind and fun 
and for not judging our family (at least not out loud). 
 Finally, I would like to thank my boyfriend and best friend, Brandyn Mark, for 
being my partner through this whole journey. He makes me laugh every day and helps 
me put things in perspective. Thank you for taking care of me when I was too busy to 
do it myself. Thank you for encouraging me, listening to me, and making sure I relax 
iv 
 
and have fun. Thank you for doing all of this while working hard and going to school 
yourself. Your perseverance in achieving your goals inspires me. 
 Oh, and thank you to my cat Farrah, for sitting on my laptop whenever I need to 




I would like to thank and acknowledge the following: 
• Dr. Kim Stroka for her mentorship and feedback regarding results, data analysis, 
manuscript editing, and data presentation. 
• My committee members Dr. John Fisher, Dr. Gregg Duncan, Dr. Giuliano 
Scarcelli, and Dr. Wolfgang Losert for their continued support and feedback. 
• The University of Maryland Imaging Core Facility for providing resources for 
confocal imaging.  
• The BioWorkshop core facility in the Fischell Department of Bioengineering at 
the University of Maryland for confocal microscope, plate reader, and gel 
imager resources. 
• The Maryland NanoCenter at the University of Maryland: its FabLab for 
providing photolithography resources and its AIMLab for providing SEM 
resources. 
Chapter 2 
• Rebecca Moriarty for co-authoring several sections in this chapter. 
Chapter 4 
• Thea Ornstein for her work on setting up experiments, imaging cells, and co-
authoring the introduction and methods of this section. 
Chapter 5 





• Katelyn Kunert for her work on experiments and analysis of MSCs treated with 
Trichostatin A. 
• Dr. Daniel Conway for providing the adenovirus and lentivirus DN-KASH 
constructs and continued support in its use. 
• Dr. Alexander Dunn and Steven Tan for providing the FRET tension sensor and 
consistent support in its use. 
Funding sources 
• University of Maryland 
o Graduate School Summer Fellowship 
o Graduate School Jacob K. Goldhaber Travel Awards 
• BMES Student Travel Award 





Table of Contents 
Personal Acknowledgements ......................................................................................... ii 
Scientific Acknowledgements ........................................................................................ v 
Table of Contents ......................................................................................................... vii 
List of Tables .................................................................................................................. x 
List of Figures ............................................................................................................... xi 
List of Abbreviations .................................................................................................. xiii 
Chapter 1: Introduction ................................................................................................... 1 
Chapter 2: Background ................................................................................................... 6 
2.1 Mesenchymal stem cells ....................................................................................... 6 
2.2 Idiopathic pulmonary fibrosis ............................................................................... 8 
2.2.1 Introduction to idiopathic pulmonary fibrosis ............................................... 8 
2.2.2 Mechanosensing in FMT ............................................................................. 10 
2.2.3 Mesenchymal stem cell therapies for IPF .................................................... 11 
2.3 Confinement ........................................................................................................ 12 
2.3.1 Clinical relevance of confinement ............................................................... 12 
2.3.2 Mechanosensing of confinement ................................................................. 14 
2.4 The cytoskeleton response to confinement ......................................................... 16 
2.5 The nucleus response to confinement ................................................................. 17 
2.6 Cellular confinement assays ............................................................................... 22 
2.7 Effect of confinement on MSC behaviors .......................................................... 24 
2.7.1 Morphology.................................................................................................. 24 
2.7.2 Migration...................................................................................................... 25 
2.7.3 Invasiveness ................................................................................................. 27 
2.7.4 Differentiation .............................................................................................. 28 
2.7.5 Cell secretome .............................................................................................. 30 
2.7.6 Gene and protein expression ........................................................................ 31 
2.8 Conclusion .......................................................................................................... 32 
Chapter 3: Physical confinement alters cytoskeletal contributions towards human 
mesenchymal stem cell migration ................................................................................. 34 
3.1 Introduction ......................................................................................................... 34 
3.2 Materials and Methods ........................................................................................ 36 
3.2.1 Cell culture and reagents .............................................................................. 36 
3.2.2 Microfluidic device fabrication .................................................................... 37 
3.2.3 Migration experiments ................................................................................. 38 
3.2.4 Immunofluorescence .................................................................................... 39 
3.2.5 Data analysis ................................................................................................ 40 
3.2.6 Statistical analysis ........................................................................................ 41 
3.3 Results ................................................................................................................. 41 
3.3.1 Confinement alters MSC morphology ......................................................... 41 
3.3.2 Passage number alters MSC speed and chemotactic index in response to 
confinement........................................................................................................... 45 
3.3.3 Inhibition of microtubule polymerization does not affect MSC migration in 
confinement........................................................................................................... 49 
3.3.4 Inhibition of myosin II-mediated contractility enhances MSC migration ... 55 
viii 
 
3.3.5 Inhibition of ROCK enhances MSC migration in wide channels ................ 55 
3.3.6 Inhibition of actin polymerization completely disrupts MSC migration ..... 61 
3.3.7 pY-paxillin-positive focal adhesions are mostly absent in MSCs migrating 
in confinement. ..................................................................................................... 63 
3.4 Discussion ........................................................................................................... 67 
3.5 Conclusion .......................................................................................................... 74 
Chapter 4: Nuclear Deformation in Response to Mechanical Confinement is Cell Type 
Dependent ..................................................................................................................... 75 
4.1 Introduction ......................................................................................................... 75 
4.2 Materials and methods ........................................................................................ 78 
4.2.1 Cell culture and reagents .............................................................................. 78 
4.2.2 Microfluidic device manufacturing and cell seeding ................................... 79 
4.2.3 Immunofluorescence .................................................................................... 81 
4.2.4 Imaging ........................................................................................................ 82 
4.2.5 Data analysis in 2D ...................................................................................... 82 
4.2.6 Data analysis in 3D ...................................................................................... 83 
4.2.7 Statistical Analysis ....................................................................................... 84 
4.3 Results ................................................................................................................. 84 
4.3.1 Nuclear deformation as a function of confinement is cell type-dependent . 84 
4.3.2 Nuclear deformation in 3D is cell type-dependent ...................................... 88 
4.3.3 Microtubule polymerization is not necessary to maintain nuclear 
morphology in confinement .................................................................................. 94 
4.3.4 Myosin II contractility is not necessary to maintain nuclear morphology in 
confinement......................................................................................................... 101 
4.4 Discussion ......................................................................................................... 108 
4.5 Conclusion ........................................................................................................ 113 
Chapter 5: Integration of Mesenchymal Stem Cells into a Novel Micropillar 
Confinement Assay ..................................................................................................... 114 
5.1 Introduction ....................................................................................................... 114 
5.2 Materials and Methods ...................................................................................... 116 
5.2.1 Cell culture and reagents ............................................................................ 116 
5.2.2 Micropillar device fabrication .................................................................... 117 
5.2.3 Scanning electron microscopy ................................................................... 119 
5.2.4 Immunofluorescence .................................................................................. 119 
5.2.5 Migration experiments ............................................................................... 120 
5.2.6 Data analysis .............................................................................................. 120 
5.2.7 Statistical analysis ...................................................................................... 121 
5.3 Results ............................................................................................................... 121 
5.3.1 MSCs completely infiltrate into micropillar arrays ................................... 121 
5.3.2 Cell density is consistent across micropillar spacings in short-term culture
............................................................................................................................. 126 
5.3.3 Cell and nucleus morphology within micropillars is altered by micropillar 
spacing ................................................................................................................ 128 
5.3.4 MSC cytoskeletal elements become more diffuse with increasing 
confinement......................................................................................................... 135 
5.3.5 MSCs migrate within micropillar arrays .................................................... 138 
ix 
 
5.4 Discussion ......................................................................................................... 144 
5.5 Conclusion ........................................................................................................ 150 
Chapter 6:  Fibroblast to myofibroblast transition is cell density dependent ............. 152 
6.1 Introduction ....................................................................................................... 152 
6.2 Materials and methods ...................................................................................... 154 
6.2.1 Cell culture ................................................................................................. 154 
6.2.2 Fibroblast to myofibroblast transition ........................................................ 155 
6.2.3 Micropillar array fabrication ...................................................................... 155 
6.2.4 Immunofluorescence .................................................................................. 156 
6.2.5 Cell lysis..................................................................................................... 157 
6.2.6 Western blotting ......................................................................................... 158 
6.2.7 MSC-CM.................................................................................................... 159 
6.3 Results ............................................................................................................... 159 
6.3.1 TGF-β1 concentration and incubation time alters α-SMA expression within 
HLFs ................................................................................................................... 159 
6.3.2 HLF seeding density alters α-SMA expression within HLFs .................... 162 
6.3.3 HLF seeding density, but not TGF-β1, alters OB-cadherin expression ..... 164 
6.3.4 Confinement does not affect FMT ............................................................. 165 
6.3.5 MSC-CM does not affect FMT .................................................................. 169 
6.4 Discussion ......................................................................................................... 170 
6.5 Conclusion ........................................................................................................ 173 
Chapter 7:  Conclusions and contributions to science ................................................ 175 
7.1 Physical confinement alters cytoskeletal contributions towards human 
mesenchymal stem cell migration ........................................................................... 175 
7.2 Nuclear deformation in response to physical confinement is cell type dependent
................................................................................................................................. 175 
7.3 Micropillar arrays successfully confine cells .................................................... 176 
7.4 Lung fibroblast to myofibroblast transition is dependent on cell density, but not 
confinement............................................................................................................. 177 
7.5 Concluding remarks .......................................................................................... 177 
7.6 Contributions to the field .................................................................................. 178 
7.6.1 Scientific contributions to the field ............................................................ 178 
7.6.2 Scientific contributions to the Stroka lab ................................................... 179 
7.6.3 Peer-reviewed journal publications ............................................................ 180 
7.6.4 Conference presentations ........................................................................... 181 
Chapter 8:  Future Work and Outlook ........................................................................ 183 
8.1 Traction forces in confined migration and the fibroblast to myofibroblast 
transition ................................................................................................................. 183 
8.2 The role of the LINC complex in confinement ................................................. 184 
8.3 Role of chromatin condensation in confined MSC migration and nucleus 
volume..................................................................................................................... 185 
8.4 Effect of confinement on lamin A/C expression and MSC multipotency ........ 187 
8.5 Effect of MSC co-culture on fibroblast differentiation ..................................... 189 
8.6 Outlook ............................................................................................................. 190 
Appendix ..................................................................................................................... 191 
Bibliography ............................................................................................................... 193 
x 
 
List of Tables 
Chapter 3 
Table 3.1 MSCs migrate with different mechanisms in narrow channels than in  
wide channels.  
Chapter 4 
Table 4.1 Statistics for nucleus area for MSCs, L929 cells, and MDA-MB-231 cells. 
Table 4.2 Statistics for nucleus minor axis for MSCs, L929 cells, and MDA-MB-231 
 cells. 
Table 4.3 Statistics for nucleus major axis for MSCs, L929 cells, and MDA-MB-231 
 cells. 
Table 4.4 Statistics for MSC nucleus dimensions. 
Table 4.5 Statistics for MSC nucleus dimensions. 
Table 4.6 Statistics for L929 cell nucleus dimensions. 
Table 4.7 Statistics for L929 cell nucleus dimensions. 
Table 4.8 Statistics for MSC nucleus dimensions when treated with 10 μM nocodazole 
 or vehicle control. 
Table 4.9 Statistics for MSC nucleus dimensions when treated with 10 μM nocodazole 
 or vehicle control. 
Table 4.10 Statistics for L929 cell nucleus dimensions when treated with 10 μM  
nocodazole or vehicle control. 
Table 4.11 Statistics for L929 cell nucleus dimensions when treated with 10 μM  
nocodazole or vehicle control. 
Table 4.12 Statistics for MSC nucleus dimensions when treated with 50 μM blebbistatin 
 or vehicle control. 
Table 4.13 Statistics for MSC nucleus dimensions when treated with 50 μM blebbistatin 
 or vehicle control. 
Table 4.14 Statistics for L929 cell nucleus dimensions when treated with 50 μM  
blebbistatin or vehicle control. 
Table 4.15 Statistics for L929 cell nucleus dimensions when treated with 50 μM  
blebbistatin or vehicle control. 
Chapter 5 
Table 5.1 Measurements of SEM images. 
Table 5.2 Micropillars used in literature. 
xi 
 
List of Figures 
Chapter 1 
Figure 1.1 Dissertation overview. 
Chapter 2 
Figure 2.1 Mesenchymal stem cells have a myriad of properties that may be harnessed 
for use in therapies. 
Figure 2.2 Idiopathic pulmonary fibrosis. 
Figure 2.3 Cells experience confinement in vivo. 
Figure 2.4 Unique conditions for each confining construct enhance MSC 
differentiation towards a particular lineage. 
Chapter 3 
Figure 3.1 Effects of confinement on MSC cytoskeletal organization and cellular  
and nuclear morphological parameters. 
Figure 3.2 Effects of confinement and passage on MSC speed. 
Figure 3.3 Effects of confinement and passage on MSC chemotactic index. 
Figure 3.4 Effects of inhibition of microtubule polymerization on MSC migration in  
confinement. 
Figure 3.5 Effects of inhibition of microtubule polymerization on hMSCs in Figure 3.4  
broken out by passage. 
Figure 3.6 Effects of inhibition of myosin II- and ROCK-mediated contractility on MSC 
migration in confinement. 
Figure 3.7 Effects of inhibition of myosin II contractility on hMSCs in Figure 3.6 broken 
out by passage. 
Figure 3.8 Effects of inhibition of actin polymerization on MSC migration in  
confinement. 
Figure 3.9 Localization of py-paxillin-rich focal adhesions in MSCs in confinement. 
Chapter 4 
Figure 4.1 Images and quantification of 2D nuclear morphology of MSCs, L929  
cells, and MDA-MB-231 cells in increasing confinement. 
Figure 4.2 Workflow for calculating 3D morphological parameters of the nucleus. 
Figure 4.3 Orthogonal views of MSC or L929 cell within 3 μm narrow channel and  
50 μm wide channel. Also shown are quantifications of the nucleus volume 
and nucleus length, width, and height of MSCs or L929 cells. 
Figure 4.4 Orthogonal views of MSC or L929 cell treated with 10 μM nocodazole or  
vehicle control within 3 μm narrow channel and 50 μm wide channel. 
Figure 4.5 Nucleus volume or length, width, and height of MSCs or L929 cells  
treated with 10 μM nocodazole or vehicle control. 
Figure 4.6 Orthogonal views of MSC or L929 cell treated with 50 μM blebbistatin or  
vehicle control within 3 μm narrow channel and 50 μm wide channel. 
Figure 4.7 Nucleus volume or length, width, and height of MSCs or L929 cells  
treated with 50 μM blebbistatin or vehicle control. 
Chapter 5 
Figure 5.1 Micropillar preparation. 
Figure 5.2 Micropillar specifications selection. 
Figure 5.3 Micropillar specifications validation. 
Figure 5.4 MSC density within micropillars. 
xii 
 
Figure 5.5 MSC morphology within micropillars. 
Figure 5.6 MSC nucleus morphology within micropillars. 
Figure 5.7 MSCs within micropillars for 3 weeks. 
Figure 5.8 MSC cytoskeleton within micropillars. 
Figure 5.9 MSC migration phenotypes within micropillars. 
Figure 5.10 Quantitative MSC migration parameters within micropillars. 
Chapter 6 
Figure 6.1 HLFs increase α-SMA in response to TGF-β1.  
Figure 6.2 HLFs increase α-SMA expression in response to TGF-β1 to a lesser degree 
at lower density. 
Figure 6.3 HLFs do not increase α-SMA expression in response to TGF-β1 at a low 
density. 
Figure 6.4 HLFs increase α-SMA expression with increasing cell density. 
Figure 6.5 HLFs increase OB-cadherin expression with increasing cell density. 
Figure 6.6 Confinement does not affect FMT.  
Figure 6.7 Confinement does not affect FMT. 
Figure 6.8 MSC-CM does not affect FMT. 
Chapter 8 
Figure 8.1 FRET tension sensor to measure cell traction forces. 
Figure 8.2 MSCs treated with TSA. 




List of Abbreviations 
AFM – atomic force microscopy 
CSC – cancer stem cell 
ECM – extracellular matrix 
FMT – fibroblast to myofibroblast transition 
FA – focal adhesion 
FBS – fetal bovine serum 
FRET – Förster resonance energy transfer 
HDAC – histone deacetylase 
HLF – human lung fibroblast 
IPF – idiopathic pulmonary fibrosis 
KASH - Klarsicht, ANC-1, Syne homology  
LAD – lamina-associated domain 
LINC – linker of the nucleoskeleton and cytoskeleton 
MMP – matrix metalloproteinase 
MSC – mesenchymal stem cell  
MSC-CM – mesenchymal stem cell-conditioned media 
MRTF-A – Myocardin Related Transcription Factor A 
NMMII – non-muscle myosin II 
PBS – phosphate-buffered saline 
PDMS – polydimethylsiloxane  
PEG – polyethylene-glycol 
ROCK – Rho-associated protein kinase 
xiv 
 
RGD – Arginylglycylaspartic acid 
SMA – smooth muscle actin 
SUN – Sad1 and UNC-84 
TGF-β – transforming growth factor-β 
TSA – Trichostatin A 






Chapter 1: Introduction 
Mechanical cues such as stiffness and shear stress have been shown to influence 
cell gene expression, cell protein expression, and cell behaviors critical for homeostasis 
and disease progression [1], [2]. Cells physically attach to extracellular matrix (ECM) 
components via focal adhesions, which consist of integrins and associated helper 
proteins, and focal adhesions subsequently attach to the intracellular cytoskeleton [3]. 
The cytoskeleton, which consists of actin filaments, microtubules, and intermediate 
filaments, is a critical component of a cell’s mechanosensing machinery [4]. The 
cytoskeletal network transmits mechanical forces to the nucleus via the linker of the 
nucleoskeleton and cytoskeleton (LINC) complex, which can thereby alter gene 
expression [5]. The nucleus itself is also a mechanosensor, sensing external forces and 
altering gene expression directly [6].  
Investigation of cell mechanosensing and ECM mechanics has led to 
advancements in almost all facets of bioengineering, including regenerative medicine 
and drug development. Consideration of the mechanical microenvironment has led to 
improved scaffolds for tissue engineering [7]. Additionally, several drugs targeting 
ECM stiffness have been approved to treat a variety of pathologies [8]. In addition to 
stiffness, cells experience the mechanical cue of confinement in vivo, such as within the 
ECM, and in vitro, such as within tissue engineered scaffolds. For example, cells may 
be confined within channels between connective tissue and the basement membrane of 





in the tumor microenvironment [12], and in interstitial tissue [13]. Despite its 
prevalence, the impact of mechanical confinement on cell fate is poorly understood. 
Mesenchymal stem cells (MSCs) are multipotent cells found within adult 
tissues, such as the bone marrow [14]. MSCs are increasingly studied due the myriad of 
beneficial properties they possess [15]. MSCs can differentiate into other cell types, 
potentially aiding in tissue regeneration, and they can secrete immunomodulatory 
factors, potentially aiding in the treatment of several pathologies [16]. Despite their 
extreme promise, very few MSC-based therapies have gained clinical approval [17]. In 
part, this is a result of the inability to precisely control MSC behavior, due to the lack 
of fundamental knowledge regarding how MSCs respond to various mechanical 
microenvironments, including mechanical confinement. 
Idiopathic pulmonary fibrosis (IPF) is one such disease where MSCs are being 
used as a potential therapy [18], [19]. IPF is a deadly disease, with an average mortality 
rate after diagnosis of 3-5 years and with no effective treatments currently available 
[20]. This highlights a basic lack of understanding regarding IPF progression. IPF is 
believed to be caused and perpetuated by a rampant inflammatory response within the 
lung, and it is characterized by fibroblastic foci consisting of dense ECM, fibroblasts, 
and myofibroblasts [21]. Myofibroblasts are contractile, ECM producing cells that 
contribute heavily to IPF progression [22]. These cells are largely not present in healthy 
lung tissue, but originate from the fibroblast to myofibroblast transition induced by 
factors such as inflammation and increased tissue stiffness [23], [24]. As myofibroblasts 
persist within the lung interstitial tissue, they deposit ECM that induces a higher degree 





The overall goal of this dissertation is to investigate the impact of 
engineered mechanical confinement on mesenchymal stem cell and lung fibroblast 
mechanobiology in order to improve mesenchymal stem cell-based therapies and 
improve our understanding of idiopathic pulmonary fibrosis. We use two forms of 
engineered mechanical confinement: a confining microchannel assay and a confining 
micropillar assay (Fig. 1.1). We subsequently use these assays to investigate MSC 
migration, morphology, and nucleus volume as well as the lung fibroblast to 
myofibroblast transition (FMT).  
 
 
Figure 1.1 Dissertation overview. 
In this dissertation, we investigated how mechanical confinement induced by 
engineered microchannels influences MSC morphology, migration efficiency, and 
migration mechanism (Chapter 3). In this chapter, we systematically varied the degree 
of confinement experienced by MSCs using a collagen-coated polydimethylsiloxane 
(PDMS)-based microfluidic device which was previously designed and characterized 





μm). These dimensions are representative of pores found in vivo, such as within 
capillaries and ECM microtracks [27], [28], and in vitro, as in tissue engineered 
scaffolds. We found that MSC migration speed is modestly biphasic as a function of 
microchannel width, and inhibitors of various cytoskeletal machinery affect MSC 
differently in confining microchannels compared to wider microchannels (Chapter 3). 
These results improve our mechanistic understanding of the mechanobiology of stem 
cell migration and outline the cytoskeletal and contractile machinery that contribute to 
migration in confined and unconfined microenvironments. 
We next investigated how mechanical confinement induced by microchannels 
influences MSC and fibroblast nuclear volume (Chapter 4). In this chapter, we 
characterized the 3D morphology of nuclei within various cell types in response to 
physical confinement induced by the same microchannels used in Chapter 3. MSCs and 
L929 cells were chosen for experimentation due to their differences in 2D nuclear 
morphology in response to confinement. Our results suggest that cell identity may 
possess a larger role in governing nuclear deformation than the force of confinement 
alone (Chapter 4). When certain cytoskeletal machinery was inhibited, nuclear 
deformation was altered only in MSCs in wide channels, suggesting diverging roles of 
the cytoskeleton in regulating nuclear deformation and migration in different degrees of 
confinement and in different cell types.  
While performing the work reported in Chapters 3 and 4, we observed a lack of 
assays that provide precise control over the degree of confinement induced on cells, 
yield a large sample size, enable long-term culture, and enable easy visualization of cells 





micropillar assay that achieves these requirements (Chapter 5). The data show that 
MSCs alter their cell and nucleus morphology in response to confinement induced by 
micropillars. Furthermore, it appears that MSCs may alter their migration mode based 
on the degree of confinement experienced or by the mere existence of micropillars 
(Chapter 5). This micropillar assay will provide new fundamental information about 
cellular mechanobiology in response to physical confinement. 
Using the confining micropillar assay designed in Chapter 5, we investigated the 
effect of confinement on lung fibroblast to myofibroblast transition (FMT), a hallmark 
of IPF (Chapter 6). Cell density was more inductive of FMT than the degree of 
confinement induced by micropillar arrays (Chapter 6). Ultimately, the results presented 
herein improve our understanding of how MSCs and lung fibroblasts respond to 












Chapter 2: Background1 
2.1 Mesenchymal stem cells 
Mesenchymal stem cells (MSCs) are generally defined as cells that can self-
renew or generate cells of a different lineage, also defined as multipotent. The definition 
of MSCs is a topic of ongoing debate, but the most widely accepted definition is laid 
out by the International Society for Cell Therapy [29]. This definition includes that 
MSCs be plastic adherent, be able to differentiate into osteoblasts, chondrocytes, and 
adipocytes in vitro, and that MSCs be positive for a set of surface markers and negative 
for a different set of surface markers [29]. MSCs can be isolated from a variety of 
different sources, most commonly from bone marrow [30]. 
MSC have many properties that make them attractive for cell-based therapies. 
These properties include immunomodulatory paracrine activity, immunomodulation via 
cell-cell contact, and the ability to differentiate and integrate into a host tissue [15]. Due 
to these attractive properties, MSCs are increasingly involved in clinical trials, where 
they are slowly progressing [31]. Since 2015, 6% of all MSC-based clinical trials were 
in stage 3 [17], [31]. This is in contrast overall drug development, where 10.8% of all 
trials are in stage 3 [32], [33], but similar to oncology drugs, where 4.9% of trials are in 
phase 3 [33]. Despite extremely promising pre-clinical results, there are only 3 clinically 
approved MSC-based therapies [31]. The scarcity of approved MSC-based therapies to 
 
 
1 Includes sections adapted from M.T. Doolin*, R.A. Moriarty*, and K.M Stroka, Mechanosensing of 






date can be attributed to many factors, including the complex regulatory landscape, 
variability in MSC dosing, and variability in MSC maintenance [34]. Additionally, there 
exists a basic lack of knowledge concerning MSCs and how they respond to their 
microenvironment. It is critical to continue investigation into how the MSC 
microenvironment influences MSC behaviors in order to ultimately develop off-the-
shelf MSC-based therapies. 
Biochemical factors have been known to influence stem cell differentiation for 
several decades, but the role of mechanical cues in MSC differentiation is a more recent 
field of investigation. In 2006, substrate stiffness was shown to alter MSC lineage 
commitment in a seminal paper for the stem cell mechanobiology field  [1]. This sparked 
the notion that mechanical cues need to be considered when using MSCs. Subsequently, 
MSCs have been shown to respond to shear stress, adhesion size and pattern, 
topography, strain, and other mechanical forces by altering their lineage commitment, 
migration, cytoskeletal arrangement, and other phenotypes [35]–[39]. Much of the 
preliminary stem cell mechanobiology work to date was performed on 2D surfaces. 
However, scientists have begun to unearth the effects of a 3D confining 
microenvironment on MSCs. An overview of how MSCs respond to mechanical 
confinement is reviewed in section 2.3 of this chapter. In Chapters 3 and 4, we 
investigate how mechanical confinement influences MSC migration efficiency, 






Figure 1 Mesenchymal stem cells have a 
myriad of properties that may be 
harnessed for use in therapies. 
 
Figure 2.1 Mesenchymal stem cells have a myriad of properties that may be 
harnessed for use in therapies. Image adapted from [15].  
2.2 Idiopathic pulmonary fibrosis 
2.2.1 Introduction to idiopathic pulmonary fibrosis 
Idiopathic pulmonary fibrosis (IPF) is a chronic disease of the lung characterized 
by the differentiation of resident fibroblasts into contractile myofibroblasts that deposit 
excessive extracellular matrix (ECM) [21]. There are no effective treatments for IPF, 
and the median survival time after diagnosis is approximately 3 years [40]. Tissue 
explanted from lungs diagnosed with IPF is stiffer than healthy lung tissue, due to the 
increased protein content of the ECM and altered collagen crosslinking [41], [42]. 





example, lung tissue from early stage IPF is typically dominated by collagen III, but the 
majority of late stage ECM protein content is collagen I [43]. Concomitant with 
increased ECM deposition and crosslinking, there is increased confinement experienced 
by cells. In Chapter 6, we examine how confinement influences the fibroblast to 
myofibroblast transition, a key aspect of IPF progression.  
A characteristic feature of IPF is the presence of fibroblastic foci within the lung, 
which consist of activated fibroblasts and myofibroblasts [41]. Myofibroblasts are 
contractile, ECM depositing cells that express α-smooth muscle actin (α-SMA) in 
association with f-actin stress fibers. Although the origin of myofibroblasts in IPF is 
debated, there is evidence that resident fibroblasts can differentiate into myofibroblasts 
when given certain physical and/or chemical cues [44]. It has been shown that 
fibroblasts cultured on stiff substrates are more likely to differentiate into 
myofibroblasts than those on soft substrates, due to increased actomyosin contractility 
[44]. Concomitantly, stiff matrices encourage stress fiber formation within cells, which 
compress the nucleus [45]. However, it is unknown to what degree direct nuclear 
compression in the absence of increased actomyosin contractility alters fibroblast 
phenotype. In Chapter 6, we investigate how mechanical confinement, which induces 





Figure 2 Idiopathic pulmonary fibrosis. 
 
Figure 2.2 Idiopathic pulmonary fibrosis. A) IPF damages alveoli and impairs 
lung function. Image adapted from [21]. B) IPF is characterized by increased 
ECM deposition by myofibroblasts. Image adapted from [41].  
2.2.2 Mechanosensing in FMT 
Lung fibroblasts respond to mechanical cues in their microenvironment 
through several pathways. Fibroblasts cultured on stiff substrates are more likely to 





actomyosin contractility playing an important role in this process [44], [46]. Stiffness 
may induce FMT through the activation of signal transducer and activator of 
transcription 3 (STAT3) and megakaryoblastic leukemia 1 (MKL1) via Rho/Rho-
associated protein kinase (ROCK) and Janus kinase 2 (JAK2) signaling pathways [47], 
[48]. Indeed, both ROCK isoforms, ROCK1 and ROCK2, play a role in FMT [49]. 
Conversely, hypoxia reduces FMT through RhoA activity [50]. Transforming growth 
factor (TGF)-β1 is commonly used to induce FMT, and TGF-β1 treated fibroblasts 
display “supermature” focal adhesions atop ED-A fibronectin, supporting the highly 
contractile myofibroblast phenotype [51]. Fibroblasts are not only mechanosensitive to 
stiffness, but to strains. Cyclic mechanical loading comparable to that induced on cells 
in vivo by breathing reduces α-SMA expression in lung fibroblasts, potentially due to 
reduced autocrine TGF-β1 secretion [52]. In Chapter 6, we begin to investigate 
mechanosensing of lung fibroblasts in response to cell density and mechanical 
confinement. 
2.2.3 Mesenchymal stem cell therapies for IPF 
The number of registered clinical trials involving MSCs is growing rapidly, and 
nearly tripled from 2011 to 2015 [17], [53]. In the case of IPF, MSC injection is being 
targeted as a prospective therapy [54]. Several pre-clinical trials have proved MSCs 
effective in ameliorating inflammation and fibrosis, motivating the initiation of clinical 
trials [18], [55]. However, other studies indicate that MSC therapy worsens outcome, 
particularly in late stage IPF [19]. Less than 1% of all injected MSCs remain in the body 





Accordingly, secreted factors derived from MSCs have been shown to block fibroblast 
differentiation into myofibroblasts [57]. In Chapter 6, we investigate how confinement 
may affect MSC paracrine activity and if MSC secreted factors influence FMT. 
2.3 Confinement 
2.3.1 Clinical relevance of confinement 
Biochemical cues are well known to influence stem cell differentiation [58], 
[59]. However, in the past decade or so, researchers have determined that mechanical 
signals are similarly important in specifying stem cell fate [1], [36], [60]–[62]. One such 
mechanical cue is confinement, which cells experience in tissues in vivo as well as in 
tissue engineered constructs and laboratory assays [63]. Confinement can significantly 
impact a multitude of cell behaviors. For example, a variety of cell types such as 
fibroblasts, cancer cells, and epithelial cells, can migrate via different mechanisms in 
response to a confined microenvironment [64]–[67].  
The use of MSCs in clinical trials increased approximately four-fold from 2011 
to 2016, yet there are only 3 clinically approved MSC-based therapies [31]. Despite the 
extreme promise of MSC-based therapies, a major limitation in the field of regenerative 
medicine is the ineffectiveness in directing MSCs to target tissues following injection 
into a patient [68]. Furthermore, direct control over stem cell fate in vivo is still difficult 
to achieve [69]. Within the past decade, it has been shown that mechanical cues can 





stiffness, shear stress, and loading on stem cell fate have been investigated, but research 
on the effects of confinement on stem cell fate is still in its early stages [1], [70].  
Stem cells experience mechanical confinement during the homing process in 
vivo as they migrate through endothelial barriers and tissues towards a target, and also 
in vitro during integration into engineered scaffolds [71]. Stem cell homing has been 
defined as the arrest of stem cells on the vasculature, followed by transmigration across 
the endothelium; this process is critical to the function of both native stem cells and 
stem cells delivered systemically as therapy [14]. When administered locally, MSCs are 
implanted in close proximity to the target site and may migrate through extracellular 
matrix or along epithelial surfaces towards the target [72]. When administered 
intravenously, stem cells extravasate from the blood vessel towards the target site, and 
subsequently through extracellular matrix [73]. In both cases, stem cells experience 
mechanical confinement as they migrate across endothelial barriers, through tissues, and 
towards a target. Indeed, MSCs have been shown to transmigrate through pores of 1-2 
μm diameter within the endothelial monolayer both transcellularly and paracellularly 
[74]. Furthermore, MSCs are commonly integrated into tissue engineered scaffolds, 
which likely impose varying degrees of confinement on the cells, depending on scaffold 
porosity and architecture [71]. Understanding how MSCs respond to confinement could 
allow for improved systemic and localized stem cell therapies, as well as improved 
regenerative therapies. It is possible that physical confinement, in combination with 
other microenvironmental cues, can be optimized to engineer stem cells for use in 






Figure 2.3 Cells experience confinement in vivo. Adapted from [12]. 
2.3.2 Mechanosensing of confinement 
In the past two decades, there have been significant strides in understanding how 
cells sense mechanical forces in 2D environments, and the field is now moving towards 
understanding mechanosensing in 3D environments. To attach to a 2D substrate, cells 
form nascent adhesions which may mature to focal adhesions or disassemble [75]. 
Traction forces are generated as cells adhere to a substrate and contract via actomyosin, 
thereby moving the cell forward [76]. Traction forces are highly dependent on, or inter-
linked with, actin dynamics, cell morphology, and cell migratory state [76], all of which 
may be altered by confinement. For example, MSC spreading, proliferation, and 
migration are suppressed when cells are not able to build up sufficient tension on non-





traction forces have been shown to ultimately influence MSC differentiation [78], [79]. 
Hence, if MSC traction forces are also reduced in confinement, there may be profound 
effects on cell behaviors. 
 Within polyethylene glycol (PEG) hydrogels, fibroblasts interrogate the 3D 
matrix via strong inward traction forces near the ends of long, slim extensions [80]. 
Additionally, fibroblast adhesions to 3D matrices are much more stable over time than 
adhesions to 2D matrices [81], and 3D adhesions can be distinct from 2D adhesions in 
phosphorylation of focal adhesion kinase [82]. Integrin clustering appears to be more 
important than stiffness for MSC differentiation in 3D hydrogels [78], though tuning 
the hydrogel’s mechanical properties towards faster relaxation promotes enhanced MSC 
spreading, proliferation, and osteogenic differentiation in 3D [83]. Diffuse focal 
adhesions have previously been correlated with different lineage selection preferences 
in collagen hydrogels [77].  
 Despite their diffuse appearance, these focal adhesion proteins still play a role 
in protrusive and matrix deforming activity [84], and are found in regions of curvature 
or edges [85], for instance, as cells begin to enter confinement. During these protrusive 
events, α4β1 integrins engage with paxillin to drive myosin II-mediated contractility 
[65]. Increased membrane tension, as may be observed in confinement, compresses the 
lamellipodium and subsequently aligns focal adhesions in fibroblasts [86]. Increased 
membrane tension also inhibits SCAR/WAVE complex recruitment and RAC 
activation, which inhibits protrusion and leading-edge signals in migrating neutrophils 
[87]. Hence, although in some situations focal adhesions appear more diffuse and 





complexes still seem to play an important role in cellular mechanosensing of the 
physical environment, albeit in a possibly different manner than the classical 2D model. 
Doyle and Yamada provide an excellent comprehensive review on cell mechanosensing 
in 3D microenvironments [88]. 
2.4 The cytoskeleton response to confinement 
 Typically, a force experienced by a cell at its membrane is transmitted to the 
cell’s cytoskeleton. Physical alterations of boundaries around MSCs influence actin 
filaments, focal adhesions, and cell contractility [85]. Actin stress fiber formation is 
enhanced in MSCs of intermediate volume with sharp edges, possibly due to the 
increased concentration of RhoA and Arp 2/3 [85]. Conversely, MSCs and carcinoma 
cells within microchannels show diffuse actin and microtubule structures that polarize 
to the leading and lagging edges of the cell [26], [64]. A well-known mechanosensitive 
ion channel is the Piezo1 Ca2+ gated ion channel, which can respond to both external 
and internal stimuli to alter Ca2+ levels in the cell. Mechanical stresses induced by 
confinement in Chinese hamster ovary cells lead to increases in intracellular calcium 
levels via increased tension activation of the Piezo1 stretch-activated cation channel, 
kick starting a feed-forward signaling loop to drive the phosphodiesterase type 1-
dependent suppression of protein kinase A [89] and possibly enhancing myosin II 
activity. It is also interesting to note that in the context of stem cells, Piezo 1 can direct 
lineage specific differentiation in neural stem cells, and an increase in its activity on 
stiff substrates can drive increased Ca2+ intracellular levels leading to increased 





physical barriers, partially due to blocking of the membrane transport protein EphA2 
[91], and in coordination with loss of linear, mature focal adhesions [26], [92]. 
Remodeling of the cytoskeleton also takes place during epithelial-to-mesenchymal 
transition, when cells adopt a more vimentin-based than keratin-based composition [93]. 
Vimentin is critical for coupling to myosin to generate adhesion and traction forces [94], 
whereas keratin aids in cell to cell adhesions common in epithelial cells [95]. 
Furthermore, accumulation of Yes-associated protein/transcriptional co-activator with 
PDZ-binding motif (YAP/TAZ) in the cytosol, as opposed to the nucleus, is seen in cells 
that have undergone actin remodeling during ciliogenesis [96], shedding light on yet 
another possible mechanosensing mechanism for confined cells. 
The cytoskeletal reorganization observed in confinement can also be driven by 
protein kinase C inhibition, which was shown to attenuate migration in conjunction with 
retinoic acid [97]. Additionally, organelle positioning, which may vary in confinement, 
can regulate cell behaviors. For example, nuclear position can be a key factor in 
determining when a fibroblast undergoes fast or slow migration [98]. Anterior 
localization of mitochondria in confined environments, via rhoGTPase-1 trafficking on 
microtubules, ahead of the nucleus in the direction of cell migration, increases cell 
velocities and directional persistence [99].  
2.5 The nucleus response to confinement 
The nucleus is a dynamic organelle, with its volume changing in response to 
altered extracellular environments [100]. Nuclei from a variety of cell types have the 





force microscope tip [101]. Environmental radii of less than 7 μm seem to be the 
threshold for nucleus remodeling [102], [103], though this value likely depends on 
unconfined nuclear size. The nucleus as a mechanosensor has previously been reviewed 
extensively [104], [105], and it is likely that nuclear deformation is a critical pathway 
for cell mechanosensing of physical confinement. 
Lamin A/C, a protein in the nuclear lamina that supports the nuclear envelope, 
has been shown to play a critical role in the successful migration of cells in confinement 
[106]. It was demonstrated that in stem cells, low nuclear stress promotes lamin A/C 
degradation and turnover, while cytoskeletal stress and tension promote lamin A/C 
maintenance [107]. This pathway acts through myosin contractility and turnover, and it 
ultimately influences gene expression [107]. Lamin A/C overexpression has been shown 
to increase the degree of anisotropic nuclear deformation in response to an applied force, 
underscoring its importance in nuclear mechanics and response to external forces [101]. 
Nuclear envelope rupture due to actin bundle accumulation at areas of low lamin A 
levels causes nuclear compression or stretching [108]. This compression or stretch leads 
to herniation of chromatin or double stranded DNA breaks, but the nuclear envelope 
integrity is restored by endosomal sorting complexes required for transport III 
(ESCRTIII), a membrane remodeling protein, rapidly after cells clear confinement [13], 
[109]. This process has also been modeled extensively during transmigration studies 
[110]. 
Lamins and the cytoskeleton can transmit mechanical forces between each other 
via the linker of the nucleoskeleton and cytoskeleton (LINC) complex. The LINC 





membrane, and SUN-domain proteins, which reside in the inner nuclear membrane 
[111]. KASH-domain proteins include nesprin -1, -2, -3, and -4 which each contain 
binding sites for one or two cytoskeletal elements, and SUN-domain proteins include 
the commonly expressed Sun1 and Sun2, as well as the testis-specific Sun -3, -4, and -
5. [112]. Microtubules link to Dynein/Lis1, which connect to members of the LINC 
complex (nesprin to SUN to lamin A) to transmit forces across the nuclear membrane 
[113]. In addition, nesprin-2 works synergistically with non-muscle myosin IIB to 
transmit forces to the nucleus [114], [115]. 
Disruption of the LINC complex prohibits cells from responding to low 
magnitude vibrations, further indicating the LINC complex as a critical component of 
the MSC mechanosensing machinery [116]. In line with this, transfer of strain from the 
cytoskeleton to the nucleus via the LINC complex has been shown to be essential for 
stretch-induced activation of the YAP/TAZ pathway [117], and nuclear localization of 
YAP/TAZ is increased in confined MSCs [85]. The YAP/TAZ mechanotransduction 
pathway plays a fundamentally important role in regulating gene expression and MSC 
differentiation and seems to present differently in different confined environments and 
cell types. The nuclear lamina interacts with the genome via lamina associated domains 
(LADs), controlling the location and accessibility of the genome [118]. In fact, lamin 
A/C deficient cells have defective gene transcription regulated by NF-κB in response to 
mechanical strain [119]. This is particularly important to MSCs, as their differentiation 
is responsive to NF-κB [120]. 
In addition to lamin A/C, confinement has been shown to alter chromatin 





chromatin and ~0% mobile proteins like those involved in DNA repair or nucleases, yet 
mobile proteins move into the nucleus unhindered when cells encounter 8 μm diameter 
pores [121]. Both the cytoskeleton and nucleoskeleton have been shown to control 
chromatin dynamics within the nucleus. In one study, confined, isotropic cells contained 
lower lamin A/C levels and more dynamic heterochromatin foci [122]. Conversely, 
polarized, elongated cells generated higher stress on the nucleus, had higher lamin A/C 
levels, and had less dynamic heterochromatin foci [122]. These results have been 
confirmed by others who have shown that loss of lamin A/C leads to increased 
chromatin dynamics [123].  
Histone acetylation patterns may also be affected by confinement. Nuclear levels 
of histone deacetylase 3 (HDAC3) were lower in cells with intermediate volume (3600-
4800 μm3), and higher when actomyosin contractility was inhibited with blebbistatin 
[85]. Stiffer embryonic stem cell nuclei with higher lamin A/C content have decreased 
histone H3 acetylation, which is correlated with increased f-actin levels and increased 
nuclear localization of myocardin-related transcription factor A (MRTF-A) [124]. 
MRTF-A, in turn, influences MSC differentiation by helping to maintain homeostasis 
in MSC osteogenesis and adipogenesis [125]. Nuclear confinement leads to alteration 
of around 180 genes, including increased expression of histones 4 and 3 [126]. 
Disruption of chromatin structure via chromatin decondensation can decrease fibroblast 
mechanosensitivity and dampen the anisotropic deformation of nuclei in response to an 
applied force [101]. In summary, the structure and composition of the LINC complex, 
nuclear lamina, and nuclear contents can be altered by mechanical confinement, and 





The nucleus is the largest organelle in the cell and is generally the stiffest 
organelle [127]. Consequently, nuclear passage into a pore is widely regarded as the rate 
limiting step in migration through confinement [127]. The steric hindrance presented by 
the nucleus is not trivial, and it has been shown that cell migration is inhibited in cells 
with larger nuclei [128]. Specifically, migration is arrested in various cell types when 
trying to migrate through a pore that is less than 10% the size of their nuclear cross 
section [129]. It should be noted that the nucleus does not get through a constriction 
without help. In dendritic cells, it has been shown that Arp2/3 nucleated actin 
accumulates at the portion of nucleus inserted into a constriction, allowing actin to 
compress the nucleus further and allow further entry into a pore [130]. Similarly, non-
muscle myosin (NMM) -IIA and –IIB have been shown to play differential roles in 
cancer cell invasion, with NMMIIA facilitating cell protrusion and NMMIIB facilitating 
nuclear translocation through small pores [114]. Migration through small constrictions 
has lasting effects on the nucleus, as Harada et al. showed that the MSC nucleus deforms 
irreversibly after migration through small pores, due to its high lamin A: lamin B ratio 
[131]. Nuclear positioning within the cell has also been suggested to impact migration 
speed [98]. It has been demonstrated that the nucleus is a key factor in determining when 
a fibroblast undergoes undergo periods of fast, persistent migration or periods of slow, 
random migration [98]. While the actin cap is intact, the nucleus translocates and the 
cell moves quickly and persistently. However, when the actin cap is dissolved, the 
nucleus rounds and rotates, during which the cell slows and moves randomly [98]. 
Motivated by the importance of the nucleus to cell migration and cell mechanosensing, 





2.6 Cellular confinement assays 
Cells experience confinement in many different environments, whether in the 
context of in vitro or in vivo assays, and to many different degrees. As a result, published 
literature varies greatly when discussing confinement, and many labs have distinct 
strategies and devices to study cell behavior in confinement. The various models of 
confined cell migration have been reviewed extensively elsewhere [10], [132], so we do 
not detail all methods extensively here. However, we do emphasize that there is a 
growing need to “define confinement” in quantitative physical terms, since there are 
many different assays that could impose a confining force on cells. Hydrogels, 
polydimethylsiloxane (PDMS), silicon, PEG, glass, and collagen are examples of the 
many materials applied in various confining devices [132]. Cells can be confined on a 
2D surface through chemical modifications of the growth surface or with plasma 
lithography [133], [134]. For example, micropatterned lines of adhesive protein can 
create a 1D track upon which cells can migrate [135], [136]. This 1D system can be 
easily fabricated and imaged, and it is a useful technique for single cell studies. 
Additionally, fibroblast migration on 1D lines has some similarities to its migration in 
3D substrates [135]. 1D patterning techniques are most similar to the migration of cells 
along extracellular matrix protein “tracks” in vivo [137]. Similarly, grooved substrates 
have been harnessed to confine cell migration through a phenomenon known as contact 
guidance [138]–[140]. Contact guidance aligns cytoskeletal features parallel to the 





Many groups study confinement using microfabricated devices, including uni-
axial “sandwich” confinement [142], [143] and bi-axial confinement [144]–[146]. One 
such method encourages cell migration through confining microchannels or nanotubes 
of various widths [25], [26], [147]–[149]. Useful to the study of cell 
mechanotransduction, these channels may be modified to measure forces exerted by 
cells or to exert forces on cells [150]–[152]. Beyond microfluidic devices, confining 
cells within micropillar arrays can be an effective method to systematically control 
degree of confinement while simultaneously assessing cell behavior [153]–[156]. 
Furthermore, microtracks can be created in softer materials, by patterning 
microchannels in polyacrylamide gels [157], or by fabricating collagen microtracks via 
micromolding [158] or two-photon laser microsurgery [159]. 
Complete 3D confinement can be achieved by encapsulating cells in 3D 
hydrogels or scaffolds, though the degree of confinement may be difficult to 
systematically control in these assays [129], [160]–[162]. Within hydrogels, cell seeding 
may be manipulated by external forces [163], [164] or confinement may be dynamically 
controlled, for example by light-triggered expansion of gelatin hydrogel microstructures 
[165]. Cells may also be confined within spheroids, where they experience increased 
cell-cell interactions and confinement due to intercellular pressures [166]. Lastly, cells 
are confined as they intravasate and extravasate into or out of the vasculature, and 
numerous groups have modeled transmigration in this facet, usually either through 
Boyden chambers or cell monolayers [167]–[170]. While these assays do not fully 
confine the entire cell at once, they do present in vivo-like constrictive environments 





mechanism used, mechanical confinement has the potential to drastically alter cell 
behavior when compared to traditional 2D culture. We utilize a confining microchannel 
assay within Chapters 3 and 4. Chapter 5 details the development and validation of a 
confining micropillar assay, which is subsequently used in Chapter 6. 
2.7 Effect of confinement on MSC behaviors 
2.7.1 Morphology 
MSCs exhibit several distinct changes in cell body and nucleus morphology with 
increased mechanical confinement. Indeed, different scaffolds can push MSCs into 
various morphologies in one, two, or three dimensions [171]. While migrating within 
channels, MSCs exhibit marked elongation, with increased aspect ratio of the cell body 
and nucleus [64]. Interestingly, MSCs display a constant nuclear major axis length as a 
function of microchannel width [64], [172], which is compensated by increased nuclear 
height as microchannels become more narrow [172], while sarcoma cells display an 
increasing nuclear major axis length as confinement increases [173]. Nuclear elongation 
during confined migration has been shown to be due, in part, to increased lamin-A:B 
ratio [131]. Within micropillars, MSCs tend to branch less than fibroblasts, maintaining 
a highly anisotropic morphology [153]. MSC morphology in confinement is also 
stiffness dependent. When cultured within micropillar arrays of anisotropic stiffness, 
MSCs preferentially align along the stiffer direction [154]. Notably, meso-scale cues 
have a greater influence on MSC alignment than micro-scale cues at certain lengths 





observed within MSCs [85]. Finally, MSC spreading can be hindered by increased 
crosslink density of 3D gels at early time points, but there is a monotonic increase in 
cell spreading with increasing adhesivity [175].  
2.7.2 Migration 
The detailed mechanisms of confined migration of several cell types has been 
reviewed extensively elsewhere [127], [176]–[178]. Therefore, we focus herein on 
studies of particular relevance to MSCs. Of note, nuclear passage into a pore is widely 
regarded as the rate limiting step in migration through confinement, likely because the 
nucleus significantly stiffer than the surrounding cytoplasm and other organelles [127]. 
Of note for stem cells, lamin A/C is critical for successful confined migration, and the 
expression level of lamin A/C can influence the migration rate of cells through small 
pores. For example, overexpression or knockout of lamin A/C reduces cell migration 
rate, but a moderate knockdown of lamin A/C expression increases the migration rate 
of fibroblasts, MSCs, and tumor cells [102], [106], [131], [179]. Furthermore, migration 
is arrested in tumor cells, T cells, and neutrophils during migration through pores that 
are less than 10% the size of their nuclear cross-section [129]. Hence, nuclear 
deformability, nuclear morphology, and lamin A/C expression are all critical 
components in determining cell migration response in confined environments. 
Notably, the effect of confining channels on MSC migration is highly dependent 
on the population doubling level. MSC invasiveness of MSCs into spaces between 
micropillars with 8 μm spacing increases with increased passage due to transition of 





MSCs from different donors, the less deformable MSCs are more likely to enter small 
channels [153]. This emphasizes the need to consider passage-dependent effects on 
behavior in MSCs. Additionally, this study highlights the inherent differences between 
MSCs from different donors and the MSCs’ subsequent response to confinement. 
Confinement in glass microtubes alters the migration phenotype of neural stem 
cells in comparison with 2D substrates, and these confining microtubes also better 
recapitulate the in vivo neural stem cell morphology than does culture on 2D substrates 
[148]. MSC migration efficiency in 3D scaffolds has been shown to be strongly 
dependent on pore size, with MSCs being most migratory in scaffolds of 12 μm pore 
diameter [180]. However, MSC migration is unaffected by tortuosity or contraction of 
wide 3D channels [181]. MSCs have also been shown to migrate through small 
physiologic pores. For example, MSCs can transmigrate through pores of 1-2 μm 
diameter within the endothelial monolayer, exhibiting non-apoptotic blebbing to 
facilitate migration [74]. 
Other physiological cues, such as stiffness or adhesivity, coupled with 
confinement may also influence MSC migration. Stiff 3D hydrogels may hinder 
migration by limiting cells’ ability to deform its ECM [182]. Similarly, cell speed 
decreases with increasing crosslink density, but persistence of migration is unaffected 
[175]. Gels with lower crosslinking density and high adhesivity support cells with more 
sustained polarization, higher migration speeds and higher spreading [175]. In contrast, 
low adhesion and vertical confinement causes mesenchymal cells to migrate faster and 
more amoeboid-like [183]. Similarly, MSC spheroids entrapped in alginate gels with a 





outgrowths, while MSC spheroids in alginate gels of low RGD ligand concentration 
have more migration and outgrowth [184]. When placed within matrix 
metalloproteinase (MMP)-degradable PEG gels, MSC migration is inhibited by an 
MMP inhibitor or blebbistatin [185], indicating the importance of MMPs and myosin 
II-mediated contractility for MSC migration in these environments. Additionally, 
migration occurs in regions of complete or near-complete hydrogel erosion [185]. Wnt 
signaling is also involved in the effective migration and invasion of MSCs [186]. 
Finally, cancer stem cells (CSCs) have enhanced motility in aligned collagen matrices, 
while the overall population of cancer cells does not have enhanced motility [187]. 
Smaller cell size, plasticity, and higher degrees of protrusive activity lead to faster 
cancer stem cell migration as opposed to other breast carcinoma cells where the nucleus 
is a limiting factor [187].  In Chapter 3, we demonstrate that confinement influences 
both the speed and migration mechanism of MSCs.  
2.7.3 Invasiveness 
Invasiveness, or the ability to permeate confined spaces, is another critical 
property of stem cells. For the sake of this chapter, we chose not to describe phenotypic 
changes in cells transmigrating through an endothelium, but rather we describe the 
effects of longer, sustained confining forces. MSCs are able to negate contact-inhibition 
and migrate around other cells on narrow micropatterned fibrillar structures, where they 
would normally retract from cell-cell contact. This increase in migratory behavior in 
MSCs may be due to the decreased N-cadherin expression [181]. Additionally, 





surrounding 3D collagen matrices [188] and which migration mechanism they use 
[189]. Confinement within the ECM can inhibit the number of cancer stem cells (CSCs) 
and their scattering from a cancer cell mass [190]. However, this inhibition may be 
overcome by increased CSC motility or increased proteolysis [190].  
2.7.4 Differentiation 
There is growing evidence that confinement can alter MSC differentiation (Fig. 
2.4). Scaffold pores, an example of circular spatial constraints, alter the differentiation 
of MSCs. Scaffolds with pore sizes of 300 μm result in higher levels of MSC 
chondrogenesis than scaffolds with 94 or 130 μm pores [191]. Interestingly, a different 
study found that 100-150 μm diameter pores enhance osteogenic differentiation, 
potentially due to actin and focal adhesion rearrangement involving α2 integrins, α5 
integrins, and vinculin [192]. When MSCs are seeded within gelatin–glutaraldehyde 
scaffolds, increased confinement of pores to an area of ~30 μm2 (~6 μm diameter) 
enhances osteogenic differentiation [193]. Additionally, pore size may be more 
important than bulk scaffold properties in directing lineage specification [193]. 
Although pore size alters MSC differentiation, crosslink density has little influence on 
stem cell fate in non-degradable covalently crosslinked systems, even when the network 
presents adhesive ligands [79]. Conversely, MSCs have a higher differentiation capacity 
in gels with a fibrillar collagen density more similar to conditions in vivo [194]. 
Confining individual MSCs to intermediate volumes enhances alkaline phosphatase 
expression and reduces MSC lipid content [85]. It has also been asserted that adhesion-





MSC differentiation is also altered in other confining environments that increase 
cell-cell contacts. For example, culturing MSCs in 3D spheroids yields better 
adipogenic and osteogenic differentiation efficiency than culture in a 2D monolayer 
[195]. Additionally, MSC colonies confined within agarose walls show increased 
adipogenic differentiation at the center of colonies, osteogenic differentiation slightly 
closer to the edge, and more undifferentiated cells at the extreme edge of colonies next 
to the wall [196]. 3D confinement or lateral confinement can speed up and enhance or 
induce, respectively, de-differentiation of fibroblasts to induced pluripotent stem cells 
[197]–[199]. However, despite potential advantages described above, there are risks to 
confining MSCs. DNA damage to MSCs, as may be induced in extreme confinement, 
has been shown to promote MSC senescence, limiting their differentiation and 






Figure 2.4 Unique conditions for each confining construct enhance MSC 
differentiation towards a particular lineage.  
2.7.5 Cell secretome  
There are a few studies that suggest the cell secretome may be altered by 
confinement. When embryoid bodies made of human pluripotent stem cells are cultured 
in microwells, ectoderm and endoderm genes are upregulated, while mesoderm genes 





of secreted factors within microwells [201]. Additionally, 3D spheroid culture of MSCs 
increases the secretion of anti-inflammatory factors when compared to 2D culture [202]. 
However, conditioned media from the 3D spheroid culture does not have an anti-
inflammatory effect on LPS (endotoxin) -treated cells [202]. Recently, manipulating the 
physical microenvironment, such as by applying strain or altering substrate protein 
coating, has been shown to alter the MSC secretome, which includes cytokines and 
extracellular vesicles [203]. To obtain MSC secreted factors, MSCs are typically 
cultured in 2D on standard tissue culture plastic and their media harvested [204], [205]. 
However, MSCs cultured in 3D spheroids have been shown to have enhanced 
therapeutic effects [206]. The effect of confinement on the MSC secretome is of special 
interest, as MSC-derived extracellular vesicles and MSC-conditioned media are 
increasingly being investigated for their therapeutic potential. However, due to the 
presence of confounding and inseparable conditions in current studies, the field is 
lacking an overall systematic evaluation of how confinement affects the MSC 
secretome. In Chapter 6, we investigate how confinement may affect MSC paracrine 
activity and if MSC secreted factors influence FMT. 
2.7.6 Gene and protein expression 
Ultimately, the phenotypic changes in cell behavior can usually be traced back 
to changes in gene and protein expression. Although we touched on this in previous 
sections, we highlight some findings here. On 2D surfaces, cells are able to control gene 
expression via spatial control of regulatory proteins [207], and studies are investigating 





nucleus can subsequently alter gene expression. For example, force on the nucleus can 
open nuclear pores to YAP/TAZ entry [208]. Additionally, MSC differentiation is 
altered based on the amount of nuclear “sagging” when seeded atop micropillar arrays 
[209].  
MSCs in spheroids exhibit higher levels of adipogenic and osteogenic mRNA 
expression as well as stem cell maintenance mRNA, in comparison with MSCs in 2D 
monolayer culture [195]. This result was confirmed by Zhang et al., who revealed MSC 
spheroids within a microgel display increased mRNA expression of chondrogenic and 
osteogenic markers without induction media, and increased mRNA expression of 
chondrogenic, adipogenic, or osteogenic markers after applying induction media, 
compared to 2D [210]. MSCs in spheroids also display increased mRNA expression of 
stemness biomarkers, anti-inflammatory biomarkers, angiogenic biomarkers, and 
differentiation biomarkers relative to monolayer culture [211]. Again, it is difficult to 
determine whether confinement specifically is responsible for these effects, or whether 
there are confounding effects from altered cell-cell contacts, build-up of trophic factors 
within the spheroid, or other factors. 
2.8 Conclusion 
Due to the pervasive nature of mechanical confinement in vivo, it is critical to 
understand how and why confinement alters cell behaviors. Furthermore, it is becoming 
increasingly evident that we must also make these links in the context of the specific 
(physical or biochemical) microenvironment. Herein, we explore how mechanical 





knowledge has the potential to improve MSC-based therapeutics or tissue engineered 






Chapter 3: Physical confinement alters cytoskeletal contributions 
towards human mesenchymal stem cell migration2 
3.1 Introduction 
The use of mesenchymal stem cells (MSCs) in clinical trials is rapidly 
increasing. According to data from the National Library of Medicine and the National 
Institutes of Health, the number of completed clinical trials involving mesenchymal 
stem cells nearly doubled from April 2015 to April 2017 (www.clinicaltrials.gov). Such 
trials include systemic or targeted delivery of MSCs in patients for the treatment of a 
variety of conditions such as graft-versus-host disease, osteoarthritis, and myocardial 
infarction. Additionally, tissue-engineered constructs that incorporate MSCs are 
becoming increasingly viable and complex [212]–[214]. The in vivo or the in vitro stem 
cell microenvironment is critical for providing signaling cues to regulate the balance 
between quiescence and activation or differentiation of stem cells and to control tissue 
formation and repair [74], [215]. Biochemical cues are well known to regulate stem cell 
behavior, and more recently, mechanical cues such as matrix stiffness and topography 
have been identified as important regulators of stem cell morphology, migration, 
proliferation, and differentiation [1], [35]–[37]. An additional mechanical cue is 
confinement, which MSCs encounter as they home to a target. 
 
 
2 Adapted from M.T. Doolin and K.M. Stroka, Physical confinement alters cytoskeletal contributions 





The homing process is critical to the success of in vivo stem cell therapies, yet it 
is still poorly understood. Similarly, cellular infiltration into or out of a construct is 
critical to the success of many tissue engineered scaffolds. Stem cells experience 
mechanical confinement during the homing process as they migrate through endothelial 
cell-lined vasculature and tissues towards a target, and also during integration into 
porous tissue-engineered scaffolds. Mounting evidence has indicated that a variety of 
cell types, including fibroblasts, cancer cells, and epithelial cells, undergo migrational 
plasticity and use different migration mechanisms for confined migration than for 
unconfined migration [65]–[67]. Specifically, confinement alters the migration 
phenotype of mesenchymal cells, making them faster and more amoeboid-like when 
there is also low adhesion [183]. Furthermore, confinement in reductionist models such 
as glass microtubes alters the migration phenotype of neural stem cells in comparison 
with two-dimensional (2D) substrates, and these confining microtubes also better 
recapitulate the in vivo neural stem cell morphology than does culture on 2D substrates 
[148]. Finally, MSC migration efficiency in 3D scaffolds has been shown to be strongly 
dependent on pore size, implying that confinement has an effect on MSCs in vitro, as 
well as in vivo [180]. Despite such studies, the effect of confinement on MSC response 
and the mechanism MSCs use to sense and respond to confinement are poorly 
understood. Understanding the mechanistic behavior of MSCS in confinement is crucial 
for specific and tunable control of MSC infiltration into tissue engineered scaffolds and 
homing to distinct tissues in vivo.  
In this work, our approach was to systematically vary the degree of confinement 





polydimethylsiloxane-based microfluidic device which we have previously designed 
and characterized [25], [26], and subsequently visualize and quantify MSC chemotaxis. 
We verified that MSCs were able to successfully migrate though microchannels 10 μm 
tall and of varying widths (3, 6, 10, 20, and 50 μm) in response to a chemotactic gradient 
created by fetal bovine serum (FBS). Intriguingly, we found that MSC migration speed 
is modestly biphasic as a function of microchannel width, and inhibitors of various 
cytoskeletal machinery affect MSC differently in confining microchannels compared to 
wider microchannels. Our results improve our mechanistic understanding of the 
mechanobiology of stem cell migration and outline the cytoskeletal and contractile 
machinery that contribute to migration in confined and unconfined microenvironments. 
3.2 Materials and Methods 
3.2.1 Cell culture and reagents  
Bone marrow-derived human mesenchymal stem cells (donor: 20 year-old 
female) were purchased from RoosterBio, Inc. (Frederick, MD, USA). Cells were 
removed from liquid nitrogen and grown in RoosterBio basal media with media booster 
(RoosterBio, Inc.) for the first day post-thaw. Thereafter, cells were cultured in media 
composed of Dulbecco’s Modified Eagle’s Medium with high glucose (ThermoFisher 
Scientific, Waltham, MA, USA), 10% Fetal Bovine Serum (FBS) (ThermoFisher 
Scientific), and 1% Penicillin-Streptomycin 10,000 U/mL (ThermoFisher Scientific). 
Cells were cultured and used until a population doubling level of 20, which occurred at 





Phosphate-Buffered Saline (PBS) (VWR, Radnor, PA, USA), and detached with 
TrypLE Express Enzyme (ThermoFisher Scientific). All cells were cultured at 37°C, 
50% humidity, and 5% CO2:95% air. 
3.2.2 Microfluidic device fabrication 
A polydimethylsiloxane (PDMS) microchannel device was prepared as 
previously described [25], [26]. All photolithography procedures were carried out in the 
University of Maryland Nanocenter FabLab. Briefly, a mask was made in AutoCAD 
(AutoDesk, San Rafael, CA, USA) to represent the microchannels or the feed lines. A 
layer of SU-8 3010 negative photoresist (MicroChem, Westborough, MA, USA) was 
spin coated onto a 4-inch diameter silicon wafer (University Wafer, Boston, MA, USA). 
Using an EVG620 mask aligner (EVG Group, Albany, NY, USA), the mask in the 
image of microchannels was placed over the wafer and exposed to ultraviolet (UV) light 
to crosslink. Excess SU-8 3010 was dissolved using SU-8 developer (MicroChem), and 
a layer of SU-8 3025 negative photoresist (MicroChem) was spin coated onto the wafer. 
Using an EVG620 mask aligner, the mask in the image of the feed lines was placed over 
the wafer, and the features were UV crosslinked. Excess SU-8 3025 was dissolved. 
Finished wafers were silanized using tridecafluoro-1,1,2,2,tetrahydrooctyl-1-
trichlorosilane (97%) (Pfaltz & Bauer, Waterbury, CT, USA) overnight in a vacuum 
desiccator. The resulting silicon master contained microchannels with 50 μm, 20 μm, 
10 μm, 6 μm, and 3 μm width, 10 μm height, and 200 μm length. The cell seeding 
channels were 50 μm tall. PDMS (Robert McKeown Company, Branchburg, NJ, USA) 





degassed in a vacuum desiccator. The PDMS and master were baked for at least two 
hours at 85°C, then the PDMS device was cut and removed from the master. A hole 
punch was used to create the media inlets and outlets in the PDMS device. The PDMS 
devices and 25 mm by 75 mm #1 glass coverslips (Electron Microscopy Sciences, 
Hatfield, PA, USA) were cleaned with ethanol and RO water, air dried, baked at 85°C, 
then placed in a plasma cleaner (Harrick Plasma, Ithaca, NY, USA) and plasma treated 
for 2.5 minutes. The devices were then bonded to the coverslips for 5 minutes while 
applying pressure, and the coverslip-device construct was UV sterilized for 10 minutes. 
20 μg/mL collagen I (SigmaAldrich, St. Louis, MO, USA) was added to all wells of the 
devices and incubated for at least one hour at 37°C. The collagen I solution was then 
removed, and devices were washed twice with PBS. 
3.2.3 Migration experiments 
Cells were rinsed with PBS, detached with TrypLE, collected with media and 
centrifuged. Cells were then resuspended in FBS-free media and centrifuged. Cells were 
then re-suspended in FBS-free media to yield 1x105 to 2x105 cells per 25 μL. Twenty-
five μL of cell suspension was added to the cell inlet of each microchannel device, and 
devices were incubated for at least 5 minutes at 37°C. Excess liquid was removed, then 
50 μL of FBS-free media was added to the cell inlet and bottom two media inlets, and 
50 μL of FBS-containing media was added to the top media inlet to induce a chemotactic 
gradient. For experiments using any inhibitor, aside from latrunculin-A, media 
containing the drug or appropriate vehicle control was added at this time. For 





2 hours so cells migrated fully into the channels. Then, media was removed and media 
containing latrunculin-A or its appropriate vehicle control was added. The drugs 
included latrunculin-A (2 μM, Cayman Chemical, Ann Arbor, Michigan, USA), 
blebbistatin (50 μM, SigmaAldrich), nocodazole (10 μM, SigmaAldrich), and Y27632 
(10 μM, Cayman Chemical). Dimethyl sulfoxide (SigmaAldrich) served as vehicle 
control in all cases except latrunculin-A, where ethanol served as vehicle control. 
Imaging began immediately after the proper media was added to the device. Images 
were acquired on an Olympus IX83 microscope (Olympus, Center Valley, PA, USA) 
using a 10x objective. A chamber adjusted to 37°C, 50% humidity, and 5% CO2:95% 
air was used on the microscope stage in order to sustain cell viability. Images were taken 
at 5-10 minute intervals overnight. 
3.2.4 Immunofluorescence 
The following steps were carried out at room temperature, unless otherwise 
specified, and reagents were added to all wells of the device. Cells were fixed in 3.7% 
formaldehyde (FisherScientific, Fair Lawn, NJ, USA) for 10 minutes, washed in 0.1 M 
glycine, then washed twice in PBS (VWR). Cells were permeabilized with 0.5% Triton-
X 100 (SigmaAldrich) for 5 minutes, washed in PBS thrice, and blocked for nonspecific 
binding in 2.5% goat serum (Abcam, Cambridge, MA, USA) for at least one hour. 
Primary antibody in 1% goat serum was added to cells and incubated at 4°C overnight. 
Primary antibodies and dilutions used were mouse anti-α-tubulin (ThermoFisher 
Scientific, 1:100) and rabbit anti-phospho-paxillin (Cell Signaling Technology, 





serum for at least one hour, and incubated with AlexaFluor 488 Phalloidin 
(ThermoFisher Scientific, 1:500), Hoechst (ThermoFisher Scientific, 1:2500), and a 
fluorescently labelled secondary antibody for one hour. Secondary antibodies and 
dilutions used were AlexaFluor 568 goat anti-mouse (ThermoFisher Scientific, 1:200) 
and AlexaFluor 568 goat anti-rabbit (ThermoFisher Scientific, 1:200). Cells were 
washed thrice in PBS, then imaged. Images were acquired on an Olympus IX83 
microscope (Olympus) using a 40x or 60x oil immersion objective for cell morphology 
measurements. Images were acquired on a PerkinElmer UltraVIEW Vox confocal 
spinning disk microscope (PerkinElmer, Waltham, MA, USA) using a 60x oil 
immersion objective to visualize actin, microtubules, and focal adhesions. Fluorescence 
settings were kept constant for each experiment, unless otherwise specified. Use of the 
PerkinElmer confocal microscope was performed courtesy of the University of 
Maryland imaging core.  
3.2.5 Data analysis 
Cell migration in the channels was manually tracked in ImageJ by tracking the 
center of mass of the cell as it migrated through the channels. Tracking began once a 
cell was entirely within the channel and ceased once a portion of the cell protruded from 
the channel. Cells were not tracked if they divided or died while in the channel. Mean 
speed and chemotactic index were calculated for each cell using a custom Matlab 
program. Chemotactic index was calculated as the end-to-end distance travelled divided 
by the total distance travelled. For cell morphology, cells and nuclei were manually 





using ImageJ built in morphology measurements. Inverse aspect ratio was equated to 
the roundness. Focal adhesion area was quantified in ImageJ by applying the same 
threshold to all immunofluorescence images for py-paxillin and measuring the area of 
each focal adhesion with the particle analyzer. We excluded any particles greater than 
5 μm2, to remove any background staining. 
3.2.6 Statistical analysis 
Data for cells from at least three independent trials was pooled for statistical 
analysis. A student’s t-test, in the case of normally distributed data, or Mann-Whitney 
test, in the case of non-normally distributed data, was performed between drug-treated 
and control groups. A one way ANOVA, in the case of normally distributed data, or 
Kruskal-Wallis test, in the case of non-normally distributed data, was performed 
between channel widths. A significance level of 0.05 was used. Error bars report the 
standard error of the mean (SEM). 
3.3 Results 
3.3.1 Confinement alters MSC morphology 
Our first goal was to determine whether MSCs were capable of migrating through 
collagen-coated microchannels down to 3 m wide (and 10 m tall), and if so, whether 
cell morphology and migration speed depended on degree of confinement. We have 
previously shown that metastatic cancer cells can successfully migrate through the 
microchannel devices used here [65], [67], [152], and we predicted that MSCs, which 





matrices, were also sufficiently deformable to squeeze through the narrowest channels. 
Indeed, MSCs seeded in the microfluidic chemotaxis devices migrated completely 
through all channel widths ranging from 3 μm to 50 μm wide, in response to a fetal 
bovine serum (FBS) chemoattractant gradient (Fig. 3.1A, 3.1B). Given the obvious 
morphological differences observed via phase contrast microscopy in narrow (Fig. 
3.1A) vs. wide (Fig. 3.1B) microchannels, we hypothesized that MSC cytoskeletal 
arrangement also depended on degree of confinement. Thus, MSCs were fixed while 
migrating through the microchannels, and subsequently stained for actin and tubulin. 
Both the actin and microtubule networks appeared more diffuse and less fibrillar in 
confining narrow (3 m) channels, compared to wide (50 m) channels (Fig. 3.1C, 
3.1D). Furthermore, MSCs in narrow channels appeared to occupy the entire height of 
the channel (Fig. 3.1C; y-z plane), while MSCs in wide channels occupied just a fraction 
of the channel height (Fig. 3.1D; y-z plane). Interestingly, in narrow channels (where 
the nucleus was deformed significantly in the x-y plane), the nucleus height in the z-
direction occupied the majority of the height of the channel (Fig. 3.1C). In wider 
channels (where the nucleus was not laterally confined in the x-y plane), the nucleus 
height in the z-direction was significantly less than the channel height (Fig. 3.1D). Due 
to the apparent differences in MSC shape and structure between channel widths (Fig. 
3.1C, 3.1D), we quantified several cell and nucleus morphological parameters. Both cell 
area and nucleus area in the XY plane decreased with decreasing channel width (Fig. 
3.1E, 3.1F). Cell inverse aspect ratio, which is a measure of the minor axis over the 
major axis of an ellipse fitted to the cell, also increased monotonically from 3 μm to 50 





Figure 3 Effects of confinement on 
MSC cytoskeletal organization and 
cellular and nuclear morphological 
parameters.  
fibroblasts causes the nucleus to deform in an anisotropic manner [101]. Thus, we also 
quantified the lengths of the major and minor axes of MSC nuclei by approximating the 
nucleus as an ellipse. In agreeance with an anisotropic model, the nucleus major axis 
length was independent of channel width, while the minor axis significantly decreased 
with decreasing channel width, even within 50 μm-wide channels, when compared to 




Figure 3.1 Effects of confinement on MSC cytoskeletal organization and cellular 
and nuclear morphological parameters. Phase contrast timelapse sequence of 
MSCs migrating in A) narrow, 3 μm channels, or B) wide, 50 μm channels. Scale 
bar on panel (B) represents 50 μm and applies to panels (A) and (B). MSC 
cytoskeleton in C) a 3 μm narrow channel, or D) a 50 μm wide channel, shown in 
both the XY and YZ planes. In panels (C) and (D) cells were fixed and stained for 
α-tubulin (red), actin (green), and the nucleus (blue). Color channels were altered 
individually, yet to the same degree for panels (C) and (D). Scale bar on panels 
(C) and (D) represents 9 μm and applies to panels (C) and (D). Area of E) MSCs 
and F) MSC nuclei as a function of channel width. G) Inverse aspect ratio of 
MSCs as a function of channel width. H) MSC nucleus major axis length and 
minor axis length as a function of channel width. Bar graphs report mean ± 
SEM. **p<0.01, ***p<0.001, ****p<0.0001. (Number on individual bars indicates 










3.3.2 Passage number alters MSC speed and chemotactic index in response 
to confinement 
Previous reports have shown that increasing MSC passage number decreases the 
invasiveness and bioactivity of MSCs [153], [216], so we investigated MSC speed as a 
function of passage and of confinement. MSCs at passage 3, 4, or 5 (P3, P4, or P5) were 
seeded in the microfluidic device, and the speed of MSCs migrating within 
microchannels was subsequently tracked. We found that P3 and P4 MSCs displayed a 
modest biphasic relationship between migration speed and microchannel width (Fig. 
3.2A and 3.2B). Meanwhile, P5 MSCs showed no significant difference in speed among 
channel widths (Fig. 3.2C). Intriguingly, when data from all passages were plotted 
together but without being pooled, it became evident that MSCs tended to move slower 
as a function of increasing passage number for all channel widths (Fig. 3.2D). However, 





Figure 4 Effects of confinement and passage on MSC 
speed. 
 
Figure 3.2 Effects of confinement and passage on MSC speed. Speed of A) passage 
3 (p3), B) passage 4 (p4), or C) passage 5 (p5) MSCs as a function of channel width. 
D) MSC speed as a function of channel width, replotted to highlight differences 
across passages. Bar graphs represent mean ± SEM. For panels A-C, number on 
individual bars indicates total number of pooled cells from N=3 independent 
experiments for each passage. *P<0.05, **p<0.01, ***p<0.001, ****p<0.0001.  
We next calculated the chemotactic index of each cell migrating within the 
microchannels, which is defined as the end-to-end distance travelled divided by the total 
distance travelled; in this measurement, a value of 1 indicates perfectly persistent 
migration. P3 MSCs moved with a significantly greater chemotactic index in 50 μm 





significantly lower chemotactic index in 50 μm wide channels than 20 μm wide 
channels (Fig. 3.3A). P4 MSCs moved with a significantly higher chemotactic index in 
6 μm wide channels than 3 μm, 20 μm, or 50 μm wide channels (Fig. 3.3B). 
Furthermore, MSCs moved with a significantly greater chemotactic index in 50 μm 
wide channels than in 10 μm wide channels (Fig. 3.3B). P5 MSCs displayed no 
significant difference in chemotactic index among channel widths (Fig. 3.3C). When all 
passages were plotted together but without being pooled, it became evident that, in 
general, P4 MSCs migrated most persistently in comparison with P3 and P5 MSCs in 
all channel widths, though chemotactic index was not statistically different across 







Figure 5 Effects of confinement and passage on MSC 
chemotactic index. 
 
Figure 3.3 Effects of confinement and passage on MSC chemotactic index. 
Chemotactic index of A) passage 3 (p3), B) passage 4 (p4), or C) passage 5 (p5) 
MSCs as a function of channel width. D) MSC chemotactic index as a function of 
channel width, replotted to highlight differences across passages. Bar graphs 
represent mean ± SEM. For panels A-C, number on individual bars indicates total 
number of pooled cells from N=3 independent experiments for each passage. 





3.3.3 Inhibition of microtubule polymerization does not affect MSC 
migration in confinement 
We have previously shown that microtubule polymerization is indispensable for 
MDA-MB-231 tumor cell migration in confined (3 μm wide) microchannels [26]. 
However, given the diffuse microtubule network observed in MSCs in narrow (3 μm) 
channels (Fig. 3.1C), we hypothesized that MSC migration in confinement may depend 
less on microtubule polymerization. Hence, we inhibited microtubule polymerization in 
MSCs by treating cells with nocodazole as they entered and migrated through the 
microchannels. Vehicle control-treated cells in 50 μm wide channels exhibited a distinct 
microtubule network that was visibly disrupted after nocodazole treatment (Fig. 3.4A). 
Microtubule inhibition also resulted in alteration of the actin cytoskeleton, with a visual 
reduction in stress fiber content and overall F-actin organization in nocodazole-treated 
cells in 50 μm wide channels (Fig. 3.4A). Meanwhile, nocodazole did not affect visual 
organization of the microtubule network in MSCs in narrow (3 μm) channels, where 
vehicle control- and nocodazole-treated cells both contained a diffuse α-tubulin network 
rather than distinct microtubules (Fig. 3.4B).  
Given the differential effects of nocodazole on microtubule organization in 
MSCs in wide vs. narrow channels, we next wanted to determine whether these effects 
carried over to migration potential of MSCs. Indeed, we found that nocodazole 
treatment significantly decreased the speed of MSCs in 20 μm and 50 μm wide channels 
but had no effect on MSC migration speed in narrower channels (Fig. 3.4C). Meanwhile, 





and 10 μm wide channels, but significantly decreased the chemotactic index of MSCs 
migrating through 50 μm wide channels (Fig. 3.4D). Microtubule depolymerization has 
been shown to result in release of guanine exchange factor-H1 (GEF-H1), leading to 
increased cell contractility via activation of RhoA, ROCK, and myosin II, [217]–[219], 
increased traction forces [220], and, possibly, decreased cell speed and persistence. To 
determine if a potential nocodazole-induced increase in cell contractility caused a 
significant effect on MSC migration, we treated cells with a combination of blebbistatin, 
which decreases cell contractility, and nocodazole, which putatively increases 
contractility. Similar to nocodazole treatment alone, a combination of blebbistatin and 
nocodazole treatment significantly decreased the speed of cells that migrated through 
20 μm and 50 μm wide channels (Fig. 3.4E). The chemotactic index of MSCs with 
combinatorial blebbistatin and nocodazole treatment was significantly increased for 















Figure 3.4 Effects of inhibition of microtubule polymerization on MSC migration 
in confinement. A) Control and nocodazole-treated MSCs in 50 μm wide channels. 
B) Control and nocodazole-treated MSCs migrating through 3 μm narrow 
channels. In panels (A) and (B) cells were fixed and stained for α-tubulin (red), 
actin (green), and the nucleus (blue). C) Effects of inhibition of microtubule 
polymerization on MSC speed and D) persistence. Also shown are percent changes 
in MSC E) speed or F) chemotactic index, with respect to the vehicle control, for 
cells treated with nocodazole, blebbistatin, or a combination of nocodazole and 
blebbistatin. Bar graphs report mean ± SEM. Scale bars represent 9 μm and apply 
to both control and nocodazole condition for each of panels (A) and (B). *p<0.05, 
**p<0.01, ****p<0.0001. For panels (C-D), number on individual bars indicates 
total number of pooled cells from N=3 independent experiments for each condition. 
In panels (E-F), data points represent nocodazole treated cells presented in (C-D), 
blebbistatin treated cells presented in Figs. 6C and 6D, and pooled nocodazole and 
blebbistatin treated cells from N=4 independent experiments for each condition as 
follows: n(3 μm channel, control)=62, n(3 μm channel, nocodazole and 
blebbistatin)=15, (6 μm channel, control)=12, n(6 μm channel, nocodazole and 
blebbistatin)=10, n(10 μm channel, control)=16, n(10 μm channel, nocodazole and 
blebbistatin)=14, n(20 μm channel, control)=59, n(20 μm channel, nocodazole and 







In view of the differences we observed in MSC speed and chemotactic index 
with increasing passage (Fig. 3.2D, 3.3D), we sought to investigate whether passage 





Fig. 3.4D to separate out MSCs by passage (Fig. 3.5). Notably, the numbers of P4 and 
P5 MSCs entering into the narrower channels (10, 6, 3 μm) were much lower than P3 
MSCs, as indicated by the n values shown on the data bars in Figure 3.5, leading to 
differences in statistical differences when comparing data from individual passages. 
Interestingly, nocodazole treatment did not alter the speed of P3 MSCs in any channel 
width (Fig. 3.5A). However, nocodazole treatment significantly decreased the speed of 
P4 and P5 MSCs in 20 μm and 50 μm wide channels (Figs. 3.5B, 3.5C). Conversely, 
the chemotactic index of nocodazole-treated P3 MSCs most similarly followed the 
pooled data (Figs. 3.5D, 3.4D). Nocodazole treatment significantly increased the 
chemotactic index of P3 MSCs in 6 μm and 10 μm wide channels, but significantly 
decreased the chemotactic index of P3 and P5 MSCs migrating through 50 μm wide 
channels (Fig. 3.5D, 3.5F). There were no statistical differences in the chemotactic 
index of nocodazole-treated P4 MSCs when compared to the respective vehicle control 






Figure 3.5 Effects of inhibition of microtubule polymerization on hMSCs in 
Figure 3.4 broken out by passage. Effects of nocodazole on speed for hMSCs of 
A) P3, B) P4, and C) P5. Effects of nocodazole on chemotactic index for hMSCs 






3.3.4 Inhibition of myosin II-mediated contractility enhances MSC 
migration 
The typical mesenchymal migration model involves an interplay between actin 
polymerization and actin-associated myosin II-mediated cell contractility, so we next 
investigated the role of myosin II in confined MSC migration. To inhibit myosin II-
mediated contractility, MSCs were treated with blebbistatin while they entered and 
migrated through the microchannels. There were no apparent changes in the MSC 
cytoskeleton between blebbistatin- and vehicle control-treated cells, with both groups 
exhibiting defined fibrillar actin and microtubule networks in wide channels (Fig. 3.6A) 
and diffuse actin and tubulin structures in confinement (Fig. 3.6B). However, 
blebbistatin-treated cells presented an increase in protrusions and exhibited lengthier, 
more spindle-like cell bodies (Figs. 3.6A, 3.6B). Inhibition of myosin II contractility 
significantly increased the speed of cells in 3 μm, 10 μm, and 50 μm wide channels in 
comparison with the vehicle control (Fig. 3.6C). Notably, the p-value for statistical 
significance decreased with decreasing channel width, indicating that blebbistatin had a 
larger effect on cell migration speed in narrower channels (Fig. 3.6C). Chemotactic 
index was significantly increased for blebbistatin-treated cells migrating in all channel 
widths except for 6 μm (Fig. 3.6D). 
3.3.5 Inhibition of ROCK enhances MSC migration in wide channels 
Given the effects of inhibiting myosin II on cell migration speed in confined vs. 
unconfined channels, we hypothesized that upstream targeting of the contractility 





Hence, we next investigated the effects of inhibition of Rho-associated protein kinase 
(ROCK) on MSC migration by treating cells with the pharmacological inhibitor Y27632 
as they entered and migrated through the microchannels. ROCK was chosen not only 
because it is upstream of myosin II in the contractility pathway, but also because it has 
been shown to influence stem cell fate [36]. Surprisingly, Y27632-treated MSCs 
migrated significantly faster in 50 μm wide channels, in comparison with vehicle 
control-treated cells (Fig. 3.6E). However, Y27632-treated cells had a significantly 
higher chemotactic index in all channel widths, compared to control (Fig. 3.6F). 
Interestingly, ROCK inhibition via Y27632 led to a greater percent increase in cell speed 
(over the vehicle control) in wide channels (50 μm) in comparison with narrow channels 
(3 μm), where there was no significant change in cell speed after blebbistatin treatment 
(Fig. 3.6E). Notably, this trend was opposite the effects of blebbistatin (Fig. 3.6E), even 
though both ROCK and myosin II act in the contractility pathway. Both ROCK 
inhibition and myosin II inhibition significantly increased the chemotactic index of cells 












Figure 3.6 Effects of inhibition of myosin II- and ROCK-mediated contractility on 
MSC migration in confinement. The microtubule and actin networks of control 
and blebbistatin-treated MSCs in A) 50 µm (wide) and B) 3 µm (narrow) channels. 
In panels (A) and (B) cells were fixed and stained for α-tubulin (red), actin (green), 
and the nucleus (blue). Fluorescence exposure times differ between panels (A) and 
(B). The red channel was altered individually, yet to the same degree for panels (A) 
and (B). In panels (A) and (B), scale bars represent 9 μm. C) Effects of blebbistatin 
on MSC speed and D) chemotactic index. Also shown are percent changes in MSC 
E) speed or F) chemotactic index, with respect to the vehicle control, for cells 
treated with Y27632 or blebbistatin. Bar graphs report mean ± SEM. (C-D) 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. (E-F) *p<0.05. For panels (C-D), 
number on individual bars indicates total number of pooled cells from N=4 
independent experiments for each condition. In panels (E-F), data points represent 
blebbistatin treated cells presented in panels (C-D) and pooled Y27632 treated cells 
from N=3 independent experiments for each condition as follows: n(3 μm channel, 
control)=48, n(3 μm channel, Y27632)=110, (6 μm channel, control)=26, n(6 μm 
channel, Y27632)=31, n(10 μm channel, control)=37, n(10 μm channel, 
Y27632)=48, n(20 μm channel, control)=105, n(20 μm channel, Y27632)=192, n(50 











As with nocodazole treatment, we investigated whether blebbistatin affected 
MSCs differently with increasing MSC passage (Fig. 3.7). The speed of blebbistatin-
treated MSCs of all passages was either not significantly different or (in a few cases) 
significantly greater than vehicle control for all channel widths (Figs. 3.7A, 3.7B, 3.7C). 
For example, most strikingly, similar to the pooled data, the speed of P3 MSCs in 3 μm 
narrow channels was significantly increased after blebbistatin treatment (Fig. 3.7A). In 
addition, the chemotactic index of blebbistatin-treated MSCs of all passages was either 
not significantly different or significantly greater than vehicle control for all channel 
widths (Figs. 3.7D, 3.7E, 3.7F). For example, similar to the pooled data, the chemotactic 
index of P3 MSCs in 3 μm, 20 μm, and 50 μm wide channels was significantly increased 







Figure 3.7 Effects of inhibition of myosin II contractility on hMSCs in Figure 3.6 
broken out by passage. Effects of blebbistatin on speed for hMSCs of A) P3, B) 
P4, and C) P5. Effects of nocodazole on chemotactic index for hMSCs of D) P3, 






3.3.6 Inhibition of actin polymerization completely disrupts MSC 
migration 
We previously reported that migration of MDA-MB-231, S180, and CH2879 
metastatic tumor cells in narrow (3 m) microchannels can persist during inhibition of 
actin polymerization [26], [67]. To assess whether actin polymerization contributes to 
confined MSC migration, cells were treated with latrunculin-A after entering the 
microchannels in order to inhibit actin polymerization. The F-actin network was visibly 
disrupted in latrunculin-A-treated cells, compared to vehicle control cells, and 
latrunculin-A-treated cells appeared rounded with reduced area regardless of channel 
width (Fig. 3.8A, 3.8B). Immunostaining of -tubulin similarly revealed significant 
disruption of the microtubule network in the latrunculin-A-treated cells (Fig. 3.8A, 
3.8B). Migration speed of latrunculin-A-treated cells was significantly decreased in all 
channel widths in comparison with the vehicle control (Fig. 3.8C), and therefore cells 
were unable to migrate across the microchannels after latrunculin-A treatment, 
regardless of width. This trend was maintained for P3, P4, and P5 MSCs and thus only 
pooled data area shown. Table 1 provides a summary of our results indicating the effects 






Figure 3.8 Effects of inhibition of actin polymerization on MSC migration in 
confinement. A) The cytoskeletal network in control cells and B) cells treated with 
latrunculin-A. In panels (A) and (B) cells were fixed and stained for α-tubulin 
(red), actin (green), and the nucleus (blue). In panels (A) and (B), scale bars 
represent 9 μm. C) Effect of latrunculin A on speed of MSCs as a function of 
channel width. Bar graphs report mean ± SEM. ****p<0.0001. For panel (C), 
number on individual bars indicates total number of pooled cells from N=3 







Table 3.1 MSCs migrate with different mechanisms in narrow channels than in 












(++++) (-) (----) (++++) 
Narrow 
channels 
(++++) (----) No effect No effect 













No effect (++++) (++++) (--) 
Narrow 
channels 
(+) (++++) (+) No effect 
 
(+) and (-) indicate relative magnitude of effects of each mechanistic process, on 
either speed (top half of table) or chemotactic index (bottom half of table). 
3.3.7 pY-paxillin-positive focal adhesions are mostly absent in MSCs 
migrating in confinement.  
Actin stress fibers typically terminate at focal adhesions on the cell’s basal 
surface, and given the lack of a distinct actin stress fiber network in MSCs in narrow 
channels, we hypothesized that MSCs in confinement might also lack focal adhesions, 
a result we have previously reported for MDA-MB-231 tumor cells [26]. Thus, MSCs 
in the microchannel device were immunostained for tyrosine-phosphorylated (py)-
paxillin, a protein which localizes to focal adhesions in cells. Tyrosine phosphorylation 





possibly cell contractility, have been approximately indicated by the presence of py-
paxillin-positive focal adhesions [65]. We found that mature py-paxillin-rich focal 
adhesions were mostly absent in cells migrating in 3 μm, 6 μm, or 10 μm narrow 
channels, where py-paxillin appeared punctate and disperse, with no visible F-actin 
stress fibers at which to terminate (Fig. 3.9A, 3.9B, 3.9C). Mature, py-paxillin-rich, 
linear focal adhesions appeared in MSCs migrating in wide channels (Fig. 3.9D, 3.9E). 
Furthermore, F-actin and py-paxillin were localized and aligned along the axis of 
migration of MSCs in 50 μm channels, indicative of mature focal adhesions (Fig. 3.9E). 
Accordingly, cells exiting narrow (3 μm) channels had few mature py-paxillin-rich focal 
adhesions on their basal surface in confinement, but exhibited mature focal adhesions 
at their unconfined leading edge (Fig. 3.9F). Interestingly, immediately upon exit from 
the channel, the actin stress fiber network appeared to begin to reform (Fig. 3.9F), 
though organization of stress fibers was much more disorganized in comparison with 
cells in wide channels or on a 2D surface (Fig. 3.1D, 3.4A, 3.6A, 3.8A). While the 
average area of focal adhesions decreased slightly with decreasing channel width (Fig. 
3.9G), the percent cell area covered by focal adhesions decreased drastically with 










Figure 3.9 Localization of py-paxillin-rich focal adhesions in MSCs in confinement. 
py-paxillin in MSCs migrating in A) 3 µm, B) 6 µm, C) 10 µm, D) 20 µm, and E) 
50 µm wide channels. F) MSCs exiting 3 µm narrow channels. In panels (A-F) cells 
were fixed and stained for py-paxillin (red), actin (green), and the nucleus (blue). 
G) Average area of focal adhesions. H) Percentage of cell area occupied by focal 
adhesions. Bar graphs report mean ± SEM. *p<0.05. Scale bars represent 10 μm 











Effective control of MSC localization in porous tissue engineered scaffolds and 
mobilization to distinct tissue sites during homing after clinical therapy requires an 
understanding of how MSCs navigate complicated 3D microenvironments with various 
physico-chemical stimuli, one of which is mechanical confinement. Mounting evidence 
has accumulated, demonstrating that other highly migratory cell types, such as 
metastatic cancer cells, can change their mode of migration, depending on the degree to 
which they are confined in a 3D environment (for recent reviews, see [12], [222]). In 
order to systematically evaluate the cytoskeletal elements contributing to migration of 
MSCs in confined vs. unconfined spaces, we introduced MSCs into chemotaxis-based, 
collagen-coated microfluidic devices containing microchannels of varying width and of 
fixed height, which we have characterized previously [25], [26]. The chemotactic 
gradient within the microfluidic devices is stable for 14 hours after addition into 
channels [25], which is approximately the length of time over which migration was 
analyzed. We subsequently treated the cells with pharmacological inhibitors of various 
migration machinery, visualized cytoskeletal organization, and quantified migratory 
potential. Our experiments have led to several novel and significant insights regarding 
MSC migration in confined spaces: (1) MSC actin and microtubule networks appear 
more diffuse rather than fibrillar in confined microchannels; (2) MSC migratory 
potential (i.e., speed and persistence) varies modestly with passage and degree of 
confinement; (3) inhibition of myosin II activity (via blebbistatin) leads to enhanced 





polymerization (via latrunculin-A) leads to loss of migration in both confined and 
unconfined microchannels, while inhibition of microtubule polymerization (via 
nocodazole) leads to slowed migration in only unconfined microchannels; (5) mature, 
py-paxillin-rich focal adhesions are diminished in MSCs in confined microchannels.  
Similar to past observations on metastatic tumor cells [26], MSCs displayed 
obvious differences in actin and microtubule cytoskeletal arrangement from wide 
channels to narrow channels. Confinement significantly altered MSC body 
morphological parameters, as MSCs exhibited a decrease in both area and inverse aspect 
ratio with decreasing channel width. Additionally, confinement significantly altered 
several MSC nucleus morphology parameters, and MSC nuclei began to deform in 50 
μm wide channels. Unlike 3 μm, 6 μm, and 10 μm channels (where only one cell body 
can fit inside the channel width-wise), cells commonly migrate alongside each other in 
20 μm and 50 μm wide channels. Accordingly, cell-cell interactions may have played a 
role in the observed nuclear deformation in wide (20 μm and 50 μm) channels. Future 
work could be aimed at determining whether nuclear deformation seen here in wide 
channels is due to channel crowding or if contact guidance of MSCs by channel walls 
can lead to cells “sensing” confinement wider than their cell body. We also note that 
while there is no statistical difference in cell inverse aspect ratio from 10 μm to 6 μm, 
or from 6 μm to 3 μm channels, the nucleus minor axis significantly decreases from 10 
μm to 3 μm. Furthermore, the nucleus minor axis width equaled the microchannel width 
in 6 and 3 μm-wide channels, while in larger channels the nucleus minor axis was 
smaller than the channel width, thus indicating that full nuclear confinement along the 





the modest decrease in MSC speed going from 6 or 10 μm channels down to 3 μm 
channels (i.e., in P3 and P4 cells) could be due to nuclear deformation rather than cell 
body deformation. Interestingly, MSC nuclei were strained along their minor axes, 
while the major axes maintained the same length in all levels of confinement. This is in 
agreeance with previous work, which showed that nuclei from 10 different cell types 
deform in an anisotropic manner and preferentially deform along their minor axis when 
an active force is applied by an atomic force microscope tip [101]. MSCs herein 
experience a passive force while migrating through microchannels, suggesting that 
anisotropic nuclear deformation can result from both active and passive forces. 
Previous reports have indicated that MSC behavior can be passage dependent, 
as increased passage leads to loss of MSC proliferative capacity and multipotency [223], 
and also reduced exosome production and invasiveness [153], [216]. Therefore, we 
hypothesized that passage number would influence MSC migration, possibly as a 
function of confinement. Indeed, even in a range of “low passages” (i.e., 3, 4, and 5, 
corresponding to a population doubling level below 21), we observed significant 
differences in MSC speed and chemotactic index as a function of passage, with MSC 
speed decreasing with increased passage number for all channel widths except 3 µm, 
where there was no difference in cell speed across passages. MSCs have been shown to 
stiffen with increasing passage doubling (PD) from PD2 to PD17 due to coarsening of 
the cytoskeleton and increase in actin stress fiber radius [224]. Similarly, increased 
passage of MSCs to P100 has been reported to decrease the expression of genes 
associated with focal adhesion formation and cytoskeletal turnover [225]. Often, MSCs 





index of approximately 0.5. P3 MSCs were much more likely to enter and migrate 
through the narrowest channels, which would be expected if the MSCs were stiffening 
in the P3-P5 passage range, as suggested in Maloney et al. Meanwhile, for all passages, 
MSCs in wide channels more often migrated to the end of the channel and exited the 
other side.  
Furthermore, the biphasic relationship between MSC speed and microchannel 
width is similar to other cell types, such as S180 sarcoma cells (unpublished data) and 
MDA-MB-231 highly metastatic breast tumor cells [146], [147], but in contrast to other 
cell types. For example, the biphasic trend is in contrast to human osteosarcoma cells in 
microchannels, where cell speed monotonically decreases in response to confinement 
[25], and NIH-3T3 fibroblasts on 1D microphotopatterned lines, where cell speed 
monotonically increases in response to spatial confinement [135]. Interestingly, contact 
guidance seems to determine the path of cell migration in channels that are larger than 
its cell body [141]. Future work should investigate whether the biphasic relationship 
seen here between cell migration speed and confinement is due to the presence of an 
optimal channel width that is narrow enough to present contact guidance cues, yet wide 
enough not to severely constrict the nucleus during migration.  
Inhibition of microtubule polymerization via nocodazole did not affect MSC 
migration in confinement, but slowed cells in wide (20 μm and 50 μm) channels and 
decreased persistence in 50 μm channels. Nocodazole has been shown to decrease total 
traction force generation in cells on a planar surface and reduce actin intensity and 
organization in addition to loss of microtubule intensity and organization [226]. We 





due to the loss of a defined fibrillar microtubule network or simultaneous loss of actin 
organization. Confinement alone, in absence of any drug treatments, led to dissolution 
of the microtubule network, and thus we hypothesize the effects of nocodazole treatment 
on cell migration may have been more apparent in MSCs in wide channels, where the 
microtubules were more organized and fibrillar. Contrarily, metastatic breast tumor 
cells migrating in confinement were significantly slowed by microtubule inhibiting 
drugs of concentrations comparable to the one used herein [26], [147]. MSC cell cycle 
has been shown to be only partially affected by nocodazole [227], whereas cancer cells 
enter cell cycle arrest post-nocodazole treatment [228], and hence there may be 
secondary effects on other processes such as mitosis that may explain the differential 
effects of nocodazole on confined migration between MSCs and cancer cells. Future 
investigations may elucidate the cause for discrepancies between these cell types. 
On the other hand, nocodazole has also been suggested to increase contractility 
and traction force generation [217], [220] through a microtubule depolymerization-
associated release of GEF-H1, which activates RhoA [217]–[219], so we explored 
whether our results were a direct effect of microtubule depolymerization, an effect of 
increased traction forces, or both. We chose an approach based on a previous study, 
which demonstrated that the nocodazole-mediated increase in cell contractility was 
abrogated by combined treatment with blebbistatin [220]. In our work, MSCs treated 
with both nocodazole and blebbistatin responded similarly to nocodazole-treated cells 
rather than blebbistatin-treated cells, and exhibited the largest changes in speed 
compared to control, especially in wide channels. Thus, we hypothesize that slowed 





contractility. Furthermore, these results suggest that decreased contractility via 
blebbistatin, or blebbistatin itself, may exacerbate the effects of microtubule inhibition 
in wide channels. 
Inhibition of myosin II contractility via blebbistatin significantly enhanced MSC 
speed in 3 μm, 10 μm, and 50 μm wide channels. However, the percent change in speed 
for blebbistatin-treated cells from vehicle control cells was greatest for narrow channels, 
and decreased as channels widened. Additionally, blebbistatin enhanced MSC 
persistence in all channel widths except 6 μm. This result is supported by previous work, 
which showed that the inhibition of myosin II via blebbistatin in metastatic breast tumor 
cells significantly increased cell speed in confinement [26]. Cell softening has been 
associated with blebbistatin treatment, [229], which may have allowed cells to more 
easily squeeze through the narrowest channels. Conversely, blebbistatin had no effect 
on neural stem cell speed in microtubes [148], perhaps demonstrating the different roles 
myosin II contractility may play in different stem cell types. Our results for nocodazole 
and blebbistatin treatment are both in opposition to what has been seen for NIH-3T3 
fibroblasts migrating on a 1D line or in 3D matrix [135].  
Cells were treated with Y27632 in order to inhibit ROCK, a signaling protein 
upstream from myosin contractility. Inhibition of ROCK enhanced MSC migration in 
wide channels, with dissimilar effects on cell speed than was seen with blebbistatin 
treatment. Similar results were found for MSCs migrating on a planar surface under 
shear stress [38] and MSCs migrating in a chemotaxis assay [230], where inhibition of 
ROCK increased MSC migration. Conversely, metastatic breast tumor cells were shown 





[26]. However, other studies have shown Y27632 to reduce the metastatic potential of 
cancer cells [231], and increased ROCK expression is correlated with poor clinical 
outcome in breast cancer patients [232]. We found that ROCK inhibition increased MSC 
persistence and increased the percentage of cells that entered channels (data not shown), 
similar to blebbistatin. Also similar to blebbistatin treatment, cell softening has been 
observed after Y27632 treatment [233], which may have allowed cells to more easily 
deform while squeezing into the narrowest channels.  
Inhibition of actin polymerization via latrunculin-A halted MSC migration, 
regardless of channel width. This is in accordance with previous work investigating the 
migration of neural stem cells in microtubes [148]. However, these results differ from 
the behavior of metastatic breast cancer and sarcoma cells, which were able to migrate 
efficiently in confinement despite having been treated with latrunculin-A [26], [67]. 
Sarcoma cells were shown to harness ion pump and aquaporin function to migrate in 
confinement via an osmotic engine model [67]. Though we did not assess ion pump and 
aquaporin expression or the osmotic engine model in the MSCs, our results suggest that 
a water permeation-based mechanism in the absence of actin polymerization is not 
sufficient to enable migration in this benign cell type.  
Given the diffuse actin network in narrow channels, we hypothesized that 
mature focal adhesions would be absent in cells in narrow channels. Indeed, the 
presence of mature, py-paxillin-rich focal adhesions in MSCs decreased with decreasing 
channel width. Similarly, metastatic breast cancer cells display smaller and less mature 





fibrosarcoma cells demonstrate a decrease in focal adhesion formation and a more 
disperse distribution of focal adhesion associated proteins [84], [234].  
3.5 Conclusion 
In summary, we have shown that MSCs respond differently to pharmacological 
inhibitors of cytoskeletal and contractile machinery in narrow vs. wide microchannels, 
suggesting that cells rely on these machinery to different degrees in confined vs. 
unconfined microenvironments. Inhibition of actin significantly hindered cell migration 
in both confined and unconfined microchannels. However, MSC migration in narrow 
channels was overall less sensitive to perturbations to the MSC cytoskeleton than MSCs 
in wide channels. These insights could allow for specific control of MSC infiltration 
into tissue engineered scaffolds and could also inform whether the degree of 
confinement in microchannels between anatomical structures directs cell migration 
during homing in vivo. Furthermore, it is possible that physical confinement, in 
conjunction with other microenvironmental cues, can be exploited to engineer and direct 
stem cells for use in regenerative therapies and/or in vitro models. A next step towards 
this goal is to further explore how mechanical confinement impacts nuclear morphology 
(Chapter 4), since deformation of the cell nucleus can influence many processes leading 








Chapter 4: Nuclear Deformation in Response to Mechanical 
Confinement is Cell Type Dependent3 
4.1 Introduction 
The way a cell senses and responds to a physical force can vary based on cell 
type or tissue microenvironment, potentially altering downstream events such as 
migration, homeostasis, differentiation, proliferation, or tumorigenesis [235], [236]. An 
important element in the force transmission pathway is the nucleus, the largest and 
stiffest cell organelle [237]. The nucleus has been characterized as a mechanosensor of 
the cell and transmits external forces emanating from the cellular microenvironment to 
the nuclear envelope housing the chromatin [6], [105], [126]. Mechanical forces 
propagate from the extracellular matrix (ECM) to mechanosensitive focal adhesions and 
cytoskeletal structures. Cytoskeletal structures are then connected to the nuclear lamina, 
below the nuclear envelope, through the linker of nucleoskeleton to cytoskeleton 
(LINC) complex [6]. Additionally, direct force application to the nucleus can induce 
chromatin stretch and transcriptional upregulation of a reporter transgene without 
involvement of the nucleo-cytoskeleton network [238]. Isolated and intracellular nuclei 
can deform anisotropically in response to both active and passive externally-applied 
forces. Active forces include atomic force microscopy (AFM) [101], biaxial stretching 
devices [239], and magnetic tweezers [240], while passive forces include glass 
 
 
3 Adapted from M.T. Doolin*, T.S. Ornstein*, and K.M. Stroka, Nuclear Deformation in Response to 
Mechanical Confinement is Cell Type Dependent, Cells, 8(5): 427 (2019) (* indicates co-first 





microtubes [241], three-dimensional (3D) hydrogels [128] or microfluidic devices [25], 
[26], [64], [146], [173]. Using AFM and micropipette nuclear aspiration, the nucleus 
can physically deform with as little as a few nanonewtons of force [101], [242]. 
Specifically, differentiated and undifferentiated nuclei alike preferentially deformed 
along their minor (short) axis in reaction to an applied force [101], [239], [243]. We 
have previously shown that the nuclear major (long) axis in human mesenchymal stem 
cells (MSCs) maintains a constant length with increasing degrees of lateral confinement 
[64]. In contrast, we have also shown that nuclear major (long) axis in mouse sarcoma 
(Ab3) cells increases in length with increasing degrees of lateral confinement [173]. 
While anisotropic deformation has been found to be inherent to nuclei of many different 
cell types, nuclear axis lengths in three dimensions have not been quantified in 
confinement.  
Physical confinement is experienced by cells in vivo in many contexts. For 
example, cells may be confined within channels between connective tissue and the 
basement membrane of muscle, nerve and epithelium [9], [10], during cell intravasation 
and extravasation [11], in the tumor microenvironment [12], and in interstitial tissue 
[13]. Indeed, the migration modes of several cell types is altered by the degree of 
confinement induced [9], [13], [66], [67], [244]. Although a vast array of cell types 
experience mechanical confinement, the components involved in mechanotransduction 
can differ among cell types. Cytoskeleton prestress, the composition of the LINC 
complex, and the organization of the nucleoskeleton can differ based on cell type [240]. 
Specifically, increased expression of lamin-A has been shown to correlate with 





particular cell type to nuclear anisotropy is influenced by lamin-A expression as well as 
chromatin organization, and lamin-A over-expression results in an increase in strain 
along the nuclear minor axis [101]. Additionally, the deformation of the nuclear major 
and minor axes can be influenced by microtubule and actin structures. In short-term 
biaxial stretching experiments with epithelial monolayers, it was discovered that 
microtubules resist deformation along the major axis while actin resists deformation 
along the minor axis [239]. Microtubule and actin networks have also been known to 
regulate cell volume, which can dynamically alter nuclear morphology [246]. In micro-
engineered 3D environments, the ratio of cellular to nuclear volume is conserved, but 
the specific volumes of the nucleus and cell is dependent on cell type [247].  It remains 
unknown whether these cytoskeletal proteins dictate nuclear deformability and nuclear 
volume in confined migration and if their role is different in varying cell types.   
In this work, we characterized the 3D morphology of nuclei within various cell 
types in response to physical confinement. Cell types were chosen for experimentation 
due to their differences in tissue origin, organism origin, disease pathology, and level of 
differentiation potency. To recapitulate and control the degree of confinement 
experienced by cells in vitro, we employed polydimethylsiloxane (PDMS)-based 
microchannels that were 30, 60, 100, 200, or 500 μm2 in cross-sectional area and 
previously designed and characterized [25], [26]. Nuclear deformation in the XYZ 
planes as well as nuclear area and volume were quantified using immunofluorescence 
and Image J software. The effects of myosin II inhibition and microtubule 
depolymerization on nuclear deformation were additionally investigated. Our results 





than the force of confinement alone and that actin and microtubules may not 
independently modulate nuclear anisotropy in confined cell migration.   
4.2 Materials and methods 
4.2.1 Cell culture and reagents 
Bone marrow-derived human MSCs (donor: 20 year- old female) were 
purchased (RoosterBio Inc., Frederick, MD) and experimentally used up until passage 
5, which is when the population reaches a doubling level of 20. Human breast 
adenocarcinoma highly metastatic cells (MDA-MB-231 cells; American Type Culture 
Collection, Manassas, VA, USA) were used up to a passage of 30 after purchase. 
Finally, adult mouse fibroblasts (L929 cells) were gifted from Dr. John Fisher (Fischell 
Department of Bioengineering at the University of Maryland, College Park) and were 
used up to a passage of 10. 
All cell types were cultured in either T-25 or T-75 polystyrene, plasma-treated 
flasks (VWR, Radnor, PA) and grown in medium comprised of 89% Dulbecco’s 
modified Eagle’s medium with high glucose (DMEM; ThermoFisher Scientific, 
Waltham, MA), 10% heat inactivated fetal bovine serum (FBS; ThermoFisher 
Scientific), and 1% penicillin/streptomycin 1000 U/mL  (P/S; ThermoFisher Scientific). 
All cells were cultured at 37 °C, 50% humidity, and 5% CO2: 95% air and passaged at 
or below 90% confluency. Cells to be passaged were first washed in phosphate buffered 





EDTA (ThermoFisher Scientific), except for MSCs, which were treated with TrypLE 
Express Enzyme (ThermoFisher Scientific). 
4.2.2 Microfluidic device manufacturing and cell seeding 
Polydimethylsiloxane (PDMS) microfluidic devices were prepared according to 
previously described protocols [25], [26], [64]. The devices contain a variety of channel 
widths or a repeating, single channel width. All photolithography procedures were 
carried out in the University of Maryland Nanocenter FabLab. In summary, separate 
masks were designed in AutoCAD (AutoDesk, San Rafael, CA) for the channels (first 
feature) and the seeding and collection reservoirs (second feature). A 4-inch diameter 
silicon wafer (University Wafer, Boston, MA) was spin coated with a 10-mm thick layer 
of SU-8-3010 negative photoresist (MicroChem, Westborough, MA), and the mask 
representing the channels was placed over the coated wafer using the EVG620 mask 
aligner (EVG Group, Albany, NY). The layers were then selectively exposed to UV to 
complete crosslinking of the SU-8-3010 in the areas dictated by the mask. Remaining 
SU-8-3010 was then dissolved using SU-8 developer (MicroChem). To create the 
second feature, a layer of SU-8 3025 negative photoresist (MicroChem) was spin coated 
onto the wafer. Then the EVG620 mask aligner was used to place the mask of the 
seeding and collection reservoirs over the coated wafer. The system was once again 
selectively exposed to UV and the extra SU-8-3010 was removed. The completed 
wafers were silanized using 97% tridecafluoro-1,1,2,2, tetrahydrooctyl-1-
trichlorosilane (UCT Inc., Bristol, PA, USA) overnight in a vacuum desiccator. The 





microchannel devices, defined by the widths of their channels, which included 50, 20, 
10, 6, and 3 μm. Regardless of channel width, all channels were 10 μm in height and 
200 μm in length. 
From the silicon masters, PDMS devices were fabricated. PDMS (Krayden, 
Denver, CO, USA) was weighed and mixed at a 10:1 base: curing agent ratio, poured 
into a silicon master, degassed in a vacuum desiccator for approximately 30 minutes 
and baked at 80 °C for at least 1 hour. Devices were cut out of the silicon master and 
holes were punched into the PDMS to create cell and media inlets and outlets. 
Microchannels and 25 mm by 75 mm #1 glass coverslips (Electron Microscopy 
Sciences, Hatfield, PA) were washed with ethanol and reverse osmosis or MilliQ water, 
dried for 5 minutes at 80°C and plasma treated in the plasma cleaner (Harrick Plasma, 
Ithaca, NY) for 2.5 minutes. The devices were then bonded to the glass coverslips by 
applying pressure for 3 minutes and UV sterilized for 10 minutes. Finally, devices were 
coated with 20 ug/mL collagen I (Sigma Aldrich, St. Louis, MO) for 1 hour at 37°C. 
After incubation, collagen was removed, devices were washed twice with PBS, and cells 
were immediately seeded into the cell inlet. 
During the collagen I coating incubation time period, cells were prepared for 
device seeding. Cells were removed from the incubator, washed once with PBS and 
detached with the addition of trypsin for 5 minutes. FBS-containing media was then 
added, and the cells were centrifuged at 1000 RPM for 5 minutes. Cells were 
resuspended in FBS-free media, counted, centrifuged again, and resuspended again in 
FBS-free media to yield 100,000 cells per 25 μl. Twenty five microliters of cell 





minutes, the cell suspension was removed and 50 μl of FBS-free media was added to 
the cell inlet and bottom two media inlets, and 50 μl of FBS-containing media was added 
to the topmost inlet to create a chemoattractant gradient. For studies including 
blebbistatin (50 μM, Sigma Aldrich) or nocodazole (10 μM, Sigma Aldrich), the 
inhibitor was added to both FBS-free and FBS-containing media, such that it was in 
equal concentrations throughout the device. Dimethyl sulfoxide (Sigma Aldrich) served 
as the vehicle control in all experiments. Cells were incubated overnight to allow for 
migration through the channels. All microchannel devices containing cells were 
cultured at 37°C, 50% humidity, and 5% CO2: 95% air. 
4.2.3 Immunofluorescence 
Following an overnight incubation period, cells and media were removed from 
the inlets and outlets. In all future steps listed below, when a reagent was added, it is 
implied that the same volume was added to all wells. Cells were washed once with PBS 
and immediately fixed with 3.7% formaldehyde (Fisher Scientific, Fair Lawn, NJ). 
After a 10-minute incubation at room temperature, cells were washed thrice with PBS. 
Cells were permeabilized by the addition of 0.5% Triton-X 100 (Sigma Aldrich) for 5 
minutes, followed by three PBS washes. Nonspecific binding was then blocked with 
2.5% goat serum (Abcam, Cambridge, MA) for 1 hour at room temperature. Primary 
antibody diluted in PBS and 1% goat serum was added and samples were incubated 
overnight at 4°C. Primary antibodies used were mouse anti-α-tubulin (ThermoFisher 
Scientific #A11126, 1:100 or 1:200). The next day, cells were washed twice or thrice in 





488 Phalloidin (ThermoFisher Scientific, 1:500), Hoechst (ThermoFisher Scientific, 
1:500 or 1:2500) and a fluorescently labeled secondary antibody for 1 hour. Secondary 
antibody and dilution used was AlexaFluor 568 goat anti-mouse (ThermoFisher 
Scientific #A11004, 1:200). Cells were washed twice or thrice in PBS and imaged 
immediately or within a few days when Fluoromount-G (ThermoFisher Scientific) was 
added for preservation.   
4.2.4 Imaging 
Widefield or confocal microscopy was used to extrapolate nuclear dimensions. 
MSC, MDA-MB-231 and L929 images for 2D measurement extrapolation were 
acquired on an Olympus IX83 microscope (Olympus, Tokyo, Japan) using a 40x or 60x 
oil immersion objective. All Z stack images were taken using a PerkinElmer UltraVIEW 
Vox confocal spinning disk microscope (PerkinElmer, Waltham, MA) with a 100x oil 
immersion objective. Z-step size was 0.1 μm or 0.2 μm, and the boundaries of the stack 
were defined as the planes in which no staining could be observed. Use of the 
PerkinElmer confocal microscope was performed courtesy of the University of 
Maryland imaging core. In all experiments, fluorescence intensity and sensitivity were 
adjusted manually to optimize visualization. 
4.2.5 Data analysis in 2D 
All data analysis for calculating 2D nuclear major axis length, minor axis length 
and area was completed in ImageJ using the built-in morphology measurements. 





then dimensions originally output as pixels were converted into microns for analysis.  
Specifically, to calculate nuclear major and minor axes lengths, ImageJ fitted the traced 
nuclei to ellipses.  
4.2.6 Data analysis in 3D 
ImageJ was used to quantify volume from acquired Z-stacks. First, the edges of 
Z-stacks were cut according to the built in ImageJ feature, Find Edges. This was 
completed to minimize the effects of background fluorescence during thresholding. The 
top and bottom planes were defined as the first and last image plane, respectively, in 
which an edge of the nucleus was visible. Next, IsoData thresholding was performed. 




. This automated thresholding method was chosen to 
exclude any bias in the analysis and for its ability to threshold consistently for nuclei in 
all channel widths. Thresholding was calculated based on the middle plane of the stack 
and applied to all other planes in the stack. After thresholding, the ImageJ feature, Fill 
Holes, was used to correct any large holes in the interior of the nuclei caused by excess 
thresholding or low fluorescence signal. The ImageJ plugin “3D Object Counter” was 
then used to automatically calculate volume based on the number of voxels of the object. 
3D object Counter also yielded the length, width, and height of the object bounding box. 
This methodology was validated by seeding 10 μm, yellow-green fluorescent 
polystyrene microspheres (ThermoFisher Scientific) inside the channels and completing 
a similar imaging protocol to experimental conditions. In a 50 μm wide channel and a 





methodology was 570 μm3, in comparison to the expected volume of 524 μm3, which 
yields a percent error of 8.8%. 
4.2.7 Statistical Analysis 
To compare nuclear dimensions in different channel widths, a one-way 
ANOVA, in the case of normally distributed data, or Kruskal-Wallis test with a Dunn’s 
post hoc test, in the case of non-normally distributed data, was completed. Data were 
pooled from at least three independent trials, except in 2D data for MSC and MDA-MB-
231, which were pooled from two independent trials. A significance level of 0.05 was 
used. Error bars report the standard error of the mean. Select graphs were unable to fit 
all comparisons, in which case we refer readers to the supplementary tables for full 
statistical analysis. 
4.3 Results 
4.3.1 Nuclear deformation as a function of confinement is cell type-
dependent 
We have previously shown that MSC morphology and cytoskeletal arrangement 
is altered with increasing confinement [64], and here we aimed to determine whether 
cells from different species origin, tissue location, and disease state display similar 
behaviors. We chose to examine MSCs, MDA-MB-231 cells, and L929 cells. These cell 
types were chosen due to their differences in tissue origin (bone marrow, mammary 
gland, and subcutaneous connective tissue, respectively) organism origin (human, 





Furthermore, these cells are extensively used throughout literature in many different 
applications and therefore we found them to be relevant cell models. We first visualized 
nuclear morphology of the three cell types within microchannels of varying width (Fig. 
4.1). We note that 50 μm wide channels served as our “unconfined” control, where cells 
were not constrained in the x-y plane. Indeed, cell nuclei in 3 μm narrow channels 
consistently appeared quite elongated and ellipsoidal in the x-y plane (Fig. 4.1A, 4.1C, 
4.1E). As the channels widened, the nucleus became more circular in the x-y plane as 
the cells themselves became more spread (Fig. 4.1B, 4.1D, 4.1F). We first quantified 
whether there were differences in x-y nucleus area, major axis length, or minor axis 
length (Fig. 4.1G) with increasing confinement (i.e., decreasing channel width). In all 
cell types, nucleus area decreased with increasing confinement, albeit with different 
levels of significance (Fig. 4.1H and Table 4.1). Similarly, the nucleus minor axis 
decreased with increasing confinement for all cell types (Fig. 4.1I and Table 4.2). Note 
that due to manual tracing of widefield microscopy images, some minor axis values 
were slightly above their respective microchannel width. We maintain that this 
variability is consistent across all channel widths. Interestingly, cell type-dependent 
trends emerged for nucleus major axis length. MSCs and MDA-MB-231 cells 
maintained a fairly constant nucleus major axis length as a function of channel width, 
with some exceptions (Fig. 4.1J and Table 4.3). L929 cells showed a marked increase 
in nucleus major axis length with increasing confinement (Fig. 4.1J and Table 4.3). 
These trends in L929 cell nuclei are similar to what we have previously shown in mouse 
sarcoma cells [173]. In summary, the nucleus major axis deformed differently in 





our previously published mouse sarcoma cells). Having made these 2D observations in 
the x-y plane, we next investigated if there were cell type-dependent differences in 





Figure 4.1 Quantification of 2D nuclear morphology in confinement. Images are 
shown for MSCs within microchannels of width A) 3 μm and B) 50 μm. Images are 
shown for L929 cells within microchannels of width A) 3 μm and B) 50 μm. Images 
are shown for MDA-MB-231 cells within microchannels of width E) 3 μm and F) 
50 μm. In panels (A-F) cells were fixed and stained for actin (green) and the nucleus 
(blue). Color channels were altered individually for optimal visualization. Scale 
bar represents 10 μm in panels (A-F). G) Definition of nuclear major and minor 
axis. Also shown is quantification of nucleus H) area, I) minor axis, and J) major 
axis of MSCs, MDA-MB-231 cells, and L929 cells. Markers on line graphs report 
mean ± SEM of n cells, pooled from N≥2 independent experiments with n(3 μm, 
MSC)=9, n(3 μm, MDA-MB-231)=178, n(3 μm, L929)=26, n(6 μm, MSC)=25, n(6 
μm, MDA-MB-231)=114, n(6 μm, L929)=21, n(10 μm, MSC)=21, n(10 μm, MDA-
MB-231)=98, n(10 μm, L929)=80, n(20 μm, MSC)=104, n(20 μm, MDA-MB-
231)=288, n(20 μm, L929)=44, n(50 μm, MSC)=289, n(50 μm, MDA-MB-231)=620, 
n(50 μm, L929)=136. Full statistical information for panels H-J is provided in 









Table 4.1 Statistics for nucleus area for MSCs, L929 cells, and MDA-MB-231 
cells, ns=not significant, *p<0.05, **p<0.005, ****p<0.0001. 
Area  MSC L929 MDAMB231 
3 vs 6 µm ns ns **** 
3 vs 10 µm ns **** **** 
3 vs 20 µm **** **** **** 
3 vs 50 µm **** **** **** 
6 vs 10 µm ns ns ** 
6 vs 20 µm **** * **** 
6 vs 50 µm **** **** **** 
10 vs 20 μm **** ns * 
10 vs 50 μm **** **** **** 








Table 4.2 Statistics for nucleus minor axis for MSCs, L929 cells, and MDA-MB-
231 cells, ns=not significant, *p<0.05, **p<0.005, ***p<0.0005, ****p<0.0001. 
Minor axis  MSC L929 MDAMB231 
3 vs 6 µm ns ns ** 
3 vs 10 µm **** **** **** 
3 vs 20 µm **** **** **** 
3 vs 50 µm **** **** **** 
6 vs 10 µm **** *** **** 
6 vs 20 µm **** **** **** 
6 vs 50 µm **** **** **** 
10 vs 20 μm **** ns ** 
10 vs 50 μm **** **** **** 
20 vs 50 µm * **** ns 
 
 
Table 4.3 Statistics for nucleus major axis for MSCs, L929 cells, and MDA-MB-
231 cells, ns=not significant, *p<0.05, **p<0.005, ***p<0.0005, ****p<0.0001. 
Major axis  MSC L929 MDAMB231 
3 vs 6 µm ns ns **** 
3 vs 10 µm ns **** ns 
3 vs 20 µm ns **** ns 
3 vs 50 µm ns **** *** 
6 vs 10 µm ns **** *** 
6 vs 20 µm ns * **** 
6 vs 50 µm * **** *** 
10 vs 20 μm ns ns ns 
10 vs 50 μm ** ns ns 
20 vs 50 µm *** ns ns 
 
4.3.2 Nuclear deformation in 3D is cell type-dependent 
To investigate the effects of confinement on nuclear height and volume, we 
narrowed our experimental cell lines to two. We selected MSCs and L929 cells due to 
their opposing trends in major axis length with increasing confinement, as measured 





microchannel width. Using ImageJ, we quantified nuclear volume and the length, width, 
and height of the nucleus (Fig. 4.2). Due to a high level of background fluorescence, we 
calculated nuclear volume of a shortened z-stack, as indicated by the “Find edges” tool 
in ImageJ. However, the images herein show the full z-stack. Therefore, a high amount 
of background fluorescence is evident above the confining microchannel in some 
figures. Both MSCs and L929 cells in 3 μm narrow channels appeared elongated, with 
diffuse microtubule structures and a defined actin ring around the cell perimeter (Fig. 
4.3A-B and Supplementary Movie S1-S2, captions for all movies found in the 
Appendix). As the channels widened, more actin stress fibers formed within MSCs, and 
the MSC nucleus became flattened in the z-axis (Fig. 4.3C and Supplementary Movie 
S3). In contrast, L929 cell nuclei maintained similar height in the z-axis as channels 
widened, and their cytoskeletal structures remained more diffuse than MSCs (Fig. 4.3D 
and Supplementary Movie S4). Length was comparable to major axis in 2D and width 
was comparable to minor axis in 2D. Nuclear volume in 20 μm wide channels was 
significantly increased in both MSC and L929 cells when compared to 3 μm wide 
channels (Fig. 4.3E-F). Additionally, L929 nuclei within 10 μm or 50 μm wide channels 
were significantly larger in volume than nuclei within 3 μm wide channels (Fig. 4.3F). 
In MSCs, nuclei in 3 μm and 6 μm channels were significantly smaller in width than 
MSCs in 50 μm channels, but nuclear length and height were unchanged with decreasing 
channel width (Fig. 4.3G and Tables 4.4-4.5). Similarly, L929 cell nuclei in 3 μm, 6 μm, 
and 10 μm wide channels all had significantly shorter widths than cell nuclei within 20 
μm channels (Fig 3.3H and Table 4.6-4.7). In contrast to MSCs, the L929 nuclear length 





channels (Fig. 4.3H and Table 4.6-4.7). Despite similar trends in nuclear volume, L929 
cells and MSCs differed in nuclear dimensionality. MSCs remained rather anisotropic 
in all channel widths; MSC nuclear length was significantly longer than nuclear width 
and height in all channel widths (Fig. 4.3G). L929 cell nuclei had similar anisotropic 
behavior in 3, 6, and 10 μm wide channels. However, L929 nuclei in 20 and 50 μm wide 
channels were isotropic, with no differences in nuclear length, width, or height (Fig. 
4.3H). Upon observing differences in nuclear volume and dimensionality with 
increasing confinement, we questioned if this behavior would be altered by 
perturbations to the cytoskeleton. 
 








Figure 4.3 Orthogonal views of A) MSC or B) L929 cell within 3 μm narrow 
channel. Orthogonal views of C) MSC or D) L929 cell within 50 μm wide channel. 
In panels (A-D) cells were fixed and stained for α-tubulin (red), actin (green), and 
the nucleus (blue). Color channels were altered individually for optimal 
visualization. Scale bar represents 10 μm and applies to panels (A-D). 3D 
renderings of nuclei shown in panels A-D are provided in Supplemental Movies 
S1-S4. Also shown are quantifications of the nucleus volume of E) MSCs or F) L929 
cells, along with nucleus length, width, and height of G) MSCs or H) L929 cells. 
Dot plots report mean ± SEM. *p<0.05, **p<0.005, ***p<0.0005, ****p<0.0001. 
(Each dot indicates one cell, pooled from N≥3 independent experiments). Full 
statistical information for panels G-H is provided in Tables 4.4-4.7. Thea Ornstein 










Table 4.4 Statistics for MSC nucleus dimensions, ns = not significant, **p<0.005, 
****p<0.0001. 
 Width Length Height 
3 vs 6 µm ns ns ns 
3 vs 10 µm ns ns ns 
3 vs 20 µm ** ns ns 
3 vs 50 µm **** ns ns 
6 vs 10 µm ns ns ns 
6 vs 20 µm ns ns ns 
6 vs 50 µm ** ns ns 
10 vs 20 μm ns ns ns 
10 vs 50 μm ns ns ns 
20 vs 50 µm ns ns ns 
 
 
Table 4.5 Statistics for MSC nucleus dimensions, ns = not significant, *p<0.05, 
**p<0.005, ***p<0.0005, ****p<0.0001. 
 Channel width (μm) 
 3 6 10 20 50 
Width vs. 
length 
**** **** **** * ns 
Width vs. 
height 
ns ns ns ns **** 
Length vs. 
height 













Table 4.6 Statistics for L929 cell nucleus dimensions, ns = not significant, 
*p<0.05, **p<0.005, ***p<0.0005, ****p<0.0001. 
 Width Length Height 
3 vs 6 µm ns ns ns 
3 vs 10 µm ns ns ns 
3 vs 20 µm **** ** ns 
3 vs 50 µm **** ** ns 
6 vs 10 µm ns ns ns 
6 vs 20 µm **** ns ns 
6 vs 50 µm *** ns ns 
10 vs 20 μm * ns ns 
10 vs 50 μm ns ns ns 
20 vs 50 µm ns ns ns 
 
Table 4.7 Statistics for L929 cell nucleus dimensions, ns = not significant, 
*p<0.05, **p<0.005, ***p<0.0005, ****p<0.0001. 
 Channel width (μm) 
 3 6 10 20 50 
Width vs. 
length 
**** **** **** ns ns 
Width vs. 
height 
** ** ns ns ns 
Length vs. 
height 
*** ns ** ns ns 
4.3.3 Microtubule polymerization is not necessary to maintain nuclear 
morphology in confinement 
To investigate the role of the microtubule network in maintaining nuclear 
volume and dimensionality in confinement, we inhibited microtubule polymerization in 
MSCs or L929 cells by adding 10 μM nocodazole to cell media. Nocodazole-treated 
cells within 3 μm narrow channels appeared similar to control, with diffuse cytoskeletal 





50 μm wide channels, nocodazole-treated MSCs and L929 cells appeared rounder, with 
less evidence of linear microtubule structures (Fig. 4.4C-D and Supplementary Movie 
S9-S12). MSCs treated with nocodazole in 10 and 50 μm wide channels contained 
nuclei with significantly larger volume than control (Fig. 4.5A). Although the nuclear 
heights appeared slightly larger in nocodazole treated cells compared to control, there 
was no significant difference in nuclear axis lengths between nocodazole treated and 
control groups for the same channel widths (Fig. 4.5B and Table 4.8-4.9). L929 cells 
treated with nocodazole showed no difference in volume or nuclear axis lengths from 







Figure 4.4 Orthogonal views of MSC treated with 10 μM nocodazole or vehicle 
control within A) 3 μm narrow channel and B) 50 μm wide channel. Orthogonal 
views of L929 cell treated with 10 μM nocodazole or vehicle control within C) 3 μm 
narrow channel and D) 50 μm wide channel. Cells were fixed and stained for α-
tubulin (red), actin (green), and the nucleus (blue). Color channels were altered 
individually for optimal visualization. Scale bar represents 10 μm. 3D renderings 
of nuclei shown in panels A-D are provided in Supplemental Movies S5-S12. Thea 











Figure 4.5 Nucleus A) volume or B) length, width, and height of MSCs treated with 
10x μM nocodazole or vehicle control. Nucleus C) volume or D) length, width, and 
height of L929 cells treated with 10 μM nocodazole or vehicle control. Dot plots 
report mean ± SEM. *p<0.05, **p<0.005, ***p<0.0005, ****p<0.0001. (Each dot 
indicates one cell, pooled from N≥3 independent experiments). Full statistical 








Table 4.8 Statistics for MSC nucleus dimensions when treated with 10 μM 
nocodazole or vehicle control ns = not significant, **p<0.005, ***p<0.0005, 
****p<0.0001. 
    Channel width (μm) 






l W vs. L *** ns *** ns ns 
W vs. H ns ns ns ns *** 
L vs. H ns ns *** **** **** 









W vs. L **** **** ** ns ns 
W vs. H ns ns ns ns ** 
L vs. H ns ns ns ** **** 
              
W Cont. vs. Noc. ns ns ns ns ns 
L Cont. vs. Noc. ns ns ns ns ns 

















Table 4.9 Statistics for MSC nucleus dimensions when treated with 10 μM 
nocodazole or vehicle control ns = not significant, **p<0.005. 
    Dimension 







3 vs. 6 μm ns ns ns 
3 vs. 10 μm ns ns ns 
3 vs. 20 μm ns ns ns 
3 vs. 50 μm ns ns ns 
6 vs. 10 μm ns ns ns 
6 vs. 20 μm ns ns ns 
6 vs. 50 μm ns ns ns 
10 vs. 20 μm ns ns ns 
10 vs. 50 μm ns ns ns 
20 vs. 50 μm ns ns ns 









3 vs. 6 μm ns ns ns 
3 vs. 10 μm ns ns ns 
3 vs. 20 μm ns ns ns 
3 vs. 50 μm ns ns ns 
6 vs. 10 μm ns ns ns 
6 vs. 20 μm ns ns ns 
6 vs. 50 μm ** ns ns 
10 vs. 20 μm ns ns ns 
10 vs. 50 μm ns ns ns 













Table 4.10 Statistics for L929 cell nucleus dimensions when treated with 10 μM 
nocodazole or vehicle control ns = not significant, *p<0.05, **p<0.005, 
***p<0.0005, ****p<0.0001. 
    Channel width (μm) 






l W vs. L **** **** ** ns ns 
W vs. H ns ns ns ns ns 
L vs. H ns ** ** ns *** 









W vs. L **** *** ns ns ns 
W vs. H ns ns ns ns ns 
L vs. H * ns ns ns ns 
              
W Cont. vs. Noc. ns ns ns ns ns 
L Cont. vs. Noc. ns ns ns ns ns 

















Table 4.11. Statistics for L929 cell nucleus dimensions when treated with 10 μM 
nocodazole or vehicle control ns = not significant, *p<0.05, ***p<0.0005, 
****p<0.0001. 
    Dimension 







3 vs. 6 μm ns ns ns 
3 vs. 10 μm ns ns ns 
3 vs. 20 μm ns ns ns 
3 vs. 50 μm ns ns ns 
6 vs. 10 μm ns ns ns 
6 vs. 20 μm ns ns ns 
6 vs. 50 μm ns ns ns 
10 vs. 20 μm ns ns ns 
10 vs. 50 μm ns ns ns 
20 vs. 50 μm ns ns ns 









3 vs. 6 μm ns ns ns 
3 vs. 10 μm ns ns ns 
3 vs. 20 μm *** ns ns 
3 vs. 50 μm **** ns ns 
6 vs. 10 μm ns ns ns 
6 vs. 20 μm ns ns ns 
6 vs. 50 μm * ns ns 
10 vs. 20 μm ns ns ns 
10 vs. 50 μm ns ns ns 
20 vs. 50 μm ns ns ns 
 
4.3.4 Myosin II contractility is not necessary to maintain nuclear 
morphology in confinement 
To investigate the role of the actomyosin network in maintaining nuclear volume 
and dimensionality in confinement, we inhibited myosin II-mediated contractility by 
adding 50 μM blebbistatin to cell media. In both wide and narrow microchannels, the 





groups (Fig. 4.6 and Supplementary Movie S13-S20). Some blebbistatin-treated L929 
cells in wide channels exhibited a longer trailing edge than control cells (Fig. 4.6D). We 
have previously shown that MSCs in microchannels do not exhibit altered microtubule 
structure upon blebbistatin treatment (Chapter 3). MSCs treated with blebbistatin in 20 
μm wide channels displayed nuclei with significantly less volume than MSCs treated 
with vehicle control (Fig. 4.7A). However, MSCs treated with blebbistatin did not show 
any differences in any axis lengths from control (Fig. 4.7B and Table 4.12-4.13). L929 
cells treated with blebbistatin showed no difference in volume or nuclear axis lengths 







Figure 4.6 Orthogonal views of MSC treated with 50 μM blebbistatin or vehicle 
control within A) 3 μm narrow channel and B) 50 μm wide channel. Orthogonal 
views of L929 cell treated with 50 μM blebbistatin or vehicle control within C) 3 
μm narrow channel and D) 50 μm wide channel. Cells were fixed and stained for 
actin (green) and the nucleus (blue). Color channels were altered individually for 
optimal visualization. Scale bar represents 10 μm. 3D renderings of nuclei shown 
in panels A-D are provided in Supplemental Movies S13-S20. Thea Ornstein 











Figure 4.7 Nucleus A) volume or B) length, width, and height of MSCs treated with 
50 μM blebbistatin or vehicle control. Nucleus C) volume or D) length, width, and 
height of L929 cells treated with 50 μM blebbistatin or vehicle control. Dot plots 
report mean ± SEM. *p<0.05, **p<0.005, ***p<0.0005, ****p<0.0001. (Each dot 
indicates one cell, pooled from N≥3 independent experiments). Full statistical 









Table 4.12 Statistics for MSC nucleus dimensions when treated with 50 μM 
blebbistatin or vehicle control ns = not significant, *p<0.05, **p<0.005, 
***p<0.0005, ****p<0.0001. 
    Channel width (μm) 






l W vs. L **** * ns ns ns 
W vs. H ns ns ns ns ns 
L vs. H ns ns ns *** **** 










W vs. L **** ** ** ns ns 
W vs. H ** ns ns ns ** 
L vs. H * ns * **** **** 
              
W Cont. vs. Bleb. ns ns ns ns ns 
L Cont. vs. Bleb. ns ns ns ns ns 
















Table 4.13 Statistics for MSC nucleus dimensions when treated with 50 μM 
blebbistatin or vehicle control ns = not significant, **p<0.005, ***p<0.0005, 
****p<0.0001. 
    Dimension 







3 vs. 6 μm ns ns ns 
3 vs. 10 μm ns ns ns 
3 vs. 20 μm ** ns ns 
3 vs. 50 μm *** ns ns 
6 vs. 10 μm ns ns ns 
6 vs. 20 μm ns ns ns 
6 vs. 50 μm ns ns ns 
10 vs. 20 μm ns ns ns 
10 vs. 50 μm ns ns ns 
20 vs. 50 μm ns ns ns 










3 vs. 6 μm ns ns ns 
3 vs. 10 μm ns ns ns 
3 vs. 20 μm ns ns ns 
3 vs. 50 μm **** ns ns 
6 vs. 10 μm ns ns ns 
6 vs. 20 μm ns ns ns 
6 vs. 50 μm ns ns ns 
10 vs. 20 μm ns ns ns 
10 vs. 50 μm ns ns ns 











Table 4.14 Statistics for L929 cell nucleus dimensions when treated with 50 μM 
blebbistatin or vehicle control ns = not significant, *p<0.05, ***p<0.0005, 
****p<0.0001. 
    Channel width (μm) 






l W vs. L **** **** *** ns ns 
W vs. H ns ns ns ns ns 
L vs. H **** *** * ns * 










W vs. L **** **** **** ns ns 
W vs. H *** * ns ns ns 
L vs. H ns ns * * * 
              
W Cont. vs. Bleb. ns ns ns ns ns 
L Cont. vs. Bleb. ns ns ns ns ns 














Table 4.15 Statistics for L929 cell nucleus dimensions when treated with 50 μM 
blebbistatin or vehicle control ns = not significant, *p<0.05, **p<0.005, 
****p<0.0001. 
    Dimension 







3 vs. 6 μm ns ns ns 
3 vs. 10 μm ns ns ns 
3 vs. 20 μm ** ns ns 
3 vs. 50 μm ns ns ns 
6 vs. 10 μm ns ns ns 
6 vs. 20 μm ns ns ns 
6 vs. 50 μm ns ns ns 
10 vs. 20 μm ns ns ns 
10 vs. 50 μm ns ns ns 
20 vs. 50 μm ns ns ns 










3 vs. 6 μm ns ns ns 
3 vs. 10 μm ns ns ns 
3 vs. 20 μm * ns ns 
3 vs. 50 μm **** ns ns 
6 vs. 10 μm ns ns ns 
6 vs. 20 μm ns ns ns 
6 vs. 50 μm ** ns ns 
10 vs. 20 μm ns ns ns 
10 vs. 50 μm ns ns ns 
20 vs. 50 μm ns ns ns 
 
4.4 Discussion 
In this study, we investigated how the passive force of confinement in 
microchannels affected nuclear deformation of various cell types. In 2D, nuclei of MSCs 
and MDA-MB-231 cells maintained a fairly constant major axis length when the minor 
axis was forcibly decreased by confining microchannel walls. In contrast, nuclei of L929 





microchannels, which is similar to what we have previously shown in mouse sarcoma 
cells [173]. It has also been reported in literature that the nuclei of several cell lines 
deform anisotropically in response to an applied force, with the minor axis exhibiting 
higher strain than the major axis [101]. These results were demonstrated to be both 
intrinsic to the nucleus and controlled by the cytoskeleton, and it was postulated that 
microtubules resist nuclear deformation along the major axis and actin resists 
deformation along the minor axis [101].  
We initially hypothesized that nuclear volume would not change with increasing 
confinement, leading us to a second hypothesis that the height of the MSC nuclei would 
increase with increasing confinement, whereas the height of L929 nuclei would remain 
constant. However, interestingly, nuclei of MSCs and L929 cells decreased in volume 
when they experienced the highest degree of confinement. This result is consistent with 
other studies that have reported changes in nuclear volume in response to the mechanical 
microenvironment. For example, nuclear volume was altered by nanotopography, 
potentially mediated by focal adhesion arrangement [100]. When confined to 
microwells, nuclear volume decreased with decreasing microwell volume [85]. 
Additionally, we observed a large range in the values of nucleus volume, and these 
values are on par with what others have reported [128], [246], [247]. Interestingly, 
nucleus volume has been shown to scale with cell volume [247], [248]. Mouse MSCs 
have been shown to have a nucleus volume of approximately 250 µm3 when osmotically 
compressed to a cell volume of approximately 1,000 µm3, which is in line with the 
nucleus volume we observed of MSCs and L929 cells in confinement [248]. When 





than observed here. Nucleus volumes ranged from approximately 170-230 µm3 when 
cell volume was modulated from 2800-9200 µm3 [85]. However, the microwells were 
approximately 10 kPa in elastic modulus, whereas the microchannels herein are 
approximately 1 MPa in elastic modulus, suggesting that there may be a complex 
interplay between physical confinement and matrix stiffness in regulating nuclear 
volume.  
 MSC nuclei were anisotropic in all channel widths, while L929 cell nuclei were 
anisotropic in the narrowest channels and isotropic in the widest channels. MSCs 
exhibited more defined actin stress fibers than L929 cells in wide channels. Given the 
flattened morphology of MSCs in wide channels, we hypothesize that actin stress fibers 
compress the MSC nucleus in wide channels, thereby reducing the nuclear height and 
increasing the nuclear width with decreasing confinement. MSCs increased nuclear 
height in response to increasing confinement, as nuclear width was forced to decrease. 
Interestingly, the MSC nuclear length remained constant in all channel widths. 
Conversely, L929 cells maintained the same nuclear height in all channel widths. We 
suggest that this is due to minimal stress fiber formation and minimal cytoskeletal 
tension in L929 cells which were more rounded. To compensate, L929 cells increased 
nuclear length in response to increasing confinement, as nuclear width was forced to 
decrease. It is interesting to note that L929 cells and MSCs have different origins – from 
mouse adipose and human bone marrow, respectively. It was previously observed that 
nuclear stiffness scales with tissue stiffness due to differences in lamin A content [45]. 
Although adipose and bone marrow are both soft tissues, MSCs have higher lamin A 





affect nuclear deformation in confinement. It has been shown that chromatin 
decondensation leads to a more isotropic deformation of fibroblast nuclei [101]. 
Additionally, it has been shown that polarized, elongated cells (similar to MSCs in wide 
channels) generate higher stress on the nucleus, have higher lamin A/C levels, and have 
less dynamic heterochromatin foci [122]. Conversely, isotropic cells contain a rounder 
nucleus, lower lamin A/C levels, and more dynamic heterochromatin foci [122]. These 
chromatin dynamics may ultimately influence nuclear deformation. 
We observed that inhibition of microtubule polymerization via nocodazole 
increased MSC nuclear volume within wider 10 and 50 μm channels. Nocodazole has 
been shown to increase nuclear volume and increase major axis strain in 2D [101], 
[246]. In two dimensions, microtubules seem to exert a force on the nucleus, as 
evidenced by a crescent shaped nucleus around the microtubule organizing center 
(MTOC) when lamin A is knocked out [249] and decreases in nuclear envelope 
fluctuations after nocodazole treatment [250]. Furthermore, inhibition of microtubule 
polymerization in the long term decreases elasticity of fibroblasts in 2D [251]. Similarly, 
we showed previously that nocodazole did not affect cell migration speed in 
confinement, but reduced cell speed in wide channels (Chapter 3). It is possible that 
microtubule polymerization has a reduced role in regulating nuclear morphology in 
confinement in comparison with 2D microenvironments. Nocodazole did not, however, 
affect the nuclear volume or dimensions of L929 cells in any channel width. The 
microtubule network in L929 cells already appeared quite diffuse in all channel widths 
before treatment, suggesting that microtubules in these cells contribute little to 





We also observed that inhibition of myosin II contractility decreased nuclear 
volume of MSCs in 20 μm wide channels. Blebbistatin is often used to decrease the 
stiffness of cortical actin [229], and may have reduced the force on the nucleus exerted 
by the actin network. Inhibition of myosin II by blebbistatin has been shown to decrease 
the force on the nucleus and increase the levels of phosphorylated lamin A/C, which is 
typically associated with lamin A/C turnover and rounding nuclei [252]. Untreated L929 
cells did not appear to have many actin stress fibers in any channel width, and hence 
they may have a low-contractile basal state. Therefore, the addition of blebbistatin did 
not seem to alter the cytoskeletal structure of L929 cells. In reporting these results, we 
also note an inherent limitation in our methods; confocal microscopy is a costly and 
time-consuming technique, so it is difficult to obtain a significantly large sample size 
for quantification of nuclear 3D volume and dimensions. Future studies could work 
towards developing a high throughput method of confining and imaging cells could 
enable larger sample sizes to support our conclusions. 
It does not appear that the external effectors of cell contractility or microtubule 
polymerization are key determinants of nuclear dimensions in confinement, which 
leaves the question if internal nuclear effectors control nuclear volume in confinement. 
Future studies may investigate the effects of chromatin decondensation or lamina 
disruption on nuclear volume, as these have both been demonstrated to decrease or 
increase, respectively, the anisotropic nucleus deformation in response to force [101]. 
Additionally, the LINC complex has been demonstrated to control the homeostatic 
position of the nucleus [253]. It is possible that the LINC complex may have a role in 





effectors ought to be investigated for their role in nuclear deformation in three 
dimensions. 
4.5 Conclusion 
In summary, we observed that different cell types deform differently in response 
to mechanical confinement. Microtubule polymerization and myosin II contractility do 
not appear essential in L929 cells for regulation of nuclear volume and dimensionality. 
Conversely, microtubule polymerization and myosin II contractility seem to play a role 
in maintaining nuclear volume and dimensionality in unconfined, but not confined, 
MSCs. This work informs our understanding of nuclear mechanics in 
microenvironments related to tissue homeostasis and disease and suggests diverging 
roles of the cytoskeleton in regulating nuclear deformation in different cell types.  
While the microchannel device used in this Chapter and in Chapter 3 was useful 
for learning new mechanobiological behavior of MSCs in confinement, exploration of 
a longer-term process, such as progression of IPF, requires a system that can support 
long-term culture and downstream biological readouts, while still exerting known 
amounts of mechanical confinement and retaining easy visualization of cells over time. 
Therefore, in the next Chapter, we designed, created, and validated confining 
micropillar arrays that achieves these requirements and, in Chapter 6, will enable us to 







Chapter 5: Integration of Mesenchymal Stem Cells into a Novel 
Micropillar Confinement Assay4 
5.1 Introduction 
While biological cues have long been recognized as important regulators of cell 
behavior, mounting evidence indicates that mechanical cues also have critical influences 
on cell migration, division, differentiation, and other essential cell processes [1], [64], 
[173]. Understanding and capitalizing on the effects of these mechanical cues can 
promote the successful outcome of tissue engineering strategies for repair and 
regeneration of tissues. Relevant external mechanical cues may include stiffness, 
topography, shear stress, viscoelasticity, and, as we discuss specifically herein, 
confinement. The field is recognizing that a variety of cell types, including fibroblasts, 
cancer cells, and epithelial cells, undergo migrational plasticity and enlist different 
mechanisms for confined migration than for unconfined migration [65]–[67]. For 
example, we have shown that confinement reduces the influence of microtubule 
polymerization on mesenchymal stem cell (MSC) migration (Chapter 3).  
Intravital imaging has revealed that cells indeed experience physical 
confinement in vivo [72], [254]. In addition, cells integrated into tissue engineered 
scaffolds likely experience physical confinement depending on the porosity and 
organization of the scaffold at the microscale. Three-dimensional cellular assays are 
 
 
4 Adapted from M.T. Doolin and K.M. Stroka, Integration of Mesenchymal Stem Cells into a Novel 





becoming increasingly popular, but many labs also have distinct methods and devices 
to study cell behavior in confinement. One approach uses micropatterned lines of a 
particular adhesive protein or grooves, creating 1D tracks upon which cells can migrate 
[135], [136], [138], [140]. This technique is advantageous due to its simplicity of 
production, ease of live cell imaging, and potential for single cell studies. While 1D 
patterning techniques can be similar to the migration of cells along extracellular matrix 
protein “tracks” in vivo, they do not account for the compression of the cell body and 
nucleus that a cell may experience in 3D in vivo microenvironments [137]. To mimic in 
vivo cell compression, systems have been designed to confine cells vertically, in which 
cell migration can be markedly different than on a 2D substrate [126], [143], [183]. 
However, in this method, cells are limited to only one axis of confinement [143]. 
Boyden chambers are also often employed for studying the effects of 3D confined 
migration on cell behavior [167]. While Boyden chambers are a useful tool for post-
confinement readouts, they do not allow for easy live visualization of cells within the 
chamber and do not easily allow for long-term culture in confinement [255]. Hydrogels 
are also commonly used to confine cells in a 3D microenvironment [129], [161]. 
However, hydrogels can lack precise control over the degree of 3D confinement 
experienced by the cells, and it is difficult to image and accurately track cells in 3D 
hydrogels over time. To address these shortcomings, we and others have analyzed cell 
migration through confining microchannels of various widths [25], [26], [144], [147], 
[148]. While this approach offers precise control over the degree of confinement 
experienced and ease of imaging, it provides a relatively small sample size that is 





require the introduction of a chemotactic gradient to encourage migration into small 
channels [25], [26], which may or may not be physiologically relevant for a given tissue 
engineering strategy. 
Here, we have developed a novel micropillar confinement assay that allows for 
precise control over the degree of confinement experienced by cells, enables 
visualization of cells in real time (on the order of weeks), and provides a large sample 
size for downstream biological assays. Our data show that MSCs alter their cell and 
nuclear morphology in response to confinement induced by micropillars. Furthermore, 
it appears MSCs may alter their migration mode based on the degree of confinement 
experienced or by the mere existence of micropillars. Overall, this micropillar assay will 
provide new fundamental information about cellular migration and mechanobiology in 
response to physical confinement. 
5.2 Materials and Methods 
5.2.1 Cell culture and reagents 
Bone marrow-derived human mesenchymal stem cells (Donor 1: 20 year-old 
female, Donor 2: 22 year-old male) were purchased from RoosterBio, Inc. (Frederick, 
MD, USA). Experiments were performed with Donor 1 unless otherwise noted in the 
figure caption. Cells were removed from liquid nitrogen and grown in RoosterBio basal 
media with media booster (RoosterBio, Inc.) for the first day post-thaw. Thereafter, cells 
were cultured in media composed of Dulbecco’s Modified Eagle’s Medium with high 





(FBS) (ThermoFisher Scientific), and 1% Penicillin-Streptomycin 10,000 U/mL 
(ThermoFisher Scientific). Cells were cultured and used until a population doubling 
level of 20 and cells were passaged at or below 80% confluency. Cells were washed 
with Phosphate-Buffered Saline (PBS) (VWR, Radnor, PA, USA), and detached with 
TrypLE Express Enzyme (ThermoFisher Scientific). All cells were cultured at 37°C, 
50% humidity, and 5% CO2:95% air. 
5.2.2 Micropillar device fabrication 
A polydimethylsiloxane (PDMS) micropillar device with micropillars of 
different spacing (Fig. 5.1A) was prepared via photolithography, as previously 
described [25], [26]. All photolithography procedures were carried out in the University 
of Maryland Nanocenter FabLab. Briefly, a mask was made in AutoCAD (AutoDesk, 
San Rafael, CA, USA) to represent the micropillars of different spacings. A layer of 
SU-8 3010 negative photoresist (MicroChem, Westborough, MA, USA) was spin 
coated onto a 4-inch diameter silicon wafer (University Wafer, Boston, MA, USA). 
Using an EVG620 mask aligner (EVG Group, Albany, NY, USA), the mask in the 
image of micropillars was placed over the wafer and exposed to ultraviolet (UV) light 
to crosslink. Excess SU-8 3010 was dissolved using SU-8 developer (MicroChem). 
Finished wafers were silanized using tridecafluoro-1,1,2,2,tetrahydrooctyl-1-
trichlorosilane (OTS, 97%) (UCT Inc., Bristol, PA, USA) overnight in a vacuum 
desiccator. The resulting silicon master contained micropillars with 50 μm, 20 μm, 10 
μm, and 5 μm spacing, and 13-17 μm height. These distances were chosen because they 





PDMS micropillar arrays were manufactured based on previously described protocols 
[143], [154]. PDMS (Krayden, Denver, CO, USA) was mixed at a 10:1 base:curing 
agent ratio, poured over the silicon master, and degassed in a vacuum desiccator. The 
PDMS and master were baked for at least 10 minutes at 100°C, and then the PDMS 
mold was cut and removed from the silicon master. The PDMS mold was then placed 
in a plasma cleaner (Harrick Plasma, Ithaca, NY, USA) and plasma treated for 2.5 
minutes. Finished molds were silanized using OTS (97%) overnight in a vacuum 
desiccator. PDMS was mixed at a 10:1 base:curing agent ratio, poured over the PDMS 
mold, and degassed in a vacuum desiccator. Glass coverslips (thickness #1, Fisher 
Scientific, Fair Lawn, NJ, USA) were then applied to each set of micropillars while 
applying gentle pressure. The PDMS and coverslips were baked overnight at 80°C, then 
the coverslip-PDMS micropillar constructs were carefully removed from the PDMS 
mold. The PDMS-coverslip construct ensured that the base PDMS layer was sufficiently 
thin for microscopy, but that cell would sense PDMS on all sides. 
PDMS blocks were coated in 8% Pluronic F127 (SigmaAldrich, St. Louis, MO, 
USA) solution for 1 hour at room temperature, then washed with DI water. Meanwhile, 
micropillar arrays were plasma treated for 2.5 minutes. Micropillar arrays were 
subsequently stamped with the Pluronic F127-coated PDMS blocks, and placed into 6-
well plates. The plates were UV sterilized for 10 minutes. 20 μg/mL collagen I 
(SigmaAldrich) was added to all wells and incubated for at least one hour at 37°C. The 
collagen I solution was then removed, and devices were washed twice with PBS before 






5.2.3 Scanning electron microscopy 
All SEM images were acquired in the University of Maryland Nanocenter 
AimLab by Dr. Sz-Chian Liou. SEM images were acquired using Hitachi SU-70 FEG 
SEM to visualize pillar spacing and Tescan XEIA FEG SEM/FIB to visualize pillar 
height. Pillar spacing and diameter were measured in ImageJ, and height was measured 
using Tescan microscope software. 
5.2.4 Immunofluorescence 
The following steps were carried out at room temperature, unless otherwise 
specified. Cells were fixed in 3.7% formaldehyde (Fisher Scientific) for 10 minutes, 
then washed two to three times in PBS (VWR). Cells were permeabilized with 0.5% 
Triton-X 100 (SigmaAldrich) for 5 minutes, washed in PBS two to three times, and 
blocked for nonspecific binding in 2.5% goat serum (Abcam, Cambridge, MA, USA) 
for at least one hour. Primary antibody in 1% goat serum was added to cells and 
incubated at 4°C overnight. Primary antibodies and dilutions used were mouse anti-α-
tubulin (ThermoFisher Scientific #A11126, 1:100) and rabbit anti-phospho-paxillin 
(Cell Signaling Technology #2541S, Danvers, MA, USA, 1:100). Cells were washed 
two to three times in PBS, incubated in 2.5% goat serum for at least one hour, then 
incubated with AlexaFluor 488 Phalloidin (ThermoFisher Scientific, 1:500), Hoechst 
(ThermoFisher Scientific, 1:2500), and a fluorescently labelled secondary antibody for 
one hour. Secondary antibodies and dilutions used were AlexaFluor 568 goat anti-
mouse (ThermoFisher Scientific #A11004, 1:200) and AlexaFluor 568 goat anti-rabbit 





PBS, then imaged. Images were acquired on an Olympus IX83 microscope (Olympus) 
using a 20x objective for cell morphology measurements or using a 60x objective for 
high magnification images. Images were acquired on a PerkinElmer UltraVIEW Vox 
confocal spinning disk microscope (PerkinElmer, Waltham, MA, USA) using a 20x 
objective to obtain z-stacks and to visualize actin, nucleus, microtubules, and focal 
adhesions. Use of the PerkinElmer confocal microscope was performed courtesy of the 
University of Maryland imaging core.  
5.2.5 Migration experiments 
Cells were seeded onto micropillar arrays and allowed to incubate overnight. 
The following day, media was changed and imaging began thereafter. Images were 
acquired on an Olympus IX83 microscope (Olympus) using a 20x objective. A chamber 
adjusted to 37°C, 50% humidity, and 5% CO2:95% air was used on the microscope stage 
in order to sustain cell viability. Images were taken at 10 minute intervals overnight.  
5.2.6 Data analysis 
For cell density, images of cell nuclei were thresholded and analyzed with the 
ImageJ Particle Analyzer. Cell density for each image was calculated by dividing the 
number of nuclei in an image by the total image area. For cell morphology, cells and 
nuclei were manually traced in ImageJ. Area, circularity, solidity, roundness, major 
axis, and minor axis were extracted using ImageJ built in morphology measurements. 
Roundness is equated to the inverse aspect ratio. Solidity was defined as the cell area 





manually identified for each frame. Only cells that stayed within frame for the duration 
of the timelapse were tracked. A custom MATLAB program was implemented to 
calculate the speed, trajectory, mean squared displacement (MSD), and turning angle 
for each cell based on the position of the cell centroid. To calculate cell migration 
parameters every 30 minutes, we considered the position of the cell centroid every 3rd 
frame since images were originally captured every 10 minutes. Skewness of turning 
angle distributions was calculated in Graphpad. 
5.2.7 Statistical analysis 
Data for cells from at least two independent trials was pooled for statistical 
analysis. A one-way ANOVA with Holm-Sidak’s multiple comparisons test, in the case 
of normally distributed data, or Kruskal-Wallis test with Dunn’s multiple comparisons 
test, in the case of non-normally distributed data, was performed to determine 
differences in data from micropillar arrays of different spacing and differences between 
time points. A significance level of 0.05 was used. Error bars report the standard error 
of the mean (SEM) or standard deviation (SD), as indicated in figure or table captions. 
5.3 Results 
5.3.1 MSCs completely infiltrate into micropillar arrays 
To entrap cells into the micropillar arrays, we aimed to encourage cell 
infiltration between pillars via cell attachment to the sides of the micropillars and 
migration on the cells’ own accord. The tops of the pillars were stamped with Pluronic 





printing method described previously [154]. The remaining surface area was coated in 
collagen type I to enable cell attachment to the micropillar sides and base (Fig. 5.1B).  
 
Figure 5.1 Micropillar preparation. A) Design of micropillar arrays. B) 
Representative workflow of micropillar array preparation. 
We next investigated whether cells were completely entrapped within the pillars 
(for a full confinement effect), or whether they protruded above the pillar height (for 
only partial confinement). Our goal was for cells to only “feel” the basal PDMS plane 
and the walls of the micropillars. When posts were shorter, with a height of 
approximately 11 μm, parts of the cell body protruded above the micropillars, and the 
cell appeared to extend over the tops of pillars in spots (Fig. 5.2A). Hence, we fabricated 
14 μm tall pillars and confirmed that these arrays fully confined the cell body and 






Figure 5.2 Micropillar specifications selection. Confocal images of MSCs within A) 
11 μm tall micropillars or B) 14 μm tall micropillars. For both panels i) shows the 
XY plane, ii) shows the YZ plane, and iii) shows the XZ plane. White arrows 
indicate cell regions atop the micropillars. Cells were fixed and stained for actin 
(green) and the nucleus (blue). Scale bars represent 50 μm. 
Next, we verified the dimensions of the 14 μm tall micropillars using scanning 
electron microscopy (SEM, Fig. 5.3). Micropillars with spacing of 5, 10, 20, and 50 μm 
were indeed measured to be approximately the theorized spacing, and the micropillar 
diameter was ~9 μm for all micropillar spacings (Fig. 5.3A-D, Table 5.1). Micropillars 
with spacing of 5, 10, 20, and 50 μm were approximately 13, 14, 13, and 17 μm tall, 
respectively, as measured by SEM (Fig. 5.3E-H, Table 5.1). We speculate that this 
height discrepancy could be minimized if each micropillar array was manufactured on 
its own silicon wafer, such that each array has its own optimized parameters during 























Figure 5.3 Micropillar specifications validation. SEM images of micropillar array 
distribution with spacings of A) 5 μm, B) 10 μm, C) 20 μm, and D) 50 μm. SEM 
images of micropillar array height with spacings of E) 5 μm, F) 10 μm, G) 20 μm, 

















(mean ± SD) 
Pillar diameter 
(mean ± SD) 
Pillar height 
(mean ± SD) 
5 μm 5.861 ± 0.21 μm 9.160 ± 0.16 μm 12.82 ± 0.29 μm 
10 μm 10.95 ± 0.30 μm 8.622 ± 0.19 μm 14.27 ± 0.21 μm 
20 μm 20.35 ± 0.25 μm 9.217 ± 0.25 μm 13.26 ± 0.20 μm 
50 μm 51.57 ± 0.60 μm 9.011 ± 0.51 μm 16.94 ± 0.92 μm 
 
5.3.2 Cell density is consistent across micropillar spacings in short-term 
culture 
After cells were seeded atop the micropillar arrays and incubated overnight, cells 
appeared to have infiltrated between the micropillars. A change in cell culture medium 
removed any cells remaining in suspension, but did not dislodge most cells within 
pillars. Cells remained within the micropillars after 48 hours, ensuring cell infiltration 
was not transient and could withstand media changes. Despite this, we wanted to ensure 
that cell density was fairly constant between micropillar arrays and for cells from 
multiple MSC donors. We quantified cell density within the micropillars at both 24 and 
48 hours post-seeding. For Donor 1 cells, at 24 hours, there was no difference in the cell 
density between micropillar arrays (Fig. 5.4A). However, for Donor 1 cells, by 48 hours, 
there were less cells within 50 μm spaced pillars than any other pillar spacing (Fig. 





from a second donor (Donor 2) within micropillar arrays. There was no difference in 
cell density between micropillar spacings at 24 or 48 hours, suggesting that cell seeding 
density may need to be optimized for each MSC donor and carefully considered when 
interpreting biological outcomes from the experiments (Fig. 5.4C-D). 
 
Figure 5.4 MSC density within micropillars. Donor 1 MSC density within 
micropillars for A) 24 hours or B) 48 hours. Donor 2 MSC density within 
micropillars for A) 24 hours or B) 48 hours. Dot plots report mean ± SD. *p<0.05, 






5.3.3 Cell and nucleus morphology within micropillars is altered by 
micropillar spacing 
Fluorescence images of cell actin demonstrated that micropillar spacing 
drastically affected cell and nucleus morphology (Fig. 5.5A-D). Qualitatively, we 
observed cell spreading behaviors typical of 2D substrates in the 50 μm spaced pillars, 
while cells in the narrow spacings displayed much more spindly, protrusive 
morphologies with most cells physically wrapping around micropillars. At both 24 and 
48 hours, cells within arrays of 20 μm and 50 μm spaced pillars were significantly larger 
in area than those in arrays of 5 μm spaced pillars (Fig. 5.5E). At both time points, cells 
within arrays of 5 μm spaced pillars were significantly less solid than cells in any other 
micropillar array and significantly less circular than cells within 20 μm arrays (Figs. 
5.5F, 5.5H), which was expected given their spindly, protrusive morphology. There was 
no significant difference in any cell morphology measure within any pillar spacing from 













Figure 5.5 MSC morphology within micropillars. MSC actin cytoskeleton and 
nucleus after 48 hours in micropillar arrays with spacings of A) 5 μm, B) 10 μm, 
C) 20 μm, or D) 50 μm. In panels (A-D) cells were fixed and stained for actin (green) 
and the nucleus (blue). E) Area, F) solidity, G) roundness, and H) circularity of 
MSC body as a function of pillar spacing after 24 hours and 48 hours within the 
micropillars. Dot plots report mean ± SEM. *p<0.05, **p<0.005, ***p<0.0005, 
****p<0.0001. Each dot indicates one cell, pooled from N=2 independent 
experiments with n(5 μm, 24 hours)=56, n(5 μm, 48 hours)=94, n(10 μm, 24 
hours)=45, n(10 μm, 48 hours)=78, n(20 μm, 24 hours)=47, n(20 μm, 48 hours)=66, 










Cell nuclei followed a slightly more consistent trend. Nucleus morphology was 
measured as above, and we additionally measured the major and minor axis. Major and 
minor axis indicate the longest and shortest axis, respectively, of an ellipse fit to the 
nucleus (Fig. 5.6A-B). In pillar arrays of 5 μm spacing, the fitted ellipse was typically 
larger than the nucleus (Fig. 5.6A). In pillar arrays of 10 μm spacing or wider, the nuclei 
were naturally ellipsoidal (Fig. 5.6B). At both 24 and 48 hours, cell nuclei within pillar 
arrays of 5 μm spacing were significantly smaller in 2D area, less solid, less round, and 
less circular than cell nuclei in any other array (Fig. 5.6C-F). Interestingly, there was no 
significant difference in the nucleus major axis among micropillars of different spacing, 
but the nucleus minor axis was significantly smallest in arrays with 5 μm pillar spacing 
(Fig. 5.6G-H). Future studies should examine if cell nuclei alter their volume in response 
to confinement within micropillars. 
 
Figure 5.6 MSC nucleus morphology within micropillars. MSC nucleus in 
micropillar arrays with spacings of A) 5 μm and B) 10 μm. In panels (A-B) cells 
were fixed and stained for actin (green) and the nucleus (blue). C) Area, D) solidity, 
E) roundness, F) circularity, G) major axis, and J) minor axis of MSC nucleus as 
a function of pillar spacing after 24 hours and 48 hours within the micropillars. 
Dot plots report mean ± SEM. *p<0.05, **p<0.005, ***p<0.0005, ****p<0.0001. 
Each dot indicates one cell, pooled from N=2 independent experiments with n(5 
μm, 24 hours)=56, n(5 μm, 48 hours)=94, n(10 μm, 24 hours)=45, n(10 μm, 48 
hours)=78, n(20 μm, 24 hours)=47, n(20 μm, 48 hours)=66, n(50 μm, 24 hours)=35, 










We have also demonstrated that cells can remain viable and integrated within 
the micropillar confinement array for at least 3 weeks, and likely longer. When MSCs 
were cultured in micropillars for 3 weeks, they formed elongated networks within the 
narrowest micropillar arrays (Fig. 5.7A-B). MSCs cultured within the widest micropillar 
arrays for 3 weeks were similar in appearance to a two-dimensional monolayer (Fig. 
5.7C-D). In addition to network formation, some cells began to protrude over the pillar 
tops (Fig. 5.7A). There were fewer cells within pillar arrays of 5 μm than those of 20 or 
50 μm; thus, quantitative biological readouts may need to be normalized to cell density 
(Fig. 5.7E). Such long-term culture and high cell counts may allow for the examination 
of cell response to confinement in situations relevant for tissue engineering applications, 








Figure 5.7 MSCs within micropillars for 3 weeks. MSCs in micropillar arrays with 
spacings of A) 5 μm, B) 10 μm, C) 20 μm, or D) 50 μm. E) MSC density after 3 
weeks. In panels (A-D) cells were fixed and stained for actin (green) and the 
nucleus (blue). Scale bars represent 50 μm. In panel (E) dot plots report mean ± 










5.3.4 MSC cytoskeletal elements become more diffuse with increasing 
confinement 
We next investigated whether the changes in cellular morphology as a function 
of micropillar array spacing were accompanied by alterations in organization of the cell 
cytoskeleton. Within all micropillar arrays, regardless of pillar spacing, some cells 
exhibited f-actin-rich protrusions wrapping entirely around the pillars (Fig. 5.8). To 
determine whether cells were adhering to the pillars via focal adhesions, we 
immunostained for tyrosine-phosphorylated (py-) paxillin, a protein associated with 
focal adhesions. Indeed, we observed areas of high py-paxillin signal associated with 
the micropillars (Fig. 5.8A-B). MSCs within 50 μm spaced micropillars exhibited many 
linear, mature focal adhesions at the end of f-actin stress fibers, indicative of highly 
contractile cells (Fig. 5.8D). These linear, mature focal adhesions decreased with each 
subsequent decrease in pillar spacing (Fig. 5.8B-C). MSCs within 5 μm spaced 
micropillars exhibited mostly punctate py-paxillin dispersed through the cell (Fig. 
5.8A). These results are consistent with our own previous work in microchannels 
(Chapter 3). 
We also examined how microtubules were arranged within MSCs via 
immunostaining of α-tubulin. Microtubules were fairly well-localized to regions of f-
actin in confined MSCs within 5 μm and 10 μm spaced micropillars (Fig. 5.8E-F). MSCs 
within 20 μm and 50 μm spaced micropillar arrays exhibited the strongest microtubule 
signal surrounding the cell nucleus, while f-actin mainly resided along the cell perimeter 





micropillars. Together, these results provide further confirmation that the cell 
cytoskeleton and adherence patterns can be altered by physical confinement, which we 
also hypothesized could result in cell phenotypes with altered functionality in behaviors, 












Figure 5.8 MSC cytoskeleton within micropillars. Basal plane of MSC cytoskeleton 
in micropillar arrays with spacing of A) 5 μm, B) 10 μm, C) 20 μm, and D) 50 μm. 
Maximum projection of MSC cytoskeleton in micropillar arrays with spacing of 
E) 5 μm, F) 10 μm, G) 20 μm, and H) 50 μm. In panels (A-D) cells were fixed and 
stained for py-paxillin (red), actin (green), and the nucleus (blue). Areas of strong 
signal are indicated by white arrows. In panels (E-H) cells were fixed and stained 
for α-tubulin (red), actin (green), and the nucleus (blue). Color channels were 










5.3.5 MSCs migrate within micropillar arrays 
Our next goal was to use phase contrast imaging to confirm that cells were 
capable of robust migration within the micropillars (Fig. 5.9). Cells displayed several 
interesting behaviors when migrating within the micropillars. In arrays where pillars 
were 5 μm or 10 μm apart, cells remained mostly elongated. MSCs typically approached 
a pillar, probed around both sides, and “chose” one of those two sides to migrate around 
(Fig. 5.9A). Occasionally, cells appeared to engulf a pillar entirely to migrate around it. 
In arrays where pillars were 20 μm or 50 μm apart, different migration patterns emerged. 
The cells often migrated in a mesenchymal mode, like their behavior in 2D (Fig. 5.9B). 
However, cells also migrated in a somewhat amoeboidal mode, characterized by 
alternating periods of fast, directional migration and slower, more random migration 
(Fig. 5.9C). Occasionally, another mode appeared where cells attached to a pillar, clung 
to it for some time, and then rapidly migrated to another pillar where it attached and 
rounded up yet again (Fig. 5.9D). These observations of different migration modes 






Figure 5.9 MSC migration phenotypes within micropillars. Representative image 
sequences of A) MSC migrating in confined 5 μm pillar spacing, B) MSC migrating 
in a mesenchymal mode within wide 50 μm pillar spacing, C) MSC migrating in 
amoeboidal mode within wide 50 μm pillar spacing, and D) MSC attaching to a 
micropillar within wide 50 μm pillar spacing (MSC of interest denoted by yellow 






To investigate cell migration, we manually tracked each cell’s movement every 
10 minutes or every 30 minutes. We hypothesized that cell migration parameters, 
including speed and turning angle distribution, would depend on time interval chosen 
for analysis, where, at short timescales, cells may be more persistent, but turn more or 
measure slower speeds when undergoing random migration. Qualitatively, MSC 
trajectories within the 5 μm spaced micropillars appeared to migrate with more 
“straight” paths, presumably due to guidance by the constricting pillars (Fig. 5.10A-B). 
As pillar spacing was increased, cell motion appeared more random (Fig. 5.10A-B). We 
quantified the turning angle of each cell for each time point as it migrated and plotted 
the relative frequency of turning angles (Fig. 5.10C-F). The turning angle represents the 
angle between a cell’s previous trajectory and its current trajectory. We observed most 
turning angles were close to 0°, and there was a slight increase in the frequency of angles 
very close to 180° for cells in 5 μm micropillars (Fig. 5.10C). In this definition, a turning 
angle of 0° indicates a cell continued moving forward in a straight line, while a turning 
angle of 180° indicates a cell completely reversed its direction. However, we also 
considered straightness of cell migration without considering directionality. In this 
definition, we considered turning angles from 0° to 90°, by subtracting the angle from 
180° if it was over 90° (Fig. 5.10D). For example, a previous turning angle of 175° 
(nearly complete reversal of migration direction) would now be represented as 5°. In 
this case, turning angles within all micropillar spacings were most frequently close to 
0°, with 5 μm being the most extreme case (Fig. 5.10D). Interestingly, different trends 
emerged when we analyzed cell turning angles using 30-minute time steps instead of 





distribution of turning angles close to 180° (complete reversal of direction), especially 
for the 5 μm pillar spacing.  We subsequently quantified the skewness of each histogram 
and found that, when considering turning angles from 0° to 90°, there was an increase 
in skewness with increasing confinement, which provided quantitative confirmation that 
more confined cells migrated in straighter paths than less confined cells (Fig. 5.10G). 
MSCs migrated faster in 50 μm spaced pillars than 3 μm spaced pillars when tracked 
every 10 minutes, but there were no differences in speed when cells were tracked every 
30 minutes (Fig. 5.10H-I). The mean squared displacement (MSD) versus time of the 
MSCs appeared very similar for all micropillar spacings over short timescales (up to 
~200 minutes), but began to diverge (with no monotonic trend) between micropillar 
spacings at larger timescales (Fig. 5.10J-K). Therefore, physical confinement of MSCs 
in this micropillar assay affects not only cell morphology and cytoskeletal organization, 















Figure 5.10 Quantitative MSC migration parameters within micropillars. 
Trajectories of MSCs within 5 μm, 10 μm, 20 μm, or 50 μm micropillar arrays 
tracked every A) 10 minutes or B) 30 minutes. Histogram displaying relative 
frequencies of turning angles for cells tracked every 10 minutes within 
micropillars, and considered from C) 0-180° where 0° corresponds to no deviation 
in migration path from previous timestep and 180° corresponds to a complete 
reversal of direction; or D) 0 to 90° where there is no distinction between forward 
and backward motion. Histogram displaying relative frequencies of turning angles 
for cells tracked every 30 minutes within micropillars, and considered from E) 0-
180° or F) 0 to 90°. G) Skewness of histograms in panel (C-F). Speed of MSCs as a 
function of pillar spacing tracked every H) 10 minutes or I) 30 minutes. G) MSD 
as a function of time for cells within micropillars spacing tracked every J) 10 
minutes or K) 30 minutes. Panels (C-K) display data for 5 μm (green), 10 μm (blue), 
20 μm (red), or 50 μm (cyan). Dot plots in panels (H-I) report mean ± SEM, and 
each dot represents one cell. n.s. = not significant, *p<0.05. Cells pooled from N=4 












We have demonstrated the potential of using a micropillar array for confining 
cells and studying their mechanobiology with a downstream goal of providing 
information that could help optimize cell culture systems for tissue engineering 
purposes. Our system was developed using information learned from many previous 
studies using micropillars in various applications. An excellent review of how 
micropillars have been used to evaluate cell behavior is found in Roca-Cusachs et al. 
[256]. In Table 5.2, we summarize studies where cells were cultured within [153]–[155], 
within and atop [209], [257]–[259], or solely atop [152], [260]–[263] micropillar arrays. 
Our system herein is distinct in that we use a wide range of micropillar spacings and 
show that cells can be maintained within micropillars over long periods of time (Table 
5.2). Additionally, cells infiltrate directly into the micropillar array, in contrast to other 
systems in which cells migrate from 2D into micropillars [153], [155]. In fact, collagen-
coated micropillar arrays can be placed within a non- cell-adhesive plate to disallow cell 
attachment to any 2D surface. This allows one to investigate the effect of confinement 











Table 5.2 Micropillars used in literature. 
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An additional important feature of our system is the non-deformability of 
micropillars by cells. Our micropillar arrays are fabricated with a stiff polymer that has 
previously been measured to be approximately 1.75 MPa [264]. Even in the most 
extreme case, if cells were to reach the top of the pillar and exert a force perpendicular 
to the pillar, the bending stiffness, 𝑘 = 3𝜋𝐷
4
64𝐿3
⁄  [265], of the tallest pillar would be 





Cells typically exert traction forces through focal adhesions of ~100-1000 nN [266]. 
Therefore, the micropillars should be primarily non-deformable to the cells and induce 
the specified degree of confinement. Although the PDMS used here is quite stiff, it is 
similar to the stiffness of various tissues in vivo such as bone, cartilage, and ligament 
[267]. To mimic other anatomical features, future studies may use gels of lower elastic 
modulus, thus enabling investigation into the coupled effects of confinement and 
stiffness.  
Distinct morphological differences appeared between MSCs in 5 μm spaced 
pillars and wider spaced pillars. Morphology is an important indicator of MSC behavior, 
as morphology alone can be used to predict the long term mineralization potential or the 
immunosuppressive capacity of MSCs [268], [269]. Future work may leverage freely 
available software such as CellProfiler to create high throughput pipelines and analyze 
cells on a population level.  Such high throughput analysis may be applied to this 
micropillar confinement system to reveal subsets of distinct cells within a heterogeneous 
population or between different populations, such as different MSC donors. 
Similar to what we saw within micropillar arrays, it has been shown previously 
that mesenchymal cells can spontaneously switch to an amoeboidal migration mode 
when they experience both vertical confinement and low adhesion [183]. One of these 
amoeboidal migration modes is initiated by an external polarization signal, such as a 
piece of debris. In our case, the micropillars may act as an external polarizer, even 
though MSCs herein attach well to the micropillars on three sides and show evidence of 
some focal adhesions. Similar to our migration assays, another group also observed cells 





encountered micropillars [270]. Furthermore, the cell and nuclear deformation and 
altered cytoskeletal organization that occur in the most confining micropillar arrays may 
lead to differences in cell growth, as we have shown for sarcoma cells [173], or cell fate, 
which is influenced by other mechanical cues that have similar impact on cell 
morphology.  
Interestingly, we saw different trends in turning angles when cells were tracked 
every 10 minutes compared to when they were tracked every 30 minutes. When cell 
migration is tracked using a 10 minute interval, the subsequent analysis is representative 
of changes in cell migration at short timescales. This potentially increases the 
histogram’s skewness towards small turning angles, as cells make small probing 
motions. Increasing the time interval to 30 minutes could be more representative of cell 
migration over long time periods, as cells move through the micropillars. Regardless of 
the time interval, cells migrated straighter within more confined micropillar arrays, 
perhaps due to the high density of micropillars guiding their migration.  
The migration patterns of MSCs we observed within micropillar arrays is in 
slight contrast to our previous reports of MSC behavior within microchannels (chapter 
3). Herein, MSCs migrated faster in 50 μm spaced pillars than 5 μm spaced pillars when 
tracked every 10 minutes. However, when MSCs migrated through microchannels, cells 
within 50 μm wide channels migrated slower than or with similar speed to those in 6 
μm or 10 μm wide channels, depending on MSC passage (chapter 3). We hypothesize 
that contact guidance has a larger influence on cell migration in microchannels than in 
micropillar arrays, as cells tend to follow the surface to which they are attached [141]. 





them in narrower spacings. Furthermore, our previous results in microchannels were in 
the presence of a chemotactic gradient, which in combination with contact guidance 
from the microchannel walls, may lead to altered trends in migration. Overall, different 
methods of confinement may induce different cell behaviors. 
It was critical that our micropillar design yield adequate sample sizes for 
downstream quantitative assays to investigate the concentration of secreted factors as 
well as gene and protein expression. We have successfully performed an ELISA on 
MSC-conditioned media at various time points (data not shown). This is possible due 
to the capacity of our micropillar arrays to support long-term cell growth. Analysis of 
cell density after 3 weeks in micropillars showed that cells did indeed proliferate within 
the micropillar arrays, yet there were significantly fewer cells within the 5 μm spaced 
micropillars. We speculate this may be due to there being less planar surface area for 
cell attachment and growth in the narrowest spaced micropillars. Additionally, we have 
previously shown that increasing confinement (in microchannels) decreases the 
percentage of cells that successfully divide [173], which may explain cells being more 
sparse in 5 μm arrays. Despite differences after 3 weeks in culture, the majority of 
seeded cells infiltrated into the micropillars, yielding a sample size of ~5x104 cells per 
micropillar array at 24 hours. This was fairly consistent for 2 different MSC donors, but 
minor differences suggest that cell seeding parameters be optimized for each new cell 
type. This cell count could provide enough RNA to allow for qRT-PCR and analysis. 
However, an order of magnitude more cells are necessary for one Western blot. This 
could be achieved by running multiple wells in parallel, increasing the area of the 





seeding density was increased to a very high number (5-10x105 cells per array), some 
groups of cells began to aggregate and did not infiltrate into the pillars (data not shown). 
The combination of our confinement assay with Western blot or PCR will reveal 
downstream effects of mechanical confinement, making it an even more powerful tool 
for tissue engineering. Through deeper understanding of cell mechanotransduction in 
the context of confinement, we can fine tune tissue engineered constructs to produce 
cell phenotypes that are optimal for a given purpose. 
5.5 Conclusion 
In summary, we have successfully developed and validated a PDMS micropillar 
array that systematically confines cells, allows for easy visualization and scale up, 
allows for long term cell culture, and provides an adequate sample size for analysis of 
the genome, secretome, or proteome. Future modifications of the micropillar 
confinement assay, including fabrication of micropillar arrays with more narrow 
spacing and applying a top confining post to the micropillar array, would enable us to 
study the effects of physical confinement on cell behaviors in greater depth. This 
knowledge is critical to improve the design of cell-laden tissue engineered constructs 
and in vivo cell therapies. By combining confinement with other physical cues, we can 
harness mechanical properties in order to encourage or inhibit cell migration, direct cells 
down a particular lineage, induce cell secretion of specific cytokines or extracellular 
vesicles, and ultimately direct cells to behave in a way conducive to tissue engineering. 
The PDMS micropillar array is an advantageous tool to study the effect of 





is a key phenomenon related to idiopathic pulmonary fibrosis (IPF) progression, and 
requires a system that can support long-term culture and downstream biological 
readouts, while still exerting known amounts of mechanical confinement and retaining 
easy visualization of cells. Therefore, in the next Chapter, we utilize the micropillar 









Chapter 6:  Fibroblast to myofibroblast transition is cell density 
dependent 
6.1 Introduction 
Idiopathic pulmonary fibrosis (IPF) is a chronic disease of the lung caused by a 
rampant inflammatory response that results in the deposition of excessive extracellular 
matrix (ECM). The excess ECM presents as scarring of the lung parenchyma and 
impairs gas exchange, making it difficult for patients to breathe [21]. There are no 
effective treatments for IPF, and the median survival time after diagnosis is 
approximately 3 years, making IPF a critical disease to investigate and treat [40].  
Lung tissue explanted from patients diagnosed with IPF is stiffer than healthy 
lung tissue, due to the increased protein content of the ECM and altered collagen 
crosslinking [41], [42]. Concomitant with increased ECM deposition and crosslinking, 
there is increased confinement imposed on cells by the ECM. In concert with increased 
confinement imposed by the ECM, there is increased confinement imposed by increased 
cell density as fibroblastic foci develop. Another characteristic feature of IPF, 
fibroblastic foci within the lung consist of activated fibroblasts and myofibroblasts [41].  
Myofibroblasts are contractile, matrix-depositing cells characterized by α-SMA-
positive stress fibers. Myofibroblasts are essential in the recovery of damaged tissues 
and critical in the inflammatory response, but cause pathology when they persist in 
tissue. Although the origin of myofibroblasts in IPF is continually under investigation, 





the fibroblast to myofibroblast transition (FMT), when given certain physical and/or 
chemical cues [44]. For example, fibroblasts cultured on stiff substrates are more likely 
to differentiate into myofibroblasts than those on soft substrates, due to increased 
actomyosin contractility [44]. Concomitantly, stiff matrices encourage stress fiber 
formation within cells, which compress the nucleus [45]. However, it is unknown to 
what degree, if any, direct nuclear compression in the absence of increased contractility 
alters FMT. We are able to induce nuclear deformation within low-contractile cells by 
confining cells within the micropillar assay detailed in Chapter 5. This micropillar array 
also allows us to investigate if increased confinement, such as that imposed by the dense 
ECM within IPF, influences FMT. 
Confining forces can also come from neighboring cells within a tissue. In 
fibroblastic foci, fibroblasts and myofibroblasts are more densely packed than in healthy 
lung tissue. Cell density is known to affect the behavior of lung fibroblasts, such as how 
they contract a 3D collagen gel [271]. In this work, we investigated the role of 
mechanical and cell-cell imposed confinement in FMT.  
One treatment being targeted as a therapy for IPF is MSC injection [54]. Several 
pre-clinical trials have proved MSCs effective in ameliorating inflammation and 
fibrosis, and clinical trials have begun [18], [55]. However, other studies indicate that 
MSC therapy worsens outcome, particularly in late stage IPF [19]. Less than 1% of all 
injected MSCs remain in the body one week after systemic injection, suggesting a 
paracrine mechanism of action [56]. Accordingly, secreted factors derived from MSCs 





Recently, manipulating the physical microenvironment, such as by applying 
strain or altering substrate protein coating, has been shown to alter the MSC secretome, 
which includes cytokines and extracellular vesicles [203]. To obtain MSC secreted 
factors, MSCs are typically cultured in 2D on standard tissue culture plastic and their 
media harvested [204], [205]. However, MSCs cultured in 3D spheroids have been 
shown to have enhanced therapeutic effects [206]. Herein, we investigated how 
increasing confinement may influence MSC secreted factors, aiming to increase our 
knowledge of how MSC culture conditions may enhance the therapeutic effects of 
MSCs. This work will enhance understanding of IPF progression at a mechanistic level 
and improve treatments for IPF. 
6.2 Materials and methods 
6.2.1 Cell culture 
Human lung fibroblasts (HLFs) were purchased from ATCC (Manassass, VA, 
USA) and cultured in fibroblast basal medium (ATCC) supplemented with 7.5 mM L-
glutamine, 5 ng/mL FGF basic, 5 µg/mL Insulin, 1 µg/mL Hydrocortisone, 50 µg/mL 
ascorbic acid, 2% fetal bovine serum (FBS, ATCC), and 1% Penicillin-Streptomycin 
10,000 U/mL (Thermo Fisher Scientific, Waltham, MA, USA). HLFs were cultured and 
used until passage 5. Cells were washed with Phosphate-Buffered Saline (PBS) (VWR, 
Radnor, PA, USA), detached with Trypsin-EDTA for primary cells (ATCC), and 
resuspended in Trypsin Neutralizing Solution (ATCC). Bone marrow-derived human 





Inc. (Frederick, MD, USA). Cells were removed from liquid nitrogen and grown in 
RoosterBio basal media with media booster (RoosterBio, Inc.) for the first day post-
thaw. Thereafter, cells were cultured in media composed of Dulbecco’s Modified 
Eagle’s Medium with high glucose (ThermoFisher Scientific), 10% Fetal Bovine Serum 
(FBS) (ThermoFisher Scientific), and 1% Penicillin-Streptomycin 10,000 U/mL 
(ThermoFisher Scientific). Cells were cultured and used until a population doubling 
level of 20 and cells were passaged at or below 80% confluency. Cells were washed 
with Phosphate-Buffered Saline (PBS) (VWR), and detached with TrypLE Express 
Enzyme (ThermoFisher Scientific). All cells were cultured at 37°C, 50% humidity, and 
5% CO2:95% air.  
6.2.2 Fibroblast to myofibroblast transition 
To induce fibroblast to myofibroblast transition (FMT), HLFs were seeded and 
allowed to attach overnight. The following day, cells were washed with PBS before 
adding FBS-free media supplemented with 10 ng/mL TGF-β1 (Peprotech, Rocky Hill, 
NJ, USA) or vehicle control (10 mM citric acid) to induce FMT. For density-dependent 
experiments, cells were seeded at 500, 5000, and 50,000 cells/cm2 for low, medium, and 
high densities, respectively and media was changed every 1-2 days. 
6.2.3 Micropillar array fabrication 
Micropillar arrays were fabricated as previously described [8]. Briefly, standard 
photolithographic techniques, as described previously [9], were used to create a silicon 





photolithography procedures were carried out in the University of Maryland Nanocenter 
FabLab. Polydimethylsiloxane (PDMS, Krayden, Denver, CO, USA) was mixed at a 
10:1 base:curing agent ratio, poured over the silicon master and baked to create a PDMS 
master, which was then removed and silanized overnight under vacuum using 
tridecafluoro-1,1,2,2,tetrahydrooctyl-1-trichlorosilane (OTS, 97%) (UCT Inc., Bristol, 
PA, USA). Then, PDMS was mixed at a 10:1 base:curing agent ratio, poured onto the 
PDMS master, baked at 80°C overnight, and removed, yielding the final PDMS 
micropillar arrays. The micropillar arrays were placed in a plasma cleaner (Harrick 
Plasma, Ithaca, NY, USA) and plasma treated with air for 2.5 minutes in order to 
increase hydrophilicity. PDMS blocks were simultaneously coated in 8% Pluronic F127 
(Sigma-Aldrich) solution for 1 hour at room temperature, then washed with DI water. 
Micropillar arrays were subsequently stamped with the Pluronic F127-coated PDMS 
blocks such that the pillar tops were rendered non-adhesive to cells, and placed into 6-
well plates. The micropillar-containing plates were UV sterilized for 10 minutes, and 
20 μg/mL collagen I (Sigma-Aldrich) was added to all wells and incubated for at least 
one hour at 37°C. The collagen I solution was then removed, and devices were washed 
with PBS before seeding cells at a density of 5x104 cells/well. Cell media was changed 
every 1-2 days.  
6.2.4 Immunofluorescence 
The following steps were carried out at room temperature, unless otherwise 
specified. Cells were fixed in 3.7% formaldehyde (Fisher Scientific) for 10 minutes, 





(Sigma-Aldrich) for 5 minutes, washed in PBS twice, and blocked for nonspecific 
binding in 2.5% goat serum (Abcam, Cambridge, MA, USA) for at least one hour. 
Mouse anti-α-smooth muscle actin antibody (Sigma-Aldrich, St. Louis, MO, USA, 
#A5228, 1:100) in 1% goat serum was added to cells and incubated at 4°C overnight. 
Cells were washed three times in PBS, blocked in 2.5% goat serum for at least one hour, 
then incubated with AlexaFluor 488 Phalloidin (Thermo Fisher Scientific, 1:500), 
Hoechst (Thermo Fisher Scientific, 1:2500), and AlexaFluor 568 goat anti-mouse 
(ThermoFisher Scientific #A11004, 1:200) for one hour. Cells were washed three times 
in PBS, then imaged. Images were acquired on an Olympus IX83 microscope (Olympus, 
Center Valley, PA, USA) using a 10x or 20x objective. 
6.2.5 Cell lysis  
Cells were washed with cold PBS, placed on ice, then incubated for 5 minutes 
in ice cold RIPA lysis buffer (Thermo Fisher Scientific) supplemented with 1:100 
protease inhibitor cocktail (Sigma-Aldrich) and 1:500 10 mg/mL phenylmethylsulfonyl 
fluoride (PMSF) in ethanol. Cells were collected using a cell scraper, and samples were 
incubated on ice for 1 hour, with vortexing every 15 minutes. Samples were centrifuged 
at 300xg for 6 minutes, and the cell lysate supernatant was collected. A Pierce BCA 
assay (Thermo Fisher Scientific) was performed to determine total protein concentration 





6.2.6 Western blotting 
Cell lysates were diluted in RIPA such that each sample was of the same 
concentration and final volume. Lysates were mixed 1:1 with 2x Laemmli sample buffer 
with 1:20 β-mercaptoethanol (BioRad, Hercules, CA, USA), then incubated for 10 
minutes at 100°C. Samples were loaded into precast 10% polyacrylamide gels (BioRad) 
and subject to SDS-PAGE at 120V for 1 hour. Protein was then transferred to a 
polyvinylidene difluoride (PVDF) membrane (BioRad) at 100V for 1 hour. Membranes 
were blocked in Tris-buffered saline (TBS)-based blocking buffer (Thermo Fisher 
Scientific) for 1 hour at room temperature, then incubated in primary antibody overnight 
at 4°C. Primary antibodies used include mouse anti-α-smooth muscle actin antibody 
(Sigma-Aldrich #A5228, 1:1000), rabbit anti-GAPDH (Cell Signaling Technology, 
Danvers, MA, USA, #2118, 1:2000), rabbit anti-OB-cadherin (Cell Signaling 
Technology #4442, 1:1000), rabbit anti-N-cadherin (Cell Signaling Technology #4061, 
1:1000), rabbit anti-vimentin (Cell Signaling Technology #5741, 1:1000), and mouse 
anti-vimentin (Santa Cruz Biotechnology, Dallas, TX, USA, 1:2000). Membranes were 
then washed thrice in TBS with 1:500 Tween 20 (TBST buffer, BioRad) at 4°C. 
Membranes were then incubated in HRP linked secondary antibody for 1 hour at room 
temperature. Secondary antibodies used were anti-mouse IgG (Cell Signaling 
Technology, #7076, 1:5000) and anti-rabbit IgG (Cell Signaling Technology, #7074, 
1:5000). Membranes were then washed thrice in TBST buffer and once in TBS buffer. 
Clarity Western ECL substrate was mixed 1:1 Peroxide solution:Luminol/Enhancer 
(BioRad), then added to the membrane and incubated for 5 minutes. Membranes were 





BioWorkshop core facility in the Fischell Department of Bioengineering at the 
University of Maryland, College Park. 
6.2.7 MSC-CM 
 MSCs were seeded atop micropillar arrays and allowed to infiltrate overnight. 
The following day, media was changed to remove suspended cells. After 3 days in 
culture, MSC-CM was harvested, centrifuged at 500xg for 10 minutes, and filtered 
through a cell strainer. The MSC-CM was then frozen at -20°C until use. For some 
experiments MSC-CM was concentrated using a centrifugal filter unit (Millipore 
Sigma). HLFs were seeded on 2D TCPS and treated with 10 ng/mL TGF-β1 or vehicle 
control for 3 days. Subsequently, HLFs were washed once in PBS and MSC-CM was 
added with HLF media. 
6.3 Results 
6.3.1 TGF-β1 concentration and incubation time alters α-SMA expression 
within HLFs 
TGF-β1 is a pro-inflammatory and pro-fibrotic cytokine that is upregulated in 
IPF [272]. TGF-β1 has been shown to induce FMT in vitro as evidenced by increased 
α-SMA expression within HLFs [273]. Our first aim was to optimize the concentration 
and timing of TGF-β1 treatment to induce FMT by examining α-SMA expression via 
immunofluorescent straining. We observed α-SMA within HLFs after a 48-hour 
incubation with TGF-β1 at 2, 5, or 10 ng/mL, and to a much greater extent after 72 hours 





when we seeded HLFs at a 50% lower density (Fig. 6.2). At low densities, HLFs did not 
express significant amounts of α-SMA even when treated with 20 ng/mL TGF-β1 (Fig. 
6.3). With the potential cytotoxic effects of the citric acid carrier in mind, we chose 10 
ng/mL TGF-β1 as our standard treatment concentration for subsequent experiments. 
Figure 6.1 HLFs increase α-SMA in response to TGF-β1. HLFs were treated with 
2, 5, or 10 ng/mL TGF-β1 or vehicle control for 24, 48, or 72 hours. Cells were fixed 
and stained for α-SMA (red), f-actin (green), and the nucleus (blue). Scale bars 







Figure 6.2 HLFs increase α-SMA expression in response to TGF-β1 to a lesser 
degree at lower density. HLFs were treated with 2, 5, or 10 ng/mL TGF-β1 or 
vehicle control for 24, 48, or 72 hours. Cells were fixed and stained for α-SMA 







Figure 6.3 HLFs do not increase α-SMA expression in response to TGF-β1 at a low 
density. HLFs were treated with 10, 15, or 20 ng/mL TGF-β1 or vehicle control for 
72 hours. Cells were fixed and stained for α-SMA (red), f-actin (green), and the 
nucleus (blue). Scale bars represent 100 µm. 
6.3.2 HLF seeding density alters α-SMA expression within HLFs 
We next investigated if HLF response to TGF-β1 remained density-dependent 
at a time beyond 72 hours. We seeded 500, 5000, or 50,000 cells/cm2 (low, medium, 
and high density, respectively) and treated with 10 ng/mL TGF-β1 for 5 days. We then 
examined α-SMA expression via immunofluorescent straining. We observed expression 
of α-SMA in HLFs seeded at a medium density or high density and treated with TGF-
β1, but this effect was most prominent in HLFs seeded at high density (Fig. 6.4A). 
Additionally, f-actin stress fibers were more prominent in medium and high density 
groups. All groups treated with vehicle control and low density cells treated with TGF-





western blot for the medium and high density groups, as the low density group did not 
contain adequate protein for analysis (Fig. 6.4B-C). TGF-β1 induced much higher α-
SMA protein expression in the high density than the medium density group. However, 
the high density group treated with vehicle control had higher levels of α-SMA than the 
medium density vehicle control group by one order of magnitude. Consequently, TGF-
β1 induced an approximately 14-fold increase in expression of α-SMA in the medium 
density group and approximately 21-fold increase in the high density group. The 
increased α-SMA expression was present in both the cytosol and cytoskeleton portions 












Figure 6.4 HLFs increase α-SMA expression with increasing cell density. HLFs 
were treated with 10 ng/mL TGF-β1 or vehicle control for 5 days. A) 
Representative images. Cells were fixed and stained for α-SMA (red), f-actin 
(green), and the nucleus (blue). Scale bars represent 50 µm. B) Representative 
western blot. C) Quantification of western blots. Dot plots report mean ± SD. 
6.3.3 HLF seeding density, but not TGF-β1, alters OB-cadherin expression 
It has been proposed that a transition within fibroblasts from N-cadherin 
expression to OB-cadherin expression is a hallmark of FMT [274]. We seeded low, 
medium, and high density HLFs and treated them with 10 ng/mL TGF-β1 for 5 days. 





cadherin (Fig. 6.5). Conversely, HLFs seeded at high density expressed more OB-
cadherin then the medium density group, irrespective of TGF-β1 treatment. 
Interestingly, TGF-β1 treatment reduced lamin A/C in all density groups by 
approximately 50% on average (data not shown). 
 
Figure 6.5 HLFs increase OB-cadherin expression with increasing cell density. A) 
N-cadherin and B) OB-cadherin expression expressed by cells of differing cell 
density and TGF-β1 treatment. 
6.3.4 Confinement does not affect FMT 
To investigate whether nuclear compression contributes to the observed density-
dependent FMT, we used the micropillar assay developed in Chapter 5 to confine cells. 





as well as a 2D PDMS and 2D tissue culture polystyrene (TCPS) controls. This system 
allows for nuclear deformation even in a reduced contractile state, i.e. in the most 
confined micropillar array. TGF-β1 increased α-SMA expression in all levels of 
confinement by a small amount, with planar PDMS having slightly higher α-SMA 
expression than the 5, 10, 20, or 50 µm confined groups (Fig. 6.6). However, α-SMA 
expression was highest in HLFs treated with TGF-β1 on 2D TCPS. When we visualized 
cells via immunofluorescent staining, we noted that HLFs began to grow over the 
micropillar tops in the 5 µm group (Fig. 6.7). This may explain why α-SMA expression 
within the 5 µm groups was slightly higher than the 10, 20, and 50 µm groups (Fig. 6.6). 
Additionally, HLFs treated with TGF-β1 tended to have higher f-actin signal and form 
discrete clumps, while control HLFs were more evenly distributed (Fig. 6.7). It has been 
suggested that the formation of small contractile units is the most effective for inducing 






Figure 6.6 Confinement does not affect FMT. HLFs were treated with 10 ng/mL 
TGF-β1 or vehicle control for 5 days. A) Representative western blot. B) 






Figure 6.7 Confinement does not affect FMT. HLFs were treated with 10 ng/mL 
TGF-β1 or vehicle control for 5 days. Cells were fixed and stained for α-SMA (red), 











6.3.5 MSC-CM does not affect FMT 
We next investigated if MSC-CM harvested from confined MSCs would affect 
its efficacy in reducing FMT. We cultured MSCs in 5, 10, 20, or 50 µm micropillars or 
on 2D TCPS and harvested their MSC-CM. Simultaneously, we induced FMT by 
culturing HLFs on 2D TCPS with TGF-β1. We then applied MSC-CM to the HLFs. 
Surprisingly, we did not see any decrease in α-SMA expression in any group relative to 
the blank control (data not shown). We concentrated the MSC-CM to potentially 











Figure 6.8 MSC-CM does not affect FMT. HLFs were treated with TGF-β1 or 
vehicle control for 3 days, followed by MSC-CM for 3 days. A) Representative 
western blot of TGF-β1 treated cells. B) Quantification of western blot. Bar graph 
reports mean. 
6.4 Discussion 
 IPF is a terminal disease with an average mortality rate of 3 years. There are no 
effective treatments for IPF, which highlights the urgent need for improved 
understanding of disease progression in order to elucidate new drug targets. We 
investigated how confining forces from neighboring cells or from physical features 
influences the lung FMT. We observed that HLFs seeded at high density expressed 





This is in contrast to other results using fibroblasts sourced from different tissues. For 
example, one group showed that α-SMA expression increased when corneal 
fibroblasts were plated at low density (500 cells/cm2) when compared to high density 
(50,000 cells/cm2), even in the absence of TGF-β1 [275]. However, this study 
analyzed cells in each group once they reached confluence. Therefore, low density 
cells were cultured for a longer time than high density cells, on the order of days. This 
is problematic, because substrate stiffness influences FMT, and traditional culture 
plastic is extremely stiff. Prolonged exposure to stiff plastic may induce FMT, and it 
has been shown that culture itself can induce FMT [276]. Others have demonstrated 
that medium density bronchial fibroblasts (5000 cells/cm2) undergo FMT more readily 
than high density bronchial fibroblasts (50,000 cells/cm2) [277]. However, this study 
investigated asthmatic bronchial fibroblasts, which is localized to a proximal site 
within the lung, while IPF affects distal alveoli. Medium density dermal fibroblasts 
undergo FMT more readily than high density cells, potentially involving the 
upregulation of OB-cadherin [278]. Again, this study analyzed cells upon reaching 
confluence, such that low density cells were cultured 8 days longer than high density 
cells.  
 There is a shift from N-cadherin to OB-cadherin expression in fibroblasts 
during wound healing [279]. We observed an increase in OB-cadherin in HLFs seeded 
at high density when compared to HLFs seeded at medium or low density. 
Interestingly, we did not see N-cadherin expression in any group. Previously, blocking 
N-cadherin in bronchial fibroblasts was shown to reduce FMT [277]. FOXF1 was 





OB-cadherin expression in FMT [280]. Adherens junctions have been implicated in 
transferring mechanical strain between myofibroblasts, thereby opening 
mechanosensitive ion channels, inducing a calcium ion influx, and subsequently 
inducing contraction in the neighbor cell [281]. 
 Despite being FBS-deprived, HLFs were still able to proliferate at a very low 
rate. HLFs seeded at low and medium density doubled approximately 2-3 times in 6 
days. HLFs seeded at high density doubled approximately 1-2 times in 6 days. This 
decrease in proliferation in the high-density group may be a confounding factor, as 
marked by the increase in α-SMA expression in the high density control group 
compared to the medium density group. Indeed, others have shown that quiescent 
myofibroblasts have reduced α-SMA turnover when compared to proliferating cells 
[282]. 
 We did not observe any effect of confinement on FMT within HLFs. 
Interestingly, our 2D PDMS control consistently had lower α-SMA expression than on 
2D TCPS. We attribute this to several factors. PDMS is an innately hydrophobic 
material that we make hydrophilic via plasma treatment and then add a coating of 
collagen I. There is a possibility that collagen I attaches differently on PDMS vs 
TCPS. Additionally, there is the potential that PDMS may have adsorbed a portion of 
TGF-β1, a hydrophobic molecule, making it inaccessible to the cells. We addressed 
this by changing media every 1-2 days, but the potential for PDMS acting as a TGF-β1 
sink should be investigated further. Additionally, the PDMS used herein is 





While both materials are extremely stiff, the 3 orders of magnitude increase in 
stiffness of TCPS could have induced a greater incidence of FMT.  
 We investigated if MSC-CM from MSCs cultured in different levels of 
confinement will alter FMT resolution. FMT can be a reversible process as a tissue 
begins to heal [283]. However, there are limitations to this reversal, as lung fibroblasts 
have been shown to have a “mechanical memory” [284]. For example, cells cultured 
on stiff substrates for 3 weeks sustained their myofibroblast activity even when 
returned to a softer substrate for 2 weeks [284]. Future studies may test the 
reversibility of FMT in our system. Additionally, future studies should utilize lung 
cells from an age-matched healthy patient to an IPF patient. Our HLFs were isolated 
from a young female, which likely behave different than an older or sick individual 
because disease state has been shown to influence FMT. For example, bronchial 
fibroblasts derived from a patient with asthma underwent FMT with higher frequency 
than those from a non-asthmatic patient [277]. 
6.5 Conclusion 
 In summary, we found that HLFs express more α-SMA in response to TGF-β1 
when seeded at a high density compared to a medium or a low density. This likely 
indicates that HLFs undergo FMT more readily in response to TGF-β1 when cells are 
densely packed. This effect could be dependent on increased OB-cadherin expression 
and/or increased quiescence within high density cultures. This work demonstrates that 












Chapter 7:  Conclusions and contributions to science  
7.1 Physical confinement alters cytoskeletal contributions towards 
human mesenchymal stem cell migration 
In Chapter 3, we showed that mesenchymal stem cells (MSCs) respond 
differently to pharmacological inhibitors of cytoskeletal and contractile machinery in 
narrow vs. wide microchannels, suggesting that cells rely on this machinery to different 
degrees in confined vs. unconfined microenvironments. Inhibition of actin significantly 
hindered cell migration in both confined and unconfined microchannels. However, 
MSC migration in narrow channels was overall less sensitive to perturbations to the 
MSC cytoskeleton than MSCs in wide channels. These insights could allow for specific 
control of MSC infiltration into tissue engineered scaffolds and could also inform 
whether the degree of confinement in microchannels between anatomical structures 
directs cell migration during homing in vivo. Furthermore, it is possible that physical 
confinement, in conjunction with other microenvironmental cues, can be exploited to 
engineer and direct stem cells for use in regenerative therapies and/or in vitro models. 
7.2 Nuclear deformation in response to physical confinement is cell 
type dependent 
In Chapter 4, we observed that MSCs and L929 cells deform differently in 
response to mechanical confinement. Microtubule polymerization and myosin II 





dimensionality. Conversely, microtubule polymerization and myosin II contractility 
seem to play a role in maintaining nuclear volume and dimensionality in unconfined, 
but not confined, MSCs. This work informs our understanding of nuclear mechanics in 
microenvironments related to tissue homeostasis and disease and suggests diverging 
roles of the cytoskeleton in regulating nuclear deformation in different cell types. These 
dissimilarities may ultimately lead to differences in cell behaviors, such as 
differentiation or migration. 
7.3 Micropillar arrays successfully confine cells 
In Chapter 5, we successfully developed and validated a polydimethylsiloxane 
(PDMS) micropillar assay that systematically confines cells, allows for easy 
visualization and scale up, allows for long term cell culture, and provides an adequate 
sample size for analysis of the genome, secretome, or proteome. Additionally, MSCs 
may use different modes of migration within the various micropillar arrays. Future 
modifications of the micropillar confinement assay, including fabrication of micropillar 
arrays with more narrow spacing and applying a top confining post to the micropillar 
array, would enable investigation into the effects of physical confinement on cell 
behaviors in greater depth. This knowledge is critical to improve the design of cell-laden 
tissue engineered constructs and in vivo cell therapies. By combining confinement with 
other physical cues, we can harness mechanical properties in order to encourage or 
inhibit cell migration, direct cells down a particular lineage, induce cell secretion of 
specific cytokines or extracellular vesicles, and ultimately direct cells to behave in a 





7.4 Lung fibroblast to myofibroblast transition is dependent on cell 
density, but not confinement 
 In Chapter 6, we observed that increased cell density increases the incidence of 
fibroblast to myofibroblast transition (FMT), but mechanical confinement imposed by 
micropillars has no effect on FMT incidence. We found that human lung fibroblasts 
(HLFs) express more α-SMA, a marker of myofibroblasts, in response to TGF-β1 
when seeded at a high density compared to a medium or a low density. This likely 
indicates that HLFs undergo FMT more readily in response to TGF-β1 when cells are 
densely packed. This effect could be dependent on increased OB-cadherin expression 
or increased quiescence within high density cultures. This work demonstrates that cell 
density is an important factor to consider when modelling IPF in vitro, and it may 
suggest decreasing cell density within fibroblastic foci as a strategy to reduce IPF 
burden.  
7.5 Concluding remarks 
 In summary, this work presents the physiological relevance of confinement as 
well as its major impact on cell phenotype and cell behaviors. The importance of all 
aspects of the mechanical microenvironment to many facets of cell behavior continues 
to be demonstrated over the years. Our use of engineered confining microchannels and 
the development of engineered confining micropillar arrays (Chapter 5) allowed us to 
investigate diverse aspects of cell phenotype within confinement. Microchannels 





volume maintenance mechanisms (Chapter 4) of MSCs within confinement, while 
confining micropillars allowed us to explore the effect of confinement on FMT 
(Chapter 6). Future examination of confinement’s effects on cell behaviors will 
improve our basic understanding of biology, thereby improving therapeutics and 
improving human health. 
7.6 Contributions to the field 
7.6.1 Scientific contributions to the field 
• Determined that MSC migration speed is biphasic and chemotactic index 
decreases as a function of increasing confinement (Chapter 3). 
• Determined that MSC actin and microtubules become more diffuse and focal 
adhesions become smaller and sparser with increasing confinement (Chapter 
3). 
• Determined that MSCs require actin polymerization to migrate, but may not 
require myosin contractility to efficiently migrate. MSCs require microtubules 
to efficiently migrate only in less confined spaces (Chapter 3). 
• Determined that nucleus volume decreases in L929 cells and MSC cells in a 
highly confined environment (Chapter 4). 
• Determined that microtubules and myosin contractility are not essential in 
maintaining nucleus volume in confinement, but play a role in wide channels 
(Chapter 4). 





• Observed MSCs migrate straighter within the most confining micropillar 
arrays (Chapter 5). 
• Determined that increased cell density, but not increased mechanical 
confinement imposed by micropillars, increases incidence of FMT in lung 
fibroblasts (Chapter 6). 
7.6.2 Scientific contributions to the Stroka lab 
• Created PDMS micropillar confining device and protocol for its use. 
• Contributed photolithography protocol updates. 
• Contributed MSC maintenance and MSC tri-lineage differentiation protocols. 
• Expanded HLFs and optimized HLF maintenance protocol as well as FMT 
protocol. 
• Executed collaborations with Dr. Amy Karlsson’s lab (University of 
Maryland) resulting in 2 publications (see Chapter 7.6.3). 
• Initiated collaborations with Dr. Alex Dunn (Stanford University) and Dr. 
Daniel Conway (Virginia Commonwealth University).  
• Established protocols for working with DN-KASH adenovirus and lentivirus 
(provided by Dr. Daniel Conway). 
• Established protocol for working with FRET tension sensor (provided by Dr. 
Alex Dunn) and analyzing FRET images. 






• Trained and mentored 2 graduate students (Rebecca Moriarty, Ariana 
Decastro) and 2 undergraduate students (Thea Ornstein, Katelyn Kunert). 
7.6.3 Peer-reviewed journal publications 
Published: 
• M.T. Doolin*, R.A. Moriarty*, and K.M Stroka, Mechanosensing of Physical 
Confinement by Mesenchymal-Like Cells, Frontiers in Physiology, 11:365 
(2020). - Invited manuscript for special issue on “Mechanosensing at 
Biointerfaces.” 
• S.P. Ikonomova, P. Moghaddam-Taaheri, Y. Wang, M.T. Doolin, K.M. Stroka, 
B. Hube, and A.J. Karlsson, Effects of Histatin-5 Modifications on Antifungal 
Activity and Kinetics of Proteolysis, Protein Science, 29(2): 480-493 (2020). 
• Z. Gong, M.T. Doolin, S. Adhikari, K.M. Stroka, and A.J. Karlsson, Role of 
Charge and Hydrophobicity in Translocation of Cell-Penetrating Peptides into 
Candida albicans Cells, AIChE Journal, 65(12): e16768 (2019). - Invited 
manuscript for special issue on “Future of Chemical Engineering.” 
• M.T. Doolin and K.M. Stroka, Integration of Mesenchymal Stem Cells into a 
Novel Micropillar Confinement Assay, Tissue Engineering Part C: Methods, 
25(11): 662-676 (2019). - Invited manuscript for special issue on “Methods in 
Biomechanics and Mechanobiology for Tissue Repair and Regeneration.”  
• M.T. Doolin*, T.S. Ornstein*, and K.M. Stroka, Nuclear Deformation in 





(2019). - Invited manuscript for special issue on “Frontiers in Cytoskeleton 
Research—From Development to Disease.” 
• M.T. Doolin and K.M. Stroka, Physical confinement alters cytoskeletal 
contributions towards human mesenchymal stem cell migration, Cytoskeleton, 
75(3): 103-117 (2018). - Featured on cover. 
In preparation: 
• M.T. Doolin and K.M. Stroka, The Fibroblast to Myofibroblast Transition is 
Enhanced by Increased Cell Density, (in preparation, 2020). 
7.6.4 Conference presentations 
• M.T. Doolin and K.M. Stroka, Lung Fibroblast to Myofibroblast Transition is 
Cell Density Dependent (poster, Cellular and Molecular Bioengineering 
Conference, January 2020, Rio Grande, Puerto Rico).          
• M.T. Doolin and K.M. Stroka, Human Mesenchymal Stem Cell Nuclei Deform 
Anisotropically in Response to Mechanical Confinement (poster, Bioscience 
Day, November 2018, College Park, MD). 
• M.T. Doolin and K.M. Stroka, Micropillar Arrays to Confine Cells in Three 
Dimensions (presentation, Fischell Department of Bioengineering Retreat, 
August 2018, College Park, MD). **Voted “Best Presentation” by FDB Retreat 
attendees. 
• M.T. Doolin and K.M. Stroka, Human Mesenchymal Stem Cell Nuclei Deform 
Anisotropically in Response to Mechanical Confinement (poster, Graduate 





• M.T. Doolin and K.M. Stroka, Human Mesenchymal Stem Cell Nuclei Deform 
Anisotropically in Response to Mechanical Confinement (poster, Cellular and 
Molecular Bioengineering Conference, January 2018, Key Largo, FL).                       
• M.T. Doolin and K.M. Stroka, Physical Confinement Alters Cytoskeletal 
Requirements for Mesenchymal Stem Cell Migration (poster, BMES Annual 
Meeting, October 2017, Phoenix, AZ).                                             
• M.T. Doolin and K.M. Stroka, I like the way you move: The Impact of 
Mechanical Confinement on Stem Cell Migration and Mechanobiology 
(presentation, Graduate Student Research Seminar, June 2017, College Park, 
MD). 
• M.T. Doolin and K.M. Stroka, The Impact of Mechanical Confinement on Stem 
Cell Migration and Mechanobiology (presentation, ResearchFest, June 2017, 
College Park, MD).                                             
• M.T. Doolin, M.A. Baird, and K.M. Stroka, The Impact of Mechanical 
Confinement on Stem Cell Migration and Mechanobiology (poster, Biophysics 
Symposium, May 2017, College Park, MD).                                             
• M.T. Doolin, M.A. Baird, and K.M. Stroka, The Impact of Mechanical 
Confinement on Stem Cell Migration and Mechanobiology (poster, Graduate 
Research Appreciation Day, April 2017, College Park, MD).                                             
• M.T. Doolin, M.A. Baird, and K.M. Stroka, The Impact of Mechanical 
Confinement on Stem Cell Migration and Mechanobiology (poster, Cellular and 






Chapter 8:  Future Work and Outlook 
 This dissertation has presented new results which contribute to the fields of 
mechanobiology, mesenchymal stem cell (MSC)-based therapies, and therapies for 
idiopathic pulmonary fibrosis (IPF). There are many questions remaining, and we 
outline our future work below based on preliminary results. 
8.1 Traction forces in confined migration and the fibroblast to 
myofibroblast transition 
As explained in Chapter 3, we observed a decrease in the size and quantity of 
focal adhesions within confined cells. Additionally, microtubule and actin filaments 
presented as more diffuse, typically indicative of a low contractile state. We hypothesize 
that if there is reduced contractility and smaller focal adhesions within confined cells, 
their traction forces are reduced. Traction forces are generated as cells adhere to a 
substrate and contract via actomyosin, thereby moving the cell forward [76]. 
Determination of the precise traction forces exerted by a cell migrating in 3D has been 
technically challenging [80], [152]. We propose a simpler approach, utilizing a Förster 
resonance energy transfer (FRET) tension sensor, supplied by Dr. Alexander Dunn at 
Stanford University, within microchannels to measure traction forces exerted by MSCs 
in confinement (Fig. 8.1). FRET is the energy transfer from a donor fluorophore to an 
acceptor fluorophore, such that the donor fluorescence is quenched and the acceptor 
fluorescence is enhanced [285]. This occurs provided that the two fluorophores are in 





This FRET tension sensor will also be useful in evaluating fibroblast to 
myofibroblast transition (FMT). We propose to coat microfabricated micropillar 
devices with FRET tension sensor, thereby visualizing cell traction forces in various 
degrees of confinement (Fig. 8.1). By measuring cell traction forces in confinement, we 
may be able to begin to decouple the effects of cellular contractility and nuclear 
deformation on cell behaviors. 
 
Figure 8.1 FRET tension sensor to measure cell traction forces. A) FRET tension 
sensor (modified from [286]). B) FRET index map of adherant MSC. Dark areas = 
high FRET/low tension. Light areas = low FRET/high tension. 
8.2 The role of the LINC complex in confinement 
Disruption of the linker of nucleoskeleton and cytoskeleton (LINC) complex in 
cells migrating in 3D decreased their pseudopodial activity and speed, implicating the 
LINC complex in supporting 3D cell migration [50]. Disruption of the LINC complex 
prohibited cells from responding to low magnitude signals, indicating the LINC 
complex as a critical component of the MSC mechanosensing machinery as well [73]. 
It was shown that low magnitude signals encourage adipogenesis of MSCs via the 





with this, transfer of strain from the cytoskeleton to the nucleus via the LINC complex 
has been shown to be essential for stretch-induced activation of the Yes-associated 
protein (YAP)/transcriptional co-activator with PDZ-binding motif (TAZ) pathway 
[74]. The YAP/TAZ mechanotransduction pathway plays a fundamentally important 
role in regulating gene expression and MSC differentiation. We plan to investigate the 
role of the LINC complex, specifically the KASH-domain proteins, nesprins, in MSC 
migration and nuclear volume, as well as lung FMT. We plan to repeat the 
experiments performed in Chapters 3, 4, and 6, but instead use cells transfected with a 
dominant negative (DN)-KASH construct or control donated to us by Dr. Daniel 
Conway at Virginia Commonwealth University. These experiments will elucidate the 
role of the LINC complex in MSC migration, nucleus volume, and FMT in 
confinement. 
8.3 Role of chromatin condensation in confined MSC migration and 
nucleus volume 
 Chapter 4 showed that microtubule polymerization and myosin II-mediated 
contractility do not affect MSC nuclear dimensions or volume within confinement, but 
play a role in unconfined nuclear dimensions and volume. Previous work which 
confined cells within microwells has shown that chromatin becomes more densely 
packed as nucleus volume decreases [85]. Chromatin decondensation or lamina 
disruption have both been demonstrated to decrease or increase, respectively, the 
anisotropic nucleus deformation in response to force [101]. As microtubules and 





that intrinsic nuclear components, such as the nuclear lamina and chromatin, regulate 
nucleus volume within confinement.  
We have begun to investigate how chemically inhibiting chromatin 
condensation via a histone deacetylase inhibitor, Trichostatin A (TSA), affects MSCs 
in confined microenvironments. TSA decondenses chromatin within the cell, typically 
increasing nucleus volume in 2D. MSCs were treated with TSA or vehicle control 
(DMSO) for various times, then lysed and analyzed via western blot to determine each 
group’s expression of acetyl-histone H3 and actin as a control. We determined that 
TSA begins to increase acetyl-histone H3 expression after 2 hours, peaking around 4 
hours. Cells remain viable for approximately 22 hours after treatment with TSA, then 
begin to undergo apoptosis. Therefore, we performed overnight timelapses of MSCs 
treated with TSA or DMSO control and analyzed MSC speed and chemotactic index 
(Fig. 8.2A-B). We also fixed cells after 4 of TSA treatment and analyzed nucleus 
volume (Fig. 8.2C). Our preliminary data suggests that TSA does not affect speed or 
chemotactic index in any degree of confinement. However, TSA may increase nucleus 
volume in unconfined channels. Future work is necessary to determine if this is true in 







Figure 8.2 MSCs treated with TSA. Effect of TSA on A) speed, B) chemotactic 
index, and C) nucleus volume. 
8.4 Effect of confinement on lamin A/C expression and MSC 
multipotency  
 Lamin A/C provides mechanical support to the nucleus, and its expression has 
been shown to scale with substrate stiffness. Cells isolated from stiff tissues contain 
higher lamin A/C levels than cells isolated from soft tissues [287]. In stem cells, low 
nuclear stress promotes lamin A/C degradation and turnover, while cytoskeletal stress 
and tension promote lamin A/C maintenance [252]. This pathway acts through myosin 
contractility and turnover, and it ultimately influences gene expression [252]. Lamin 





deformation in response to an applied force, underscoring its importance in nuclear 
mechanics and response to external forces [101]. Additionally, lamin A/C 
overexpression encourages osteogenesis, and lamin A/C silencing inhibits osteogenesis 
[287]–[289]. In contrast, it has been shown that culturing MSCs on nanogratings 
decreases lamin A/C expression, yet shifts cell lineage away from adipogenesis [290]. 
Lamin A overexpression has also been shown to inhibit chondrogenesis [291]. We aim 
to determine how mechanical confinement may modulate lamin A/C expression in 
MSCs and, in turn, influence MSC differentiation. 
 Preliminary data from two independent trials indicates that lamin A/C 
expression is reduced on 2D PDMS compared to tissue culture polystyrene (TCPS, Fig. 
8.3). Interestingly, there may be a slight increase in lamin A/C expression in MSCs 
confined within micropillar arrays compared to those on 2D PDMS (Fig. 8.3). However, 
future work is needed to expand on these preliminary studies. MSCs were also cultured 
within micropillars in basal media or media containing adipogenic or osteogenic factors. 
We subsequently stained the cells using Oil Red O to evaluate adipogenesis, or Alizarin 
Red to investigate osteogenesis efficiency. Due to imaging limitations, these results 
were inconclusive, but this should certainly be investigated further in the future. The 
impact of confinement on MSC differentiation could have major implications for tissue 






Figure 8.3 Effect of confinement on lamin A/C expression in MSCs. Averaged 
data from 2 independent western blots, with lamin A/C expression normalized to 
actin. 
8.5 Effect of MSC co-culture on fibroblast differentiation  
We did not observe any effect of MSC-CM on FMT, which was surprising given 
other reports describing the therapeutic effects of MSC-CM on IPF. Therefore, we 
propose to explore the role of MSC co-culture on FMT. Hydrogels containing MSCs 
only, fibroblasts only, or no cells will serve as controls. ECM deposition by cells will 
be evaluated via second harmonic generation imaging after each day in culture. 
Additionally, we will stain cells within hydrogels for α-SMA. We expect co-culture 
hydrogels to decrease incidence of α-SMA positive cells. These experiments will reveal 
how a more in vivo-type co-culture environment influences fibroblast differentiation 






This dissertation provides further evidence that mechanical confinement alters 
cell mechanosensing and cell behaviors. However, there is still a need to link these two 
areas in greater depth. Merely observing a behavior without elucidating the mechanism 
behind it or, conversely, learning of a mechanosensing mechanism without observing 
its impact is not enough to significantly improve therapeutic outcomes. Due to the 
pervasive nature of mechanical confinement in vivo, it is critical to understand how and 
why confinement alters cell phenotype. Furthermore, it is becoming increasingly 
evident that we must also make these links in the context of tissue-specific physical and 
biochemical microenvironments. Together, this knowledge has the potential to improve 










For all movies: First frame represents the x-y plane, and the nucleus revolves around 
the y-axis. Stacks were thresholded and cut according to the workflow described in 
Fig. 4.2 before being rendered. 
 
Movie S1. 3D rendering of MSC nucleus in 3 μm channel.  
Movie S2. 3D rendering of L929 nucleus in 3 μm channel.  
Movie S3. 3D rendering of MSC nucleus in 50 μm channel.  
Movie S4. 3D rendering of L929 nucleus in 50 μm channel (center cell).  
Movie S5. 3D rendering of MSC nucleus in 3 μm channel treated with vehicle control.  
Movie S6. 3D rendering of MSC nucleus in 3 μm channel treated with nocodazole.  
Movie S7. 3D rendering of L929 nucleus in 3 μm channel treated with vehicle control.  
Movie S8. 3D rendering of L929 nucleus in 3 μm channel treated with nocodazole.  
Movie S9. 3D rendering of MSC nucleus in 50 μm channel treated with vehicle 
control.  
Movie S10. 3D rendering of MSC nucleus in 50 μm channel treated with nocodazole. 
Movie S11. 3D rendering of L929 nucleus in 50 μm channel treated with vehicle 
control (bottom right cell).  
Movie S12. 3D rendering of L929 nucleus in 50 μm channel treated with nocodazole 
(top cell).  






Movie S14. 3D rendering of MSC nucleus in 3 μm channel treated with blebbistatin.  
Movie S15. 3D rendering of L929 nucleus in 3 μm channel treated with vehicle 
control.  
Movie S16. 3D rendering of L929 nucleus in 3 μm channel treated with blebbistatin.  
Movie S17. 3D rendering of MSC nucleus in 50 μm channel treated with vehicle 
control.  
Movie S18. 3D rendering of MSC nucleus in 50 μm channel treated with blebbistatin. 
Movie S19. 3D rendering of L929 nucleus in 50 μm channel treated with vehicle 
control.  
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